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AcOEt ethylacetate 
2-acpy 2-acetylpyridine 
Alk alkyl 
bpy 2,2'-bipyridine 
ɧ-BuLi n-butyllithium 
DFT density functional theory 
dHFT 4'-(9,9-dihexyl-9H-fluoren-2-yl)-2,2':6',2''-
terpyridine 
DIPA diisopropylamine 
DIBAL-H Diisobutylaluminum hydride 
DMAFCCT (E)-7-(2-([2,2':6',2''-terpyridine]-4'-yl)vinyl)-9,9-
dihexyl-N,N-dimethyl-9H-fluoren-2-amine 
DMAFT 7-([2,2':6',2''-terpyridine]-4'-yl)-9,9-dihexyl-N,N-
dimethyl-9H-fluoren-2-amine 
DMF dimethylformamide 
DMP 1,1,1-Triacetoxy-1,1-dihydro-1,2-benziodoxol-
3(1H)-one (Dess-Martin periodinane). 
DMSO dimethylsulfoxide 
EPR electron paramagnetic resonance 
equiv equivalent 
Et ethyl 
Et3N triethylamine 
EtOH ethanol 
FCCT (ȿ)-4'-(2-(9,9-dihexyl-9H-fluoren-2-yl)vinyl)-
2,2':6',2''-terpyridine 
FCC3T 4'-((9,9-dihexyl-9H-fluoren-2-yl)ethynyl)-
2,2':6',2''-terpyridine 
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FT 4'-(9H-fluoren-2-yl)-2,2':6',2''-terpyridine 
HOMO highest occupied molecular orbital 
HPLC high-performance liquid chromatography 
HRMS high-resolution mass-spectrometry 
in vitro  in laboratory conditions 
in vivo in living organism 
IR infrared 
LUMO lowest unoccupied molecular orbital 
Me methyl 
MeOH methanol 
MeO-Phtpy 4'-(4-metoxyphenyl)-2,2':6',2''-terpyridine 
MGD N-methyl-D-glucamine dithiocarbamate 
mp. melting point 
NADP Nicotinamide adenine dinucleotide phosphate 
NLO nonlinear optics, nonlinear optical 
NMR nuclear magnetic resonance 
NONOate 1,1-R1,R2-2-hydroxy-2-nitrosohydrazine 
ɈɊȺ linear absorption (one-photon absorption) 
o-tolyl ortho-tolyl
Ph phenyl 
PhMe toluene 
ppm point per million 
py pyridine 
RNS reactive nitrogen species 
ROS reactive oxygen species 
rt room temperature 
SCE saturated calomel electrode 
SNP sodium nitroprusside 
SOMO singlyoccupied  molecular orbital 
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TD-DFT time-dependent density functional theory 
Tf triflate 
THF tetrahydrofuran 
TLC thin-layer chromatography 
TMS trimethylsilyl 
ɌɊȺ two-photon absorption 
UV ultraviolet 
ǻ heating at the boiling point 
į chemical shift, ppm (NMR-spectroscopy) 
ĳ quantum yield 
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INTRODUCTION 
Last decades, since nitric oxide was proclaimed “Molecule of the Year” by 
the journal “Science”, many research teams has been aiming at in-depth study of 
physiological role of NO. Nowadays this compound is considered one of the main 
constituents in biological processes. The idea of a controlled nitric oxide release 
has become very attractive, for instance in order to be able to cause a selective 
influence on malignant cells. Indeed, depending on concentration, NO can inhibit 
the tumour growth or lead to the cell apoptosis. Exogenous NO-donors as 
modifiers of NO-levels in biological tissues are one of the most promising ones. S-
nitrosothiols, organic nitrates, sydnonimines are practically important nowadays. 
Especially interesting group of promising potent NO-donors is metal-nitrosyl 
complexes, in particular ruthenium-nitrosyls. The last ones are stable in aqueous 
media as opposed to the majority of alternative metal-nitrosyls. But the most 
important advantage of ruthenium-nitrosyl complexes is their ability to release NO 
under irradiation exclusively, that makes them perfect candidates as prodrugs for 
photodynamic therapy. 
One of the targets for modern photodynamic therapy is the development of 
photosensitization methods of prodrugs in optical therapeutic window (700-1300 
nm). Beyond this range of wavelengths the activation is ineffective due to a high 
extinction of electromagnetic waves intensity because of their absorption by 
biological tissues. Most of known photoactive NO-donors nowadays are able to 
release NO while being activated with waves of 350-600 nm waveband. Therefore 
the question of photosensitization of such compounds in vivo is a keystone for their 
future implementation in medical practice. 
One of approaches, opening up the possibilities for photoinitiation of Ru-N 
bond dissociation in ruthenium-nitrosyl complexes in optical therapeutic window 
is two-photon absorption (TPA). This modern method has not been widely 
implemented in medical practice, however it is being thoroughly studied by 
scientists of different fields of science and technology – from medicine and 
microconstruction to 3D-data storage. High spatial selectivity of electromagnetic 
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waves influence on organism and reduced destructive effect (when employing IR-
range waves) makes the local NO-release without damage dealt to adjacent tissues 
possible. 
Revealing of main structural elements of ruthenium-nitrosyl coordination 
compounds capable of participating in two-photon absorption process and 
understanding the mechanism of NO-release process, is thereby an actual task in 
designing of promising NO-donors prodrugs. 
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CHAPTER 1. LITRERATURE OVERVIEW 
1.1 Nitric oxide: molecular structure and general chemical characteristic. 
Nitric oxide (or nitrogen monoxide) is a colorless gas, which is monomeric at 
standard conditions; its molecules consist of an oxygen atom and a nitrogen atom 
connected by a multiple bond. Odd number of electrons in NO molecule makes the 
substance paramagnetic; in addition, it is the smallest thermally stable molecule-
radical known. In terms of the molecular orbital method, it is logical to compare 
the structure of the compound with the structure of N2 molecule or with one 
isoelectronic to it – CO (figure 1.1). 
Figure 1.1. A diagram of atomic and molecular orbitals of nitrogen and 
nitric oxide and schematic configuration of molecular orbitals 
Appearance of an additional electron (in transition from nitrogen to nitric 
oxide), which is located on the antibonding ʌg NO orbital causes decreasing of the 
bond order from 3 (for N2 molecule) to 2.5 (for NO molecule). This has a 
corresponding effect on the nitrogen monoxide physical and chemical properties. 
In particular, bond length in NO molecule is 0.115 nm. It is an intermediate value 
between the length of the typical double bond N-O (0.120 nm) and the interatomic 
distance in ionized NO+ particle (0.106 nm), which bond order is 3.1 And vice 
versa reducing the compound to NO- increases the bond length to 0.126, which is 
caused by appearance of one more electron on the molecular antibonding orbital 
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Distribution of electron density in the molecule is shown on figure 1.2. 
Being the simplest molecule with an odd number of electrons, nitrogen 
monoxide is a rather well studied compound from the point of view of its chemical 
properties. A great number of reactions between NO and radicals, atoms and other 
paramagnetic species became classical unique examples of reactions for kinetics 
study. 
There are several number of commonly used laboratory methods of NO 
generation. Though the obtained nitric oxide as a rule contains impurities of other 
nitrogen oxides or volatile compounds. The most used method is reduction of 
dilute (~30%) nitric acid by copper: 
8HNO3 + 3Cu = 3Cu(NO3)2 + 4H2O + 2NO 
NO synthesized in this way is to be later purified in order to remove the 
impurity of nitrogen(IV) oxide by running the mixture of generated gases through 
aqueous solution of alkali. Another method of NO obtaining is reduction of 
alkaline metal nitrites: 
2NaNO2 + 2NaI + 2H2SO4 = I2 + 4NaHSO4 + 2NO 
2NaNO2 + 2FeSO4 + 3H2SO4 = Fe2(SO4)3 + 2NaHSO4 + 2H2O + 2NO 
An up-to-date but considerably more expensive method of obtaining NO in 
laboratory conditions is use of so-called NONOate-compounds. The method is 
used when controllable NO synthesis is essential, for example, in biological studies 
(see section 1.3.2)
In contrast to nitrogen, nitric oxide is an endothermic compound, therefore it 
is less stable. Even at a temperature slightly higher than the room temperature 
(30-50°C), but only under high pressure, nitrogen monoxide disproportionates with 
generating nitrogen(I) oxide and nitrogen(IV) oxide. Decomposition to the 
elementary substances is happening at significantly higher temperature – close to 
7000 C in the presence of a catalyst. 
Strong oxidizers can convert nitric oxide into compounds where nitrogen has 
higher oxidation states.5 The most typical nitric oxide reaction is interaction with 
oxygen, at which the compound is oxidized to nitrogen(IV) oxide: 
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2NO + O2 = 2NO2 
Whereas interaction of NO with atomic oxygen, at which chemiluminescence 
is observed, was used for qualitative and quantitative determination of atomic 
oxygen:6
NO + O = NO2 + hȞ
Naturally, the presence of water in nitrogen monoxide and oxygen interaction 
changes the reaction path since NO2 itself can react with water. That’s why as a 
result of NO-oxidation by oxygen in humid condition nitrite-ions are generated. 
The reaction is commonly described by the following equation:7
4NO + O2 + 2H2O = 4H+ + 4NO2-
NO+ ion predicted by the theory indeed exists. Compound containing 
nitrosonium cation could be obtained in the reaction: 
N2O3 + 3H2SO4 = 2NO+ + 3HSO4- + H3O+
Solidity at standard conditions of nitrosylsulfate acid NOHSO4 and similar 
compounds NO+ClO4-, NO+BF4 as well as their electrolysis mechanism 
corroborate an ionic nature of the compounds.5
1.2 Nitric oxide biological role 
Number of published works devoted to nitric oxide biological role is rapidly 
growing during last four decades. As of February 2018, number of publications 
found in SciFinder search system were 196712. 0.4% of them were published 
before 1980, 22.4% - during 1981-1999, and the major part – 77,2% appeared as 
late as in the 21 century. 
It was the discover of the role of this small molecule as a signaling molecule 
in cardiovascular and nervous systems that aroused so rapidly an increasing 
interest to it. In 1992 the journal Science called nitric oxide “Molecule of the year” 
and in 6 years, December 10, 1998 the Nobel prize for physiology and medicine 
was given to three researchers from the USA – Robert F. Furchgott, Louis G. 
Ignarro and Ferid Murad – for  investigation of nitric oxide biological functions.
Physiological effects caused by nitrogen monoxide influence onto biological 
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environment are often contradictory.8 For instance, nitrogen monoxide is the best 
example of a substance that demonstrates at the same time both cytotoxic and 
cytoprotective action. 
A large number of chemical reactions characteristic for NO, in industrial or 
laboratory routine proceed quite slowly and thus requires using high temperature 
and pressure being at the same time thermodynamically disadvantageous9. From 
the other side, nitric oxide chemical transformations in biological environments 
take time from 0.002 to 2 s.10 These processes in NO biochemistry are usually 
divided into two types: direct and indirect. Direct effects caused by NO proceed 
quite fast and during them nitric oxide interacts directly with a biological target, 
whereas indirect ones are the results of NO interaction with oxygen or superoxide, 
that generates reactive nitrogen species (RNS), further interacting with biological 
objects. One of the advantages of such a differentiation is that the direct effects are 
caused generally by low NO concentrations ( 200 nM), while the indirect ones 
are the results of influence of significantly higher concentrations (! 400 nM).9
Nitric oxide principal biological functions are generalized on diagram 
1.1.9,10,11 
Scheme 1.1. Nitric oxide biological functions. 
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The main difference between direct and indirect processes is rate of its 
proceeding. High-speed reactions of immediate interaction between NO and 
biomolecules – mainly reactions with radicals or metalloproteins – are the direct 
processes. 
A large number of NO main regulatory functions realize through its easy and 
rapid interaction with metalloprotein heme-prosthetic groups, such as guanylate 
cyclase (sGC), cytochrome P450, NO- synthase, hemoglobin etc. In such kind of 
processes the rate-determining step is diffusion of reacting molecules. Process of 
interaction between nitric oxide and Fe-S cluster protein aconitase proceeds 
considerably slower.12
Biomolecules having in their structure other metal ions, apart from Fe, are 
also susceptible to the influence of NO. This type of interaction could be 
represented by the vitamin B12 derivative, cobalamin, the nitrosylation of which 
leads to its reduced activity in the role of a cofactor of methionine synthase. 
Reactions between nitric oxide and radical particles can have both positive 
and negative effects on cells. Lipidic and carboradicals are generated as a result of 
both oxidative stress and normal metabolism in a living organism. Nitrogen 
monoxide is able to attenuate effects caused by such reactive particles. For 
example, inactivation of tyrosyl radical generated in the process of ribonucleotide-
reductase regular catalytic cycle by nitric oxide leads to inhibition of the 
mentioned enzyme.13 DNA synthesis suppression is an example of harmful effects 
of NO interaction with radicals in biological environment.12
But it is often that the reactions of NO are of the nature of “protective” 
functions for cells. NO is able to interact with radicals generated in the process of 
lipidic peroxidation – an important component of inflammatory processes and cell 
death – and so terminate the chains of reactive oxygen species (ROS) radical 
reactions, thus protecting the lipidic membranes:14
LOO· + NO· = LOONO 
L· + NO· = LNO 
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Macrophages protective functions in a living organism are also related to their 
ability to generate nitric oxide. Concentration of the latter in this case can 
considerably change depending on the “needs”. Due to the ability to vary NO 
concentration macrophages are able to participate in a wide range of processes 
aimed at organism protection – phagocytosis, cancer development suppression, 
tissues restoration, wounds healing etc. 
As for NO indirect effects, they also can be divided into two categories – 
nitrosation and oxidation. The subjects of nitrosation are, first of all, thiol and 
aminogroups while oxidation is a process that refers to quite a number of 
substrates – from relatively easily oxidizable catecholamines and metal centers to 
compounds with a high oxidation-reduction potential, such as lipids, proteins 
DNA. As in the case of the direct effects, oxidation and nitrosation are regular cell 
metabolism processes but at the same time they can influence negatively 
generating substances toxic for cells. 
Main RNS responsible for nitrogen(II) oxide indirect effects are nitrogen(III) 
oxide, N2O3, peroxynitrite, ONOO-, nitroxyl, HNO, and nitrogen(IV) oxide, NO2. 
Each of the particles depending on the redox potential, electrophilicity etc. 
interacts with certain biological substrates. Thus, the main nitrosating agent for 
amines and thiols is N2O3, which transforms them into nitrosamines and S-
nitrosothiols, respectively.12 In turn, NO2 participates in oxidation processes. The 
molecule does not possess potential high enough for DNA oxidation15 but it can 
trigger lipidic peroxidation processes.16 Among the mentioned particles, 
peroxynitrite anion shows the strongest oxidizing ability. Under its influence, 
thiols, lipids, DNA can be oxidized, this particle also participates in the processes 
of tyrosine, guanosine and methionine nitration.16
Nitric oxide has a broad spectrum of effects on cancer growth – from 
triggering cell mutation to destructing malignant tumours. There are several 
reviews devoted to nitric oxide effects on the course of cancer.17,18 Numerous 
studies on the issue show that commonly nitrogen monoxide low concentrations in 
cancerous tumour, which is a result of permanent hypoxia, create so-called “safe 
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zone” and are a positive factor for cancer extension, promoting faster angiogenesis 
and metastasis (Figure 1.3).19,20 If, however, NO concentration changes in the 
direction of decreasing or increasing this leads to transferring to the “inhibition 
zone” or to the “kill zone”, respectively. Both concentration ranges are unfavorable 
for cancerous tumors and are potential targets in their treatment. Transferring to 
the very low concentrations range can be achieved by using NO-synthases (NOS) 
enzymes inhibitor compounds in therapy. The opposite approach is using nitric 
oxide donor compounds for NO concentration essential increasing, transferring to 
the “kill zone” and triggering cell death. 
Generalizing the effects that NO can cause in the concentration range from 
1nM to 1ȝM, we can say that NO low concentrations promote cells protection, 
their proliferation while high concentrations are responsible for blocking cell-
cycle, apoptosis, aging.9 Besides, NO plays a central role in the cardiovascular 
system as an endothelium-dependent relaxing factor,21 in the central nervous 
system it is involved in the nerve impulses transmission and memory processes, 
and also performs a regulatory function in the cerebral circulation. 
Having chosen nitric oxide as such a multifunctional biological regulator, 
nature provided living organisms with mechanisms of its biosynthesis. 
Figure 1.3. Cancerous tumour reaction to nitric oxide at its 
different concentrations
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1.3 NO generation from organic compounds 
1.3.1 Natural pathway of nitric oxide production 
Nitric oxide is one of the most universal molecular regulators of cellular 
metabolism. The main way of its synthesis in living organism is oxidation of the 
amino acid L-arginine in the presence of the NOS enzymes. The conversion occurs 
in two steps (Scheme 1.2).22
Scheme 1.2. Enzymatic transformation of L-arginine into L-citrulline with 
the formation of NO molecule 
Initially, the 2-electron oxidation of L-arginine and its hydroxylation in the 
presence of oxygen and NADPH23 leads to the formation of NȦ-hydroxy-L-
arginine (NOHLA). Tetrahydrobiopterin accelerates the course of this step acting 
as a cofactor.24 Further NOHLA oxidation (the next transformation step) leads to 
the formation of L-citrulline and one molecule of nitric oxide. The general scheme 
of the conversion of L-arginine to L-citrulline can be described by the following 
equation: 
2L-arginine + 3NADPH + 3H+ + 4O2 = 2L-citrulline + 2NO + 4H2O + 3NADP+
Moreover there are four other cofactors, the absence of which either slows 
the reaction or makes it impossible to pass.25 The NOS enzyme group includes 
three main enzymes - endothelial NO synthase (eNOS), neuronal NO synthase 
(nNOS), and inducible NO synthase (iNOS); the fourth type - mitochondrial 
synthase (mtNOS) is identical with the Į-form of nNOS.25 The first two enzymes 
are calcium-dependent and are activated in the presence of high concentration of 
calcium ions by calcium-calmodulin complex; typically, their activity period does 
not exceed few minutes after stimulation. Activated eNOS and nNOS are involved 
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in the conduction of nerve impulses, peristalsis regulation and instantaneous 
regulation of blood pressure.26  Although all three forms of NOS require a calcium-
calmodulin complex, iNOS exhibits a much higher affinity for it, which leds to 
longer activity period (up to days) and lower calcium-calmodulin complex 
concentration required.25 iNOS activation is the response to the internal stimulation 
with a variety of microorganisms metabolic products, some cancer cells, cytokines 
etc. Activated enzymes produce millimolar amounts of NO (interacting with ROS 
– peroxynitrite), showing an immune-protective function by oxidizing proteins and 
DNA.26 However, in the lack of oxygen (i.e. chronic inflammatory processes), the 
level of RNS can be significantly lower, and the nitric oxide provokes mutagenesis 
and angiogenesis instead, thus connecting directly inflammation and the initiation 
of cancer.25
Considering such a large number of biological processes in which nitric oxide 
is involved and which in its absence or its low concentration slow down, stop or 
activate undesirable chemical reactions causing a number of diseases, it seems 
attractive to obtain a mechanism for regulating the concentration of NO in living 
organism. 
1.3.2 Classical donors of nitric oxide based on organic compounds. 
Nitric oxide donors or NO-donors is a group of compounds or functional 
fragments of supramolecular systems that can release nitrogen monoxide when 
exogenously applied.27 Lack of NO in a particular place of a living organism can 
trigger a number of pathological processes that will manifest themselves as 
symptoms of various diseases. Although free nitric oxide is used successfully for 
medical purposes (locally, for the treatment of dermatitis,28 or in the form of 
inhalations in pulmonary hypertension in newborns29), the use of NO-donors can 
significantly increase the range of possible exogenous effects on the body.28
Chemical stability and the capability of local NO elimination of NO-donors allow 
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the controlled delivery of nitrogen monoxide to various parts of the living 
organism.  
NO-donors can be divided into several groups depending on the method of 
NO-release activation. According to the classification proposed by Philish and 
Stamler,30  three major groups can be distinguished: 1) NO-donors that liberate NO 
spontaneously; 2) NO-donor that release NO after chemical interaction with acids, 
alkalis, metals, thiols; 3) NO-donors that release nitric oxide after their enzymatic 
oxidation (Scheme 1.3).  
Scheme 1.3. Classification of NO-donor by the initializing of the NO release. 
In this work we propose to sort out one more type of donors – compounds 
that are able to release NO under their photochemical activation, since many 
studies and research papers published recently are devoted to photoactive 
compounds that are amenable to NO release.  
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Organic nitrates are the most widespread example of NO-donors. Since they 
were the first approved drugs used for NO-level control they are worthy of special 
attention. Organic nitrates are esters of alcohols (polyols in general) and nitric acid. 
Glyceryl trinitrate (GTN) is the most thoroughly studied compound of this 
class (Figure 1.4). Its use is not limited to vasodilating effects on the vessels. 
Among the pathologies for the treatment of which the use of GTN is approved, one 
can mention cardiac dysfunctions31, hypotension and headaches,32 angina and 
cancer.33 Other drugs used are isosorbide dinitrate (ISDN), pentaerythril 
tetranitrate (PETN), isosorbide-5-mononitrate (ISMN) (Figure 1.4).34 The 
mechanisms by which the nitric oxide is liberated from organic nitrates are still 
contradictory. However, the proposed schemes include the stage of interaction with 
one of the enzymes: glutathione-S-transferase, cytochrome P450, xanthine 
oxidoreductase, aldehyde dehydrogenase.35
    
Glycerinetrinitrate 
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tetranitrate 
(PETN) 
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Figure 1.4. The main representatives of the class of organic nitrates 
The use of organic nitrates can lead to a number of side effects,34 since these 
drugs show their effects in the body in whole, without specific localization. 
However, the most significant disadvantage of using organic nitrates is the 
tendency of the body to rapidly developed tolerance to these compounds.36
This feature of organic nitrates can be very useful in the treatment of cancer. 
The growth of cardiovascular tolerance to GTN allows its use in complex cancer 
therapy, along with cytostatic drugs (i.e. doxorubicin) without systematic side 
effects from continuous high NO levels. Research on the use of such a combination 
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in the treatment of mice prostate cancer shows a more effective inhibition of tumor 
growth than in the treatment of exclusively doxorubicin.37
Other commonly used compounds in cancer treatment studies are S-
nitrozotioles, diazeniumdiolates (NONOate) and sydnonimines (Figure 1.5). S-
nitrosothiols are compounds with a nitroso group which is directly linked to the 
sulfur atom. Most compounds of this class are unstable, but several of them are 
sufficiently stable and have already proven themselves as active drugs (i.e. S-
nitroso-N-acetylpenicillamine (SNAP)) (Figure 1.5).32
   
S-nitroso-N-
acetylpenycillamine
(SNAP) 
3-morpholine-
sydnonimine 
hydrochloride 
(SIN-1) 
Sodium (Z)-1-(N,N-
diethylamino)diazen-
1-ium-1,2-diolate 
Figure 1.5. Representatives of other classes of NO-donors used in 
oncology practice 
The main advantage of S-nitrosothiols is better biocompatibility compared to 
other NO-donors, in particular NONOate. This conclusion comes from the fact that 
S-nitrosothiols are naturally present in biological systems, as for instance S-
nitroso-L-cysteine (CysNO) or S-nitroso-L-glutathione (GSNO).38 The mechanism 
of NO-release from S-nitrosothiols is strongly dependent on the external conditions 
(Scheme 1.4). 
Scheme 1.4. Mechanisms for the release of nitric oxide from S-
nitrosothiols 
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Despite the large number of publications devoted to the study of these 
compounds in vivo, they have not yet found direct application in medicine. Their 
ability to release NO in different environments, the ability to release it in the form 
of a radical or nitrosonium-cation, predictable pathway of metabolic degradation, 
and an almost complete absence of tolerance development with prolonged use – all 
these benefits make S-nitrosothioles compounds of interest as nitric oxide donors 
in medical practice.39
Another class of NO-donors is diazeniumdiolates (or NONOates). These 
compounds are known since the 1960s, when its first DEA/NO agent was 
synthesized for the first time.40 However, they became the object of numerous 
studies only in the 90s of the last century,39 after the biological role of nitric oxide 
had been discovered. In their structure diazoniumdiolates contain [N(O-)N=O] 
group. Considering the atom the group is bound to, NONOate are divided into S-
linked, O-linked, N-linked, or C-linked. However, only Nitrogen-bound 
NONOates play significant role in biology.38,41 
Under physiological conditions (pH 7.4 and temperatures of 37 °C), 
compounds of this class undergo acid hydrolysis producing 2 equivalents of nitric 
oxide per diazeniumdiolate group:32,41 
Spontaneous NO release, no need for additional activators of this process 
(i.e. thiols, metal complexes or enzymes), first order reaction rate moves 
diazeniumdiolates in one row with S-nitrosothiols and sydnonimines of promising 
NO-donors. 
Easy predictable NO-liberation rate and its final concentration are important 
qualities of NONOate, due to which compounds of this class are widely used in 
studies aimed at desing of anticancer drugs.27 On the other hand, the main 
advantage easily transforms into the serious drawback when using this compound 
as drug – NO-donors based on NONOate can release NO before reaching the main 
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target. The use of targeted drug delivery can help to overcome this disadvantage, 
although it significantly complicates the drug preparation process. 
One of approaches of targeted delivery of this class of compounds is 
demonstrated in the paper of Wang and coworkers.42 Using one of NONOates – 
PYRRO/NO compound as NO-donor, the researchers inactivated the compound by 
binding it with a certain amino acid sequence through the oxygen atom of the 
diolate group. The use of amino acid sequence of one segment of the substrates of 
prostate-specific antigen (PSA)  allowed making modified PYRRO/NO compound 
sensitive to the presence of this enzyme. PSA is an enzyme produced by both 
healthy and cancerous cells of the prostate epithelium in significant amounts.42
Increased concentration of this enzyme is observed in metastases of prostate 
cancer. 
The resulting PYRRO / NO based drug must be inactive before hydrolysis 
that occurs in the presence of PSA or Į-chymotrypsin. As a result, spontaneous 
release of NO in vitro from the resulting compound was observed only in the 
presence of one of these enzymes in solution (Scheme 1.5).42
Scheme 1.5. Nitric oxide release from peptide-bound PYRRO/NO by enzyme 
activity PSA 
Another class of NO-donors already used as medicines are sydnonimines. 
Sydnonimines are mesoionic heterocycles, which include the 1,2,3-oxadiazole ring 
and contain an imino group in the 5 position. For the first time, independently of 
each other, compounds of this class were synthesized in 1957 by Brooke43 and 
Ohta.44 Under normal conditions and in the absence of light sydnonimines are 
stable solids. 
Sydnonimines release nitric oxide in an alkaline medium and the passage of 
this process is greatly facilitated by the presence of oxygen or under excitation 
with UV irradiation. The most studied example of this class is 
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3-morpholinosydnonimine (SIN-1, linsidomine) (Figure 1.5). The medicinal 
product under the brand name "Molsidomine" is based on this compound. The 
release of NO from this product is shown in Scheme 1.6.45 The first step of 
decomposition is the enzymatic deacetylation of molsidomine in the liver with the 
formation of linsidomine. At physiological or alkaline pH linsidomine undergoes a 
non-enzymatic cycle opening. The formed product is completely stable at pH 7.4 
in absence of oxidants, but even small amounts of oxygen lead to the formation of 
radical cation which decays producing nitric oxide and N-morpholino-
aminoacetonitrile. 
Scheme 1.6. NO-release from medicinal product "Molsidomine" 
Typically sydnonimines donate NO in peroxynitrite anion form.44 As shown 
on the Scheme 1.6 during the molsidomine transformation the stoichiometric 
amount of the superoxide radical is formed, and since the interaction of nitrogen 
monoxide with the superoxide radical is extremely rapid and the diffusion is the 
only limiting process, the formation of toxic peroxynitrite is inevitable. This 
feature of sydnonimines, of course, reduces the spectrum of their possible use in 
medicinal purposes. The advantage of these compounds is that addiction to them 
does not appear, and a tolerance to sydnonimines does not arise even with 
prolonged use. 
1.3.3 Nitrobenzenes as examples of photoactive NO-donors 
The ultimate goal of most studies of nitric oxide donors is the compound that is 
capable of controlled and predictable local NO-release. This substance would be 
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able to give a clear answer to the question of how different concentrations of NO 
affect different biological objects and to allow finding the optimal rate and the 
required concentration of nitrogen monoxide for a particular physiological effect.46  
The use of a controlled NO-donor will reduce the dose required for treatment and 
reduce the side effects associated with the release of nitric oxide beyond the 
immediate biological target.47 It is clear that controlled release of NO is also 
extremely important for the effective treatment of cancer with the use of NO-
donors, since it significantly reduces the toxic effect of RNS on healthy cells of the 
body.48 Another potential use of materials capable of controlled NO-release is the 
creation of various devices, such as artificial blood vessels or tubes for 
hemodialysis.49 One of the main ways of obtaining of such compounds is the 
design of photoactive NO-donors. 
Among the substances that are capable of photoinduced release of NO, the 
most promising and studied are derivatives of nitrobenzene and metal nitrosyl 
complexes. However, a large number of works is also devoted to the study of 
supramolecular ensembles (i.e. liposomes, micelles), nanoparticles and polymer 
materials that are capable of releasing or activating the NO-donors, which in turn 
can produce nitric oxide locally.27,41,50,51,52 
 The investigation of aromatic nitrocompounds as NO-donors was started by 
Sortino and Miyata groups. In general, the functional group that directly acts as a 
donor of NO in these compounds is an 
aromatic ring with a nitrogroup and bulky 
substituents in the ortho-position (i.e. CH3, 
CF3, Ar etc.) (Figure 1.6a).27 Due to the 
presence of closely located substituents, the 
nitrogroup is forced to accept the position 
almost perpendicular to the plane of the 
aromatic ring, loosing the conjugation with 
the benzene ring.53 In this arrangement, the p-orbital of the oxygen atom 
considerably overlaps with the orbitals of the aromatic ring, both in the main and 
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Figure 1.6. Nitrobenzene-based 
NO-donors 
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excited states. In this view the process NO-release from o-substituted derivatives 
of nitrobenzene occurs, probably, through the stage of isomerization of the nitro 
into the nitrite derivative and the subsequent decomposition of the latter into NO 
and the phenoxy radical due to O-N bond breakage (Scheme 1.7).54 According to 
the authors, the key factor for the possibility of isomerization is the orthogonal 
arrangement of the nitrogroup and the benzene ring.55,56 
Scheme 1.7. The mechanism of nitric oxide release from an anticancer 
drug flutamide 
Nitrobenzene-based NO-donors are thermally stable under physiological 
conditions, and the release of nitric oxide from these compounds can be controlled 
by electromagnetic irradiation. Also, the advantage of nitrobenzenes as photoactive 
NO donors is the absence of metal ions, the presence of which could itself provide 
cytotoxic properties. However, the significant disadvantage of this class of NO-
donors is the need to use electromagnetic radiation of UV-region, which is 
significantly absorbed by biological tissues and fluids and is hazardous to healthy 
cells. 
An example of work aimed at overcoming this lack of nitrobenzenes is the 
work of Naoki Miyata group.55,57 Modification of the starting 2,6-
dimethylnitrobenzene (which is responsible for the NO release) by the introduction 
of a compact fluorophore (such as 7-hydroxycoumarin or 7-aminocoumarin) made 
it possible to shift the band of absorption of compounds from UV to the visible 
domain of electromagnetic waves (Figure 1.7a and 1.7b).57 An interesting fact was 
that in the case of a DEAMC-DNB in which there is a complete conjugation of the 
aminogroup with the nitrogroup through the ʌ-chain, release of nitric oxide is not 
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observed under the irradiation of compound at 430-460 nm. Owing to the efficient 
intramolecular charge transfer, the bond order of C-N(NO2) bond increases to 
double, and nitro-nitrite isomerization becomes impossible. However, in the case 
of a compound where the ʌ-system cross-conjugation is present (Bhc-DNB), the 
irradiation results in NO-release. Under excititation of the compound no significant  
a
O
Br
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NO2
ON O
NO2
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b
Figure 1.7. New compounds based on 2,6-dimethylnitrobenzene 
(a) and their electronic spectra (b). 
 charge transfer occurs in the molecule (as could be concluded from the absence of 
an intense band in the UV-visible spectrum) and the band 350-430 nm appears due 
to the absorption of coumarin fragment, which acts as an antenna. Thus the 
researchers were able to shift the excitation wavelengths required for nitrobenzene 
activation from UV to visible domain.57
30 
 Another elegant way to 
avoid the UV irradiation to initiate 
NO-release from nitrobenzenes is 
the use of two-photon absorption 
method. This approach allows 
shifting of the excitation 
wavelength up to the infrared (IR) 
region, which does not show a 
deleterious effect on the body and 
is more permeable for biological 
tissues. 
Binding of 2,6-dimethylnitrobenzene through a styryl and weakly 
conjugated amide fragment to fluorescein (which is famous for its ability to 
produce two-photon excited fluorescence58) researchers obtained a Flu-DNB 
compound (Figure 1.8) that released nitric oxide when irradiated with an IR pulse 
laser with a wavelength 720-800 nm.  
Figure 1.8. Flu-DNB is a compound capable 
of releasing NO by two-photon photo-
excitation in wavelengths of 720-800 nm. 
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1.4 NO-donors based on coordination compounds 
1.4.1 General characteristics of nitrosyl complexes. 
Today metal-nitrosyl complexes are considered as promising objects for targeted 
delivery of nitric oxide.59 They are especially interesting as photoactive NO-donors. 
Before consideration of the particular examples of the NO-donor compounds one 
should first concentrate on several aspects of the coordination behavior of nitric 
oxide. 
The most typical and common way of coordination of nitric oxide to metal is a 
monodentatable type of binding, in which the nitrogen is a donor atom. Upon such 
coordination, two types of geometry are possible depending on the angle M-N-O – 
straight and angular. The differences between them can be explained by the valence 
bond and orbital hybridization theories. 
Considering that straight or almost straight geometry of the complex is a result 
of the sp-hybridization of nitrogen orbitals, it is assumed that the nitric oxide in such 
compounds is in the form of NO+; while the angular geometry requires sp2-
hybridization, and in this case NO is in the form of NO-. Resonance forms, whose 
combinations could describe the linear and angular geometry, are shown in the 
Scheme 1.8.2 Those resonance structures where radicals are present can be considered 
as forms that possess a lone pair of electrons, and the corresponding complexes 
accept an intermediate geometry between the linear and angular, which is 
characteristic of the nitroxyl complexes. 
The formation of nitrosonium-containing compounds requires the transfer of 
one electron from nitric oxide to a metal center, followed by ı-binding and ʌ-
backbonding interaction dM ĺ ʌ* (Figure 1.9), and the formation of complexes that 
could be described as those containing nitroxyl anion is preceded by the transition of 
the electron from metal to the nitric oxide (Scheme 1.8).60
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Scheme 1.8. Resonance forms of linear and angular geometry of metal-nitrosyl 
complexes 
Nitrosonium cation NO+
Nitric oxide NO· Nitroxyl anion NO-
Figure 1.9. Simplified schemes of molecular orbitals for straight and bent geometries 
of mononitrosyl complexes 
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Thus, in the linear coordination form the oxide acts formally as a donor of 3 
electrons, whereas in the angular form it is a donor of 1 electron. Both the method of 
valence bonds and the method of molecular orbitals showed that the increase in the 
electron density at the M-N bond due to the backdonation leads to the increase of this 
bond’s order though by reducing the energy of N-O bond. 
Due to the discovery of the biological role of nitrogen (II) oxide, the interest in 
the coordination compounds of this molecule with metals has exponentially increased 
since the 1980s. Table 1.1 presents a general information about all nitrosyl complexes 
found in the Cambridge Structural Database (CSD) in 2014.60
Angle (°) Number of 
structures 
Geometry Example 
180-160 2519 Linear [Mn(NO)(CO)4]61
160-140 121 Intermediate [Ir(NO)2(PPh3)2]62
140-100 115 Angular [Co(NO)(S2CN(CH3)2)2] 
Table 1.1 Generalization of metal-nitrosyl complexes from the CSD database in 2014 
There are complexes (absent in the table above) that contain metal atoms bound both 
to oxygen and nitrogen atom of the NO group. Total number of such complexes is 
small; usually they are unstable and could form as a result of photoexcitation of 
nitrosyl complexes as transitional states. The particular example of such compounds 
is [Ni(NO)(Ș5-Cp*)], where Cp - pentamethylcyclopentadienyl anion. The Ni-N 
distance in it is only 0.4 Å shorter than the Ni-O distance, and the Ni-N-O angle is 
93°.63
Apparently, the vast majority of compounds have a linear M-N-O fragment. 
Complexes in which this angle is much smaller are basically the complexes of the 
right half of d-metals. An explanation for this lies in the presence of bigger number of 
electrons at the d-sublevel that reduces the ability of metals to accept three electrons 
from nitric oxide. But only in this case the linear geometry of the complex is 
possible.1
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Among the compounds found in CSD, 
there are also those containing from 2 to 4 NO-
fragments that can assume either the same or 
different geometry.64 For example, in the 
compound [RuCl(NO)2(PPh3)2]+ (Figure 1.10)65, 
both atoms of one of the nitrosyl ligands and the 
metal atom lie on one straight line, while the 
other nitrosyl ligand is bound with an angle 
substantially less than 180°.
As shown in Figure 1.10, the lengths of 
the Ru-N and N-O bonds are somewhat larger 
in bent conformation, indicating a weakening of these bonds compared to a linear Ru-
NO fragment. 
Nitric oxide in linear conformation in complexes is a very strong ʌ-acceptor. 
The use of photoelectron spectral methods allowed to assess the ability of NO and 
other ligands to withdraw electron density from metal atoms through the ʌ-
backdonating interaction.66 Among other ligands, nitrosyl cation occupies leading 
positions. In particular, its ʌ-withdrawing ability is the highest in the following series: 
NO > CO > Ș2 - MeCŁCMe > H2C=CH2 > SO2 > N2 > PMe3 > SiCl3 > NH3 > 
CN > H > Cl > SiMe3 > CŁCH 66
Due to the significant shift of the electron density, the M-N distance 
significantly decreases with increase of dM ĺ ʌ* dative interaction. For example, in 
complexes that contain both linearly coordinated nitric oxide and ammonia as 
ligands, the M-NNO bond length is less than the bond length of M-NNH3 by 0.35-
0.4 Å. The values of the M-N bond lengths in complexes indicate that these bonds are 
covalent for the most part. In view of this, the description of complexes as ionic 
compounds of nitrosonium-cation or nitroxyl anion becomes less relevant. 
Another approach of describing complexes with non-innocent (redox-active) 
ligands (one of which is nitric oxide) is the Enemark-Feltman notation. Its advantage 
is the omitting of the concept of oxidation states of the central atom and ligands. 
Figure 1.10. Structure of cation
[RuCl(NO)2(PPh3)2]+ (the phenyl 
fragments are omitted)
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When utilizing the Enemark-Feltman formalism for complexes with nitric oxide, the 
latter are designated as {M(NO)x}n, where x is the number of NO ligands and n is the 
total number of electrons located on the d-orbitals of the metal atom and ʌ* – orbitals 
of nitric oxide. It is assumed that the metal atom is in its formal oxidation state, and 
nitric oxide is neutral.64 Examples of the use of the Enemark-Feltman notation for 
coordination compounds nitric oxide are shown below: 
[Co(NH3)5NO]2+ CoII d7 {Co(NO)}8
[Fe(SR)2(NO)2]- FeI  d7 {Fe(NO)2}9
[RuCl2(terpy)(NO)]+ RuIII d5 {Ru(NO)}6
[Mn(CN)5NO]3- MnII d5 {Mn(NO)}6
(terpy – terpyridine) 
Although the description of NO-complexes in this way eliminates ambiguity in 
determining the oxidation state of central atom and ligands, in some cases assigning a 
charge to them helps in understanding of electronic and magnetic properties of 
compounds. 
To complete a picture of the coordination capabilities of NO, its ability to act as 
a bridging ligand should be considered as well. Similarly to the coordination behavior 
of carbon monoxide, nitric oxide is capable of binding two, three, and in some cases 
four metal atoms, stabilizing metal cluster complexes (Figure 1.11). An example of 
such a cluster is homobimetallic nitrosyl copper complex [(Cu2(XYL-O-)(ȝ-
NO)](PF6)2, where XYL-O is 2,6-bis(bis(2-pirydyletyl)-aminomethyl)phenolate) 
(Figure 1.11a). This compound is interesting because of the fact that ineracting with 
a b c 
Complex cation67
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Figure 1.11. Some bridging-coordination types of nitric oxide 
N
pyO
Cu
py
N
py
Cu
py N
O
2+
Ru Ru
Ru
N
O Pt
N
(CO)3
Re
(OC)4Re
Re
(CO)3
O
Re
(CO3)
Re(CO)4
(CO3)
Re
36 
nitrite anion and transforming into [(Cu2(XYL-O-)(ȝ-O)]+ it emulates the nitrite 
reductase activity (an enzyme consisting of diatomic copper cluster). Indeed, it is 
known that the main mechanism of this transformation includes the copper-nitrosyl 
complex as an intermediate stage.70
1.4.2 Study of metal-nitrosyl complexes by means of IR spectroscopy 
Modern physicochemical methods allow an accurate characterization of metal-
nitrosyl complexes; in particular, it is possible to determine the binding parameters 
and electronic structure of the M-N-O fragment without X-ray diffraction analysis. 
However, the interpretation of the obtained spectral data should be carried out with 
extreme caution and captiousness. In cases of possible ambiguity in the interpretation 
of certain results, methods of quantum chemistry serve as an auxiliary tool and enable 
a deeper understanding of the electronic structure of the complex. 
The most important and frequently used spectral methods in the study of 
nitrosyl complexes are IR, EPR, UV and NMR spectroscopy. Less commonly used 
and more specific methods are the Mössbauer spectroscopy, X-ray (XAS) 
spectroscopy, magnetic circular dichroism, and the study of magnetic susceptibility.71
The use of vibrational spectroscopy for the study of nitrosyl complexes has 
become widely used. In fact, the dependence of the characteristic vibrations of NO on 
the donor-acceptor properties of the environment can serve as a tool for 
understanding the nature of the interaction of metal atom with nitric oxide. As 
indicated in section 1.1, the valence vibrations of free NO radical have a frequency of 
1875 cm-1. After coordination of NO to the metal atom, the value may either increase 
or decrease depending on different parameters such as the nature of other ligands in 
the coordination sphere, the electronic configuration of the central atom, the total 
charge of the complex and its geometry. For metal-nitrosyl complexes there is a 
general tendency for the increase of vibrations frequency with the increase of the 
positive charge of nitrosyl ligand from 1300 cm-1 to 1950 cm-1.2 In addition, for 
compounds with linearly coordinated nitric oxide this value lies within the limits of 
1950-1450 cm-1, and for those in which the M-N-O angle is considerably less than 
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180° vibrations in the region of 1720-1400 cm-1 are more typical; for bridging nitric 
oxide – from 1650 cm-1 to 1300 cm-1 (Figure 1.12). 
Figure 1.12. Frequency ranges of valence vibrations of the N-O bond
depending on the type of nitric oxide coordination 
As shown, these ranges strongly overlap and an unambiguous determination of 
the coordination type on the basis on the value of the frequency is not possible. 
Nevertheless, if the frequency value is higher than 1750 cm-1, the linear geometry can 
be accurately established. 
More correct and reliable correlation can be considered for the complexes 
similar in their electronic structure. For example, if the central atom is represented by 
one of the transition elements of 8th group (Fe, Ru, Os), and the complex have the 
following structure {M(NO)}6-8 (by the Enemark-Felthman notation) (Table 1.2).71  
Complex Frequency 
{M(NO)}8 1270-1500 
{M(NO)}7 1600-1700 
{M(NO)}6 1800-1960 
Table 1.2. Valence vibrations 
of N-O in complexes of metals 
of the 8th group metals. 
As it was mentioned, the frequency of the valence vibrations of nitric oxide in 
complexes depends on many factors (in particular, on the nature of other ligands 
present in the complex). In the work of De La Cruz and Sheppard, authors made an 
attempt to summarize the effects of other ligands on the variation of the frequency of 
the vibration of the N-O bond.72 A brief summation is presented in Table 1.3. 
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Charge and ligands ǻȞ(NO) (cm-1) 
Ⱥ. Ionic charges  
 Unit of positive charge  +100 
 Unit of negative charge -145 
B. Electron-withdrawing ligands  
 Linear cyanide +50 
 Linear halogens +30 
 Bridging halogens <+15 
C. Linear or bridging CO ligand § 0 
D. Electron-donating ligands  
 PF3 +10 
 P(OPh)3 -30 
 PAlk3 (Alk – alkyl) -70 
Ș5-C5H5 -60 
Ș5-C5H4Me -70 
Ș5-C5Me5 -80 
Table 1.3. The influence of ligands of different nature and 
charges on the vibrational frequency of nitric oxide in 
complexes. 
1.4.3. Ruthenium-nitrosyl complexes as NO donors 
The idea of utilizing of metal complexes as NO-donors falls in line with the 
fact that the primary goal for the attack of NO in the human body is iron-containing 
enzymes.32 Among the coordination compounds with nitric oxide donating ability 
sodium nitroprusside (SNP) is the most studied and well known one. More than for 
90 years SNP is used for medical purposes as a hypotensive drug of the class of 
vasodilators. In the solid state Na2[Fe(CN)5NO]·2H2O can be stored for years in the 
absence of light and moisture, but in the solution the compound becomes extremely 
photosensitive and reactive to oxygen.44
The mechanism of NO release from SNP in vivo is not yet fully understood, 
but this process is thought to be initiated by photoexcitation or one-electron 
reduction, and the presence of thiols accelerates it (Scheme 1.9).44
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Scheme 1.9 Possible mechanisms for the release of nitric oxide 
from SNP 
As can be seen from the scheme, the process of reduction and subsequent 
decomposition of SNP is accompanied by the release of cyanide anion (sometimes up 
to 5 equivalents in biological conditions)44; this can lead to significant toxic effects 
on the whole body if significant amount of SNP was used. Also, the spontaneous 
decomposition of the compound increases the local concentration of the cytotoxic 
peroxynitrite anion. But, although SNP has some deleterious effects, its use as a 
vasodilating agent is justified, since the use of even small amounts of the drug is 
often enough to provoke biological effects. However, the use of this compound is 
very limited, and the search for new cooordination compounds that would be devoid 
of these shortcomings is a topical issue. 
Among other metals, ruthenium attracts attention due to its ability to emulate 
the coordination features of iron.2 Unlike the latter, the ruthenium complexes are 
always low-spin ones, both in the oxidation states +3 or +2, which contributes to their 
higher stability compared to iron complexes, as well as the lower lability of the 
ligands (including nitric oxide) in its coordination environment;59,73 this is a 
prerequisite for their biological application. Confirmation of this can be a found in 
comparison of SNP with its Ruthenium analogue [Ru(CN)5NO]2-. Like sodium 
nitroprusside, [Ru(CN)5NO]2- is capable of being excited with electromagnetic 
waves, but unlike SNP, this compound does not release toxic cyanide ions in 
solution.70
Ruthenium-nitrosyl complexes also have several advantages, which are often 
not typical for coordination compounds of other metals - good water solubility, 
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resistance to air oxidation and low cytotoxicity.74 The kinetics of ruthenium 
interaction with bioligands is often compared to the effects caused by platinum on the 
body;75 however, numerous studies indicate a significantly lower toxic effect of 
ruthenium, which may be due to its close to iron coordination behavior and its ability 
to bind albumin molecules and iron-transporting transferrin proteins.76
Depending on the type of ligands in the coordination sphere, ruthenium can 
exhibit several basic oxidation levels that can exist in the biological environment – 
Ru(II), Ru(III) and Ru(IV). In the presence of reducing agents as glutathione or 
ascorbate Ru(III) could easily be reduced to Ru(II). Coordination compounds in 
which ruthenium is in the oxidation state +2 are more susceptible to ligand exchange 
and readily interact with N-donor or S-donor biomolecules.44 By changing the donor-
acceptor properties of the ligands (i.e. their ability to ʌ-binding) the energy and 
strength of the bond Ru-NNO in the ruthenium-nitrosyl complexes can be varied 
affecting the efficiency and rate of nitric oxide release.44
An important advantage of ruthenium (along with Mn and Fe) in comparison 
with other metals is the photoactivity of its nitrosyl complexes. Despite the high 
stability of the coordination compounds of ruthenium with nitrogen monoxide, they 
are capable of releasing NO under irradiation by electromagnetic waves of a certain 
length.48 Due to this feature ruthenium-nitrosyl complexes are intensively studied for 
the purpose of obtaining the NO-donor capable of local, time-controlled, 
photosensitive release of nitric oxide. 
The first studies of NO-release from ruthenium-nitrosyl complexes under the 
influence of light were carried out on {Ru(NO)}6 compounds with monodentate 
ligands – mainly amines and halogens (Figure 1.13).
The investigation of nitric oxide photorelease and the nature of corresponding 
photoproduct was carried out in 1983 by Sinitsyn and his collaborators; in this case 
the compound K2[RuCl5(NO)] was chosen as NO-donor. The signal observed in EPR 
spectroscopy during the experiment of photorelease having g-factor equal to 2.34 
denoted the presence of paramagnetic low-spin d5-Ru(III) particles in the solution.77
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The anion of
K2[RuCl5(NO)] 
RuNOCl3 Cation of trans--
[Ru(NH3)4(X)(NO)]3+
Figure 1.13. Examples of the photoactive {Ru(NO)}6 complexes 
with monodentate ligands 
 The stoichiometric ratios confirmed the previously proposed NO-release 
mechanism: 
Ru-(NO) + solv ĺ RuIII-(solv) + NO 
The quantum yields (ĳ) found for compounds K2[RuCl5(NO)] and RuNOCl3 are 0.06 
and 0.012 respectively.78 This difference in the values for two quite similar 
compounds arises from the fact that the presence of a greater number of negatively 
charged ligands (5 chlorine atoms per ruthenium atom in the first compound against 3 
chlorine atoms in the second) facilitates the process of NO-photorelease. Today these 
compounds are well studied and are commercially available.77
Studies of analogous compounds in which chlorine atoms in the equatorial 
plane are replaced with ammonia molecules – trans-[Ru(NH3)4(X)(NO)]3+ – have 
shown that the ligand that is in the trans-position to nitric oxide has a significant 
effect on the rate and efficiency of NO-release. Thus, in the case of the phosphite 
P(OEt)3 ligand the quantum yield of NO-release was ĳ = 0.3, while for the compound 
with the imidazole ligand in the trans-position to NO this value was only 0.04.77
Giving preference to polydentane ligands over monodentate ones in the study 
of compounds for the purpose of their further use for medical purposes is determined 
by a greater stability of chelating complexes and complexes with macrocyclic 
ligands.77 The necessity of using complexes with high stability constants becomes 
clear if we take into account the infinite number of biomolecules in the body that can 
strongly bind metal atoms, competing with monodentate ligands. Thus, polydentane 
H3N
H3N NH3
NH3
Ru
NO
X
X = NH3, py, 4-acpy,
P(OEt)3
3+
Cl
Cl Cl
Cl
Ru
NO
Cl
2-
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ligands make it impossible to bind metals with bioligands, thus reducing or 
eliminating the harmful effects of the former;77 and also, which is important for 
photoactive compounds, polydentate ligands provide the stability of complexes, and 
therefore thir photochemical characteristics. 
Since prosthetic groups of heme proteins (hemoglobin, sGC, cytochromes) are 
the primary targets for nitric oxide attack in the body (see section 1.2), one of the first 
attempts to receive NO-donor based on coordination compounds of ruthenium with 
polydentane ligands was made precisely with the use of porphyrins.73 The resulting 
compounds of the general formula [(P)Ru(NO)Cl], where P is porphyrin, were 
thermally more stable and less susceptible to oxidation by oxygen in the absence of 
irradtiation than similar iron complexes. However, the reverse recombination of 
released NO molecule was too fast (k § 1*108 M-1s-1), that made these compounds 
unsuitable for targeted NO delivery.48,73,79 
More promising from a practical point of view are non-porphyrin-type ligands 
– Schiff's bases, thiolates, polypyridyl and other polydentane ligands. Examples of 
some typical ligands of these classes are shown in Figure 1.14. 
Schiff's bases are the classic example of the podand ligands. In 2002 Ford and 
coworkers synthesized several {RuNO}6 complexes using 
N,N'-bis(salicylidene)ethylenediamine (H2salen) as a ligand (Figure 1.14). Like the 
porphyrin ligand, compounds of this type contain four donor atoms, two nitrogen 
atoms in imine group and two phenolic oxygen atoms occupying four positions in the 
equatorial plane of the ruthenium polyhedron (Figure 1.15). 
The study of the NO-release from these compounds under irradiation (Ȝ = 365 
nm) showed a certain dependence on the nature of the solvent in which the process 
took place. Donor solvents such as acetonitrile have been shown to be able to 
stabilize the generated photoproduct, and the reverse process of the released NO-
molecule coordination is relatively slow (k § 10-2-10-4 M-1s-1).77 If tetrahydrofuran 
(THF) or toluene (PhMe) is used instead of acetonitrile the process of photo-release is 
immediately followed by a very rapid recombination.80
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In this work it was also found the dependence of 
the photochemical activity of complexes on the ligand 
donor strength (Figure 1.15): with decreasing of ı-
donating activity moving from Cl to H2O in the series ɋl-
– ONO- – H2O quantum yield decreases as follows 0.13 - 
0.067 - 0.005 respectively,. 
Deep investigation of ruthenium-nitrosyl 
complexes with PaPy3H type ligands (Figure 1.14) were 
performed by Mascharak’s group. The principal feature of 
the structure of these ligands is the presence of the 
carboxamide nitrogen atom in its structure. The idea of 
using such a fragment was suggested by the structure of 
the enzyme nitrile hydratase.81 Two of the six donor 
atoms in the iron coordination polyhedron in active cite of 
this enzyme are carboxamide Nitrogen atoms, and its 
activity is regulated by the coordination of nitric oxide to 
the central iron atom. 
Formation of the complex [(PaPy3)Ru(NO)]2+  
with this ligand (Figure 1.16) occurs with deprotonation 
of the nitrogen atom of the carboxamide group. Thus, in 
the formed complex the negatively charged nitrogen atom 
acts as ı-donor in the trans-position to the nitrosyl ligand. 
Such an important nuance in the structure of the complex 
makes the compound stable in an aqueous medium at pH 
ranging from 5 to 9, despite the fact, that vast majority of 
ruthenium-nitrosyl coordination compounds undergo the 
transformation into nitrite form at pH>5:77
Ru–NO + H2O ї Ru–NO2 + 2H+
The absence of this transformation even in the 
Figure 1.14. Ligands 
for the synthesis of 
ruthenium-nitrosil 
complexes
Figure 1.15. 
Cation of ruthenium 
nitrosyl complexes with 
salen ligand 
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presence of hydroxide anions indicates that a strong ı-donor 
ligand in the trans-position to nitric oxide in the {RuNO}6
complex protects the NO-group from the nucleophilic attack. 
Along with the high stability of [(PaPy3)Ru(NO)]2+ in 
solution, the compound also exhibits good photochemical 
properties. Nitric oxide is easily released from the compound 
(ĳ = 0.05), and the process of reverse recombination is not 
observed.77 These parameters (stability and NO-release 
ability) make the compound interesting in terms of its direct use in biological 
research. Successful attempts to use [(PaPy3)Ru(NO)]2+ for the transport of NO to 
myoglobin and cytochrome oxidase are described by Mascharak group.82
Many works have recently been aimed at finding ways to sensitize ruthenium-
nitrosyl complexes in the visible and infrared domains of light. For the purpose of the 
bathochromic shift of the transition dʌ(Ru) – ʌ*(NO), Mascharak group attempted to 
attach the ruthenium-nitrosyl complex to a molecule of a dye that absorbs light in the 
visible domain. Resorufin (Resf) and fluorescein derivatives (FlEt) were used as such 
molecules (Figure 1.17). 
  
Figure 1.17. Dyes resorufin Resf (left) and 
fluorescein ethyl ester FlEt (right) 
Using the ruthenium complex containing the dimethyl derivative H2bpb 
(Figure 1.14) as the basic platform, the researchers replaced the chlorine atom in the 
trans-position to the nitrosyl group with the molecule of a dye (Dye) that was bound 
to ruthenium atom through a covalent bond with hydroxyl group:83,84
Figure 1.16.
Complex structure
[(PaPy3)Ru(NO)]2+ 
HO O O
COOEt
FlEt
O
N
OHO
Resf
N
N N
N
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O
N
NO
2+
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 The absorption maxima (Ȝmax) of the lowest energy transitions in the electronic 
spectra of the obtained complexes [Ru(Resf)(Me2bpb)NO] (abbreviated 1-Resf) and 
[Ru(FlEt)(Me2bpb)NO] (abbreviated 1-FlEt) lie in visible part of the spectrum 
(Figure 1.18). Compared to the starting complex with chloro-ligand 
[RuCl(Me2bpb)NO] (abbreviated as 1-Cl), for which Ȝmax lies in the near-UV region  
(390-400 nm), for compounds 1-Resf and 1-FlEt these values are 500 nm and 475 nm 
respectively. At the same time, the alteration of the donor atom exclusively – 
substitution of chlorine atom with the oxygen atom (in the comlex 
[Ru(OH)(Me2bpb)NO] (abbreviated 1-OH)) - does not significantly affect the shift of 
Ȝmax.83
The release of NO from these compounds under irradiation showed not only 
their ability to be effectively sensitized in the visible region, but also revealed the 
unique ability of these complexes. The presence of molecules capable of 
luminescence in their structure, provided a tool for the NO-release control. 
Interestingly, the compound 1-Resf is fluorescent, in contrast to 1-FlEt.83,84 
Fig. 1.18 Electronic spectra of ruthenium nitrosyl complexes with dyes: a) 
comparison of the free resorufin spectrum with the spectrum of the 1-Resf complex 
and the 1-OH complex; 2) comparison of the spectrum of the 1-FlEt complex with 
the spectrum of the 1-Cl complex 
ɚ ɛ
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But the situation changes to the opposite at the moment of NO-release. The 
photoproduct produced from compound 1-Resf does not show fluorescence, that 
caused by the presence of a paramagnetic d5-Ru(III)-center.84 In the case of 1-FlEt 
irradiation of the compound is accompanied with a liberation of a nitric oxide 
molecule and a molecule of a dye (Fig. 1.19), that restores its intense emission in a 
free state. These studies indicate the possibility of shifting the absorption band of 
ruthenium-nitrosyl complexes into visible region and exemplify the release of NO 
when these compounds are irradiated with waves of this domain. 
Another widely used ligand for synthesis of ruthenium-nitrosyl complexes is 
terpyridine. As with other polypyridyl complexes, ruthenium compounds with 
terpyridine exhibit high stability. In addition to the chelate effect of terpyridine, the 
high stability of these complexes is supported by a significant d-ʌ* backdonating 
interaction.85 An intensive study of ruthenium-nitrosyl complexes with these ligands 
was performed by Roberto Santana da Silva and Isabelle Malfant groups. 
The use of terpyridine ligand in ruthenium nitrosyl complexes leaves two of the 
coordinating positions in the polyhedra of ruthenium free. Consequently, these 
positions may be occupied by either two monodentate ligands (amines, ammonia, 
halogens, etc.) or bidentate ligand. 
In the year 2014 the group of I. Malfant obtained ruthenium-nitrosyl complexes 
with terpyridine ligand and two chloro-ligands (Figure 1.20).86
Fig. 1.19 The process for the release of nitric oxide with the simultaneous 
liberation of the dye molecule from 1-FlEt  
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cis-(Cl,Cl)-[RuII(FT)(Cl)2(NO)]+ trans-(Cl,Cl)-[RuII(FT)(Cl)2(NO)]+
Figure 1.20. The structure of complexes with terpyridine ligand and two 
monodentate chloro-ligands 
Synthesis was carried out in full accordance with the method described by 
Nagao et al. in which K2[RuCl5(NO)] reacts with an unsubstituted terpyridine.87
However, unlike in the published method the use of terpyridine with the fluorenyl 
substituent (9H-fluorenyl) in the 4th position results in the formation of a mixture of 
compounds. In addition to the two isomers shown in Figure 1.20, the so-called 
homoleptic [Ru(FT)2]2+ complex (Figure 1.21) is formed as well.86
Figure 1.21. The structure of homoleptic complex [Ru(FT)2]2+
The separation of these complexes was carried out using the method of 
high-performance liquid reverse-phase chromatography (HPLC). The frequency of 
the NO vibrations in IR spectroscopy was proposed for the distinction of isomers: for 
the trans-isomer (the nitrosyl moiety is in the trans-position to the pyridine ring of 
terpyridine) this value is 1901 cm-1, and for the cis-isomer (nitrosyl in trans-position 
to chloro-ligand) – 1894 cm-1.86
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The electronic spectra of the two 
complexes are similar, although for the trans-
isomer (Ȝmax = 414 nm), the lowest transition is 
shifted by an energy of 0.2 eV into the visible 
region (for the cis-isomer Ȝmax = 389 nm). 
Quantum-chemical calculations with the use of 
the density functional theory (DFT) show that 
the electronic transition responsible for the 
appearance of the band B (Figure 1.22) is 
mainly the transition between the highest 
occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital 
(LUMO) (Fig. 1.23). In both complexes, HOMO is a binding orbital located on an 
electron-donating 9,9-hexyl-9H-fluorenyl moiety. At the same time the transition 
from HOMO to LUMO is essentially the transfer of the electronic density from the 
terpyridine ligand to the antibonding dRu – ʌ*(NO) bond. 
Taking into account that the electronic transition corresponding to the band B 
leads to a weakening of Ru-N(NO) bond the study of the release of nitric oxide from 
both isomers was carried out under the irradiation with Ȝ = 405 nm – the wavelength 
at which both complexes show a significant absorption coefficient. Quantum yields 
for cis-[RuII(FT)(Cl)2(NO)](PF6) and trans-[RuII(FT)(Cl)2(NO)](PF6) are 0.106 and 
0.307 respectively.86 Despite 
the fact that these compounds 
show good photochemical 
characteristics, the authors 
emphasize that their practical 
use is limited because of the 
need to irradiate the 
complexes with 
electromagnetic irradiation 
Figure 1.22. Electronic absorption 
spectra of cis- and trans-
[RuII(FT)(Cl)2(NO)](PF6) 
Fig. 1.23 HOMO and LUMO for cis- and trans-
[RuII(FT)(Cl)2(NO)]+, calculated with DFT
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that is poorly permeable into biological objects. 
The confirmation of nitrogen monoxide release in this work was done with the 
use of indirect method – the Griess test, which consists in the photometric 
determination of pink diazo-dye (Ȝmax = 548 nm), which is formed as a result of the 
reaction of nitrite anions (formed as a result of oxidation of NO in solution) with 
sulfanilic acid.88 Another, more reliable direct method for the determination of nitric 
oxide is the use of iron-N-methyl-D-glucamine dithiocarbamate (Fe(MGD)2) as a 
specific spin trap for nitric oxide with further determination of the Fe(MGD)2-NO 
complex by EPR spectroscopy.89
As an example of terpyridine ruthenium-nitrosyl complexes, the coordination 
sphere of which is complemented with the bidentate ligand, we can also cite the 
compounds synthesized by Liu’s group. 
In order to integrate the 
ruthenium-nitrosyl complex into 
nanoparticles for subsequent NO targeted 
delivery into biological objects, the 
terpyridine ligand has been 
functionalized with the carboxyl group, 
which will enable covalent binding of the 
NO donor to "nano-carriers", in particular 
TiO2. The photosensitization of the obtained compound in the visible region of the 
spectrum was done by attachment of the DAMBO dye (8-(3,4-diaminophenyl)-4,4-
difluoro-1,3,5,7-tetramethyl-4-boron-3a, 4a-diaza-s-indacene) directly to the metal 
center. The resulting complex [Ru(tpyCOOH)(DAMBO)NO](PF6)3 integrated on the 
TiO2 surface was stable in the absence of light and was capable of releasing nitric 
oxide when irradiated.48,90 An interesting feature of this complex is the ability to 
generate both NO and singlet oxygen 1O2 when irradiated with visible light; this is the 
first example of compounds capable of releasing both particles that play a key role in 
photodynamic therapy.90 Thus, the use of terpyridine for the strong binding of 
Figure 1.24. Complex cation
[Ru(tpyCOOH)(DAMBO)NO](PF6)3
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ruthenium ion may be promising in the design of ruthenium-nitrosyl complexes as 
NO donors. 
1.4.4 Mechanism of nitric oxide release from ruthenium-nitrosyl complexes: 
theoretical studies 
A detailed theoretical study of the release of NO from ruthenium-nitrosyl 
polypyridyl complexes was carried out by Juan Sanz Garcia.91
The theory developed by J. Garcia 
and co-authors shows that the process of 
NO-release is not one-step mechanism, 
but rather occurs in several steps, which 
include the transition between several 
geometric forms conjugated with 
different electronic states of cationic 
ruthenium-nitrosyl complexes. The main 
(stationary) forms in this process are 
three isomeric structures of the 
ruthenium-nitrosyl complexes: the ground state, GS (ground state), metastable state-
1, MS1 (metastable state), and metastable state-2, MS2 (Figure 1.25). In essence, 
they are linkage isomers: GS -ruthenium nitrosyl complex, MS1 - ruthenium 
isonitrosyl complex, MS2 - complex containing bridged NO ligand [Ru(Ș2-NO)]. The 
possibility of obtaining of all three isomers was shown for the compound 
[RuCl(py)4NO]2+ (Figure 1.25). 
In the solid state, the transition from one of them to another occurs when the 
complex is irradiated by electromagnetic waves of different lengths (Fig.1.26).92
According to the results of theoretical studies, the release of nitric oxide from 
ruthenium-nitrosyl complexes is preceded by isomerization of the latter. 
Figure 1.25. Three main isomeric forms 
of [RuCl(py)4NO]2+ - GS, MS1 ɬɚ MS2.
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Therefore, a detailed study of the 
processes underlying the isomerization of 
the {Ru-NO} complexes can reveal the 
key structural and electronic features of 
the ligands that affect the process of NO-
release. 
All the processes occurring during 
the isomerization of the ruthenium-
nitrosyl complex from GS to MS1 are 
schematically depicted in the scheme 
1.10. The principal feature of this 
sequence of transformations is the presence of two cases of photon absorption - 
process "a" and process "g". The initial absorption of one photon (process a) excites a 
molecule being in the ground state. Further intersystem crossing leads to the 
population of the triplet excited state Tn (process b), which through internal 
conversion, transforms into the main 3GS triplet state (process c). The transition to 
the main electronic state of the isomer [Ru(Ș2-NO)] - MS2 can pass by two ways. 
Given that the Ru-NO angle considerably changes with this transition (from 134.2° in 
3GS to 84.7° at MS2), the transition from the lower vibrational level to 3GS requires 
Figure 1.26. Color change of the 
[RuCl(py)4NO](PF6)2 crystal under
irradiation by 476.5 and 980 nm waves 
at 180 K. 
Scheme 1.10 Schematic representation of all electronic transitions involved 
in the GS-MS1 isomerization process according to Garcia's theory. 
Transitions between states with the same multiplicity are represented by 
solid arrows, between different - dotted. Singlet states are depicted in blue, 
triplets - in red. 
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an overcoming of the energy barrier of 0.67 eV, which in principle is the limit of the 
possible vibrational activation of the molecule at 3GS-level (process d); an alternative 
to this transition can be a direct intersystem crossing from the excited triplet state Tn
(transition e). Further isomerization requires a transition to the triplet state 3MS2, 
from which, through j and k transitions that do not require additional activation, the 
molecule could isomerize to the isonitrosyl complex (MS1). The presence of a deep 
potential hole (an energy barrier of 0.73 eV) in the state MS2 makes it impossible to 
switch to a triplet state by thermal activation. Therefore, the most probable 
mechanism for overcoming such a barrier is photoexcitation. 
The absorption of a photon transfers the molecule into a singlet excited state 
(process g), from which the 3MS2 triplet level population occurs as a result of 
intersystem crossing (process h) and subsequent internal conversion (process i).93
It should be noted that the magnitudes of the energies corresponding to the 
phototransitions a and g are very close. Calculated electronic spectra using a time-
dependent density function theory (TDDFT) for all three isomers are shown in Figure 
1.27. 
As can be seen from the compounds spectra, electromagnetic irradiation with a 
473 nm wavelength is absorbed by both GS and MS2 isomer. In this case, the 
Fig. 1.27 Electronic spectra of all three GS, MS1 and MS2 isomers 
calculated using TDDFT 
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isonitrosile complex (MS1) is not excited by the light of such energy (İ § 0). From 
experimental studies it is known that isomerization of the nitrosyl complex 
[RuCl(NO)(py)4]2+ occurs when it is irradiated with wavelength Ȝ = 473 nm. In view 
of the isomerization mechanism, we can say that the use of light for this process leads 
to the absorption of two photons instead of only one that eventually leads to the 
population of an unstable 3MS, from which the molecule transforms into isonitrosyl 
complex. At the same time the photons of this energy are not absorbed by the MS1 
complex. However, under irradiation with the red light the resulting isonitrosyl 
complex isomerizes into the starting ruthenium complex, which does not absorb light 
of this wavelength domain. 
According to the study, reaching of the 3MS2 level is important not only for the 
isomerization process, but also for the release of nitric oxide from the complex. In 
previous works (Bitterwolf et al.94, Woike et al.95) attention has already been paid to 
the importance of linkage isomers in the process of NO-release from ruthenium-
nitrosyl complexes. 
An attempt to explain the inclinations of the ruthenium-nitrosylcomplexes 
either to isomerization or the release of NO based on the structure of complexes was 
made in the work of García et al.91 It is noteworthy that the proposed mechanism and 
the explanation for different values of quantum yield for NO-release is consistent 
with experimental data obtained in various scientific groups. When the compound 
transit to the 3MS2 triplet state its further transformation can take place in two ways: 
isomerization with the formation of the MS1-isomer or the release of NO. The 
competition between them is determined by the kinetics of both processes or rather 
by the difference between the energy of the dissociation De2 and the energy barrier 
that must be overcome for isomerization (Figure 1.11). 
Thus, when De2 <3B2, the release of nitric oxide occurs easier, otherwise the 
complexes are more prone to isomerization. 
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In summary, we can say that, like the process of isomerization, the process of 
NO-release from ruthenium-nitrosyl complexes occurs as a result of absorption of 
two photons. In this case, as a result of several electronic transitions, the molecule 
transits to a triplet state, and then, depending on the relation between the dissociation 
energy and the isomerization energy, both the NO-release and the isomerization with 
the formation of the isonitrosyl complex can take place.  
1.5 Two-photon absorption as a method of photosensitization of compounds 
within the therapeutic window 
The two-photon absorption phenomenon was predicted by Maria Göppert-
Mayer96 in 1931, although it was practically observed for the first time only 30 years 
later by Kaiser and Garrett.97 The TPA process is the excitation of a molecule, which 
occurs when absorbing not one, as in the case of linear absorption, but two photons 
(must not be confused with the mechanism described in 1.4.4, which includes two 
separate steps of absorption of photons). The process of absorption of two photons 
occurs simultaneously, but it is still considered that the transition to a "stable" excited 
state is preceded by the transition to the so-called "virtual level" when molecule 
absorbed one of two photon (Scheme 1.12).  
Scheme 1.11 Competition between the release of nitric oxide and 
isomerization in ruthenium-nitrosyl complexes. 
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The lifetime of this virtual state is of the 
order of several femtoseconds, and the very 
phenomenon of TPA will be possible only if 
the second photon is absorbed up to the 
moment of the reverse transition of the 
molecule to the ground state. And, unlike 
single-photon absorption, the probability of 
which is linearly proportional to the 
intensity of light, the possibility of two-
photon absorption depends on the temporal and spatial availability of two photons, 
and quadratically depends on the intensity of the exciting radiation.98
Two-photon absorption (TPA) is a third ofder nonlinear optical phenomenon.99
It is possible to describe the response of a substance on the action of light using the 
dependence of the macroscopic polarization P on the intensity of the electric field E: 
P = P(1) + P(2) + P(3) + … = İ0(Ȥ(1)E + Ȥ(2)E + Ȥ(3)E + …), 
where İ0 is the dielectric constant in a vacuum, P(n) is the polarization of the nth order, 
Ȥ(n) is the optical susceptibility of the nth order; while Ȥ(1) describes the linear 
properties of the materials, Ȥ(2) is an important parameter for the phenomena of the 
second harmonic generation, sum-frequency generation etc. The third-order 
susceptibility Ȥ(3) is associated with such phenomena as generation of the third 
harmonic, nonlinear refraction, two-photon absorption and others. 
When light passes through substances capable of one- (OPA) and two-photon 
absorption (TPA), its intensity I(z) change as follows: 
݀ܫሺݖሻ
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where Į and ȕ are the coefficients of one- and two-photon absorption of the medium, 
respectively. The index z indicates the propagation of light along the conventional 
axis z in the medium. In the case when the substance does not exhibit linear 
absorption of the light, and only two-photon absorption is present, the expression 
simplifies to the next form:100
Scheme 1.12 Schematic comparison 
of one- (OPA) and two-photon (TPA) 
absorption processes . 
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The physical interpretation of this expression is that the magnitude of the two-photon 
absorption is proportional to the square of the intensity of light. The solution of this 
differential equation is: 
ܫሺݖǡ ߣሻ ൌ  ܫ଴ሺߣሻͳ ൅ ߚሺߣሻܫ଴ሺߣሻݖ
In this expression, I0 is the initial intensity of the exciting radiation, z is the thickness 
of the medium layer in which light propagation occurs. ȕ(Ȝ) is a macroscopic 
parameter, which depends on the concentration of molecules capable of two-photon 
absorption, and can be represented in the following form: 100
ߚ ൌ ߪ ஺ܰܿͫߥ ǡ
where c is the concentration of the photoactive substance, NA is Avogadro number, h 
is Planck's constant, Ȟ is the frequency of the light, and ı is the two-photon 
absorption cross-section. ı is a parameter that characterizes the intensity of the 
absorption of two photons by a molecule. As a unit of measure for ı it is common to 
use cm4·s. But since the values of ı in practice vary within 10-51 - 10-46 cm4·s, a 
special unit of measurement GM (from the name of Maria Göper-Meyer) was 
introduced for convenience: 
1 GM = 10-50 ɫm4·ɫ
Two-photon absorption is a modern, promising tool for in vivo photoactivation 
of biologically active substances, in particular recent researches are devoted to the 
design of nitric oxide donors with high TPA cross-sections.101 The reason for such an 
interest in this method of activation is the benefits of the TPA. The main advantage of 
using the TPA approach is the possibility to activate the compounds with 
electromagnetic radiation in the "therapeutic window" area. Most donors of nitric 
oxide known today have an absorption maximum in the visible or near UV 
region.48,55 Waves of such lengths are poorly permeable in the biological environment 
and, in the case of UV radiation, can cause significant negative effects. An effective 
extinction coefficient of biological tissues against the wavelength is shown in figure 
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1.28 in a pink color. The range of wavelengths of 700-1100 (1300) nm102 is called 
"therapeutic window"; waves of this region are the most permeable in the biological 
environment. According to the scheme 1.12, in the case of TPA, the transition energy 
S0ĺ Sn is divided into two photons, for example, if the excitation of a molecule in a 
single-photon process requires the use of a wave with Ȝ = 400 nm, in the case of TPA 
the wavelength will be twice as large as 800 nm. Thus, the activation of the 
compound becomes possible under irradiation with electromagnetic waves of 
therapeutic window. 
Figure 1.28. Absorption of electromagnetic irradiation by 
biological tissues and fluids. The area of the therapeutic 
window (700-1300 nm). 
Another important advantage of using TPA is the accurate localization of the 
effect on the biological object, which is the result of the quadratic dependence of the 
two-photon absorption on the intensity of the applied irradiation. From figure 1.29 it 
is clear that in the case of TPA, the excitation of a photoactive substance takes place 
in a small volume around the focus of the laser radiation source – this is where the 
necessary "concentration" of photons is attained, and where the phenomenon of TPA 
becomes possible. 
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Fig. 1.29 Comparison of sample volumes in which one-
and two-photon absorption take place.103
Many organic compounds such as polymeric and small-size molecules 
containing ʌ-conjugated chains exhibit nonlinear optical properties. The highest 
values of the TPA cross-section (ı) to date are 104 GM.104 The application of 
photoactive compounds for the treatment or in vivo imaging of objects requires the 
development of substances with high ı values. Two basic approaches for obtaining of 
such compounds are: the design of the linear and the two-dimensional structures. 
Increasing TPA efficiency in linear molecules (which, in particular, are studied in this 
work) can be achieved by forming structures D-ʌ-A (D-donor, A-acceptor), D-ʌ-A-ʌ-
D, A-ʌ-D-ʌ-A. Donor-acceptor molecule character increases the TPA due to the 
increased difference between the dipole moment in its ground and excited state.104
The most common donor groups in the design of compounds with high ı are 
dyphenilamino-, diethyl- and dimethylaminogroups. Phenyl, fluorenyl, thiophene and 
other linkers often play a role of the bridges with long conjugation chain; they can 
form planar structures that improve the interaction of the ʌ-systems of the molecule 
fragments. Also some studies indicate that the triple bond can play the role of an 
effective ʌ-bridge as well.104
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CHAPTER 2. THE REPLACEMENT OF CHLORO-LIGANDS WITH 
2,2'-BIPYRIDINE IN {Ru-NO} COMPLEXES AND ITS EFFECT ON TPA OF 
COMPOUNDS 
The basis for the structures of 
compounds studied in this dissertation were 
the complex ions of ruthenium-nitrosyl 
complexes obtained by I. Malfant research 
group in 2014,86 - cis- and trans- 
[RuII(FT)Cl2(NO)](PF6). These are cationic 
complexes that according to Enemark-
Feltman notation are the complexes {RuNO}6. This is evidenced by the data of NMR 
and IR spectroscopy. In particular, the frequency of the valence oscillations of the N-
O bond in cis- and trans- isomers is 1894 cm-1 and 1901 cm-1, respectively, which is 
typical for compounds with a formal charge distribution {RuII-(NO)+}. The 
octahedral environment of the central ruthenium atom is formed by the nitrosyl 
moiety NO, two chlorine atoms which may be in the cis- or trans- position, and by 
the three nitrogen atoms of the pyridine rings of the terpyridine ligand (Figure 2.1). 
Terpyridine provides high stability of the complex with ruthenium due to the 
formation of two five-membered chelate cycles and ʌ-backdonation. At the same 
time the two positions remaining unoccupied in the coordination polyhedron (without 
considering nitric oxide) leave the possibility for altering the redistribution of 
electronic density in the complex through variation of the ligands nature there. The 
relative position of the three monodentate ligands (Cl, Cl, NO) has a significant effect 
on the photochemical behavior of the compounds. The complex 
cis(Cl,Cl)-[RuII(FT)Cl2(NO)](PF6) where the chloro-ligand is located in the 
trans-position to the nitrosyl ligand, releases nitric oxide with quantum yield of 0.31 
under irradiation Ȝmax = 405 nm, whereas the quantum yield of NO-release from the 
trans-isomer, in which the nitrogen of the central pyridine ring is located in the trans-
position to NO, is 0.11 under the same conditions.86,105 
Figure 2.1. The structure of cation of 
cis-[RuII(FT)Cl2(NO)](PF6) (cis1).
N
N
N
Ru Cl
Cl
NO
+
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As in the studies of ruthenium-nitrosyl complexes with other ligands (see 1.4.3), 
the authors emphasize the decisive influence of the ligand in the trans position to NO 
on photochemical properties of the complex. For the sake of simplification the 
compound cis(Cl, Cl) – [RuII(FT)Cl2(NO)](PF6) is designated as cis1, trans(Cl, Cl) – 
[RuII(FT)Cl2(NO)](PF6) as trans1. 
As noted in Chapter 1, the presence of monodentate ligands in the complexes is 
generally undesirable when designing drugs. The alternative proposed in this work 
for chloro-ligands is 2,2'-bipyridine. The choice of this ligand is justified by several 
factors: (i) higher stability of such complex in the biological environment due to 
increased thermodynamic stability of the {Ru(tpy)bpyNO} complex compared to 
{RuCl2(tpy)NO}; (ii) eliminating the need for a painstaking and complex process of 
separating the mixture of cis- and trans-isomers when monodentate ligands are 
present; (iii) the potentially higher ability of the compound with 2,2'-bipyridine to 
participate in two-photon absorption process (TPA). The last statement needs a more 
detailed explanation. 
First, the very presence of an additional fragment with a long chain of 
conjugation in the compound can lead to an increase of its ability to undergo two-
photon absorption. Another argument favoring the idea of increasing the TPA cross 
section (ı) when introducing 2,2'-bipyridine into the complex is the results of the 
quantum-chemical calculations performed for these compounds, in particular the 
calculated angles between the mean plane of the fluorenyl fragment and the mean 
plane of terpyridine. According to the DFT calculations in a row of trans1-cis1-bpy1 
(where bpy1 is a complex in which two chloro-ligands are replaced by a 2,2'-
bipyridine molecule) the angle between the planes decreases (Table 2.1). This could 
be explained from the point of view that removing of two negatively charged chloro-
ligands will necessarily increase the withdrawing effect of {Ru(tpy)NO} moiety. 
Moreover, inserting of ʌ-accepting fragment (2,2'-bipyridine) will increase this 
withdrawing effect, thus the fluorene moiety will be more effectively conjugated with 
terpyridine fragment. 
As is known, the ef
cosine of the angle betwe
these three compounds 
parameter may increase 
increase in the efficiency o
a 
c  
Figure 2.2.
The compound bpy1
us, and its structure was p
Table 2.1.  The 
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b 
 Crystal structures of trans1 (a,c) ɬɚ bp
 of the formula [Ru(FT)(bpy)NO](PF6
roved by NMR, IR spectroscopy and 
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single crystal of the complex was also obtained and the structure was confirmed by 
X-ray diffraction analysis.107
Interestingly, there is no correlation between the values of the torsion angles 
fluorene-terpiridine in complexes in solutions obtained by DFT computations and 
torsion angles observed for compounds in the crystalline state. The torsion angles in 
cis1 and trans1 in the solid state are approaching 180 °, while the corresponding 
angle in the compound bpy1 is 38.08 ° (Figure 2.2a, b). Such a significant difference 
is probably due to the peculiarities of the interaction in the crystalline state of the 
compounds: ʌ-ʌ stacking becomes possible between the molecular ions of the 
complexes cis1 and trans1 owing to the close (§ 3.4 Å) arrangement of the layers of 
the molecules (Figure 2.2c), whereas the presence of significantly larger 2,2'-
bipyridyl ligand and the three bulky PF6Ø-anions makes such interaction impossible in 
the solid state of the compound bpy1, and the geometry of the molecule is closer to 
that in the solution. 
2.1 Comparison of electronic spectra of compounds bpy1, cis1 and trans1. 
Electronic spectra of acetonitrile 
solutions of all three compounds are 
shown in Figure 2.3. The main 
absorption band B is at the boundary 
of the visible spectral region, but for 
the bpy1 compound there is a 
bathochromic shift of this band 
compared to complexes containing 
chloro ligands. In this case, the molar 
extinction coefficient for the band B 
of the compound bpy1 is slightly 
lower.  
The values of Ȝmax obtained theoretically using the time-dependent theory of 
density functional (TD-DFT) do not differ significantly from the experimental data: 
the experimental values of energies are shifted by less than 3000 cm-1. Nevertheless, 
Figure 2.3. Electronic spectra of cis1, trans1 
bpy1 solutions in CH3CN.
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in both cases, there is a tendency toward a bathochromic shift and a decrease in the 
absorption rate in a series of cis1-trans1-bpy1 (Table 2.2). 
Compound Experimental data TD-DFT computations 
Ȝmax İ Ȝmax f 
cis1 389 24950 355 0.724 
trans1 414 23600 370 0.665 
bpy1 440 16700 428 0.331 
Table 2.2. Comparison of experimental and theoretical parameters of band B in 
electronic spectra of compounds  
A detailed analysis of the electron excitations responsible for the appearance of 
the band B in the spectra shows that for all three compounds, the most intense 
transitions are mostly the HOMO-LUMO transitions, with some contribution of 
HOMO-LUMO + 2 excitation. HOMO concentrates mainly on the fluorenyl moiety 
that is a donor substituent in the complexes, while the main contribution to the 
LUMO makes ruthenium nitrosyl fragment in which the interaction dRu-ʌ*(NO) has 
an antibonding character (Figure 2.4). 
Figure  2.4. HOMO(136 for cis1 and trans1, 159 for bpy1) and LUMO 
(137 for cis1 and trans1, 160 for bpy1) visualization for cis1, trans1, bpy1.
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Expectedly, the energy of these transitions decreases in a row cis1-trans1-bpy1, 
which is antibate to the change of Ȝmax in experimental UV-visible spectra of 
compounds. A more detailed description of electronic transitions with the electron 
density transfer toward {Ru-NO} fragment calculated by TD-DFT methods is 
presented in Table 2.3. 
Compound transition Ȝmax f ǻȝ Main excitations contributions 
cis1 g0ĺe6 355 0.724 18.96 Ȥ136ĺ137(50.8 %) + Ȥ136ĺ139 (19.7 %) 
trans1 g0ĺe6 370 0.665 22.77 Ȥ136ĺ137(69.2 %) + Ȥ136ĺ139 (10.8 %) 
bpy1 g0ĺe1 428 0.331 30.07 Ȥ159ĺ160(80.6 %) + Ȥ159ĺ162 (4.8 %) 
Table 2.3. TD-DFT-computed parameters of electron transitions with electron charge 
transfer onto {Ru-NO}. (Orbitals 136 are HOMO, orbitals 137 – LUMO for 
compounds cis1 and trans1; orbital 159 is HOMO, orbital 160 – LUMO for bpy1. g0
– ground state, ɟn – nth excited state.)
Neither of the terpiridine {Ru-NO} complexes obtained in this work nor of the 
similar complexes obtained in the group of I. Malfant exhibits luminescence. None of 
coordination compounds obtained at intermediate stages of the synthesis of final {Ru-
NO} complexes exhibits luminescence either. Moreover, as noted in chapter 1, the 
introduction of typical fluorescent dyes in the nitrosyl complexes completely 
quenches the fluorescence of the first ones, or at least sharply decreases its intensity 
as in the case of complexes with resorufin and fluorescein derivatives (paragraph 
1.4.3).83,84 
An explanation for such a phenomenon can be found in the structure of the 
energy levels of polypyridyl ruthenium complexes. Let’s consider the main 
transitions that occur in the complex upon its excitation using as an example the 
substance [RuCl(py)4NO]2+ investigated theoretically by J. Garcia.108 The absorption 
of a certain energy photon excites the compound to one of the excited singlet energy 
levels, which, undergoing the internal conversion, passes to the lowest excited level 
S1 (Figure 2.5). Formally the process boils down to the transition S0 ĺ S1. For a 
molecular ion [RuCl(py)4NO]2+ this transition corresponds, in fact, to the electron 
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transition from the Ru(dxy) orbital to 
an antibonding Ru(dʌ)NO(ʌ*) orbital. 
After absorption of the photon, an 
ultra-fast intersystem crossing (ISC) 
takes place  
and subsequent internal conversion 
(IC) results in the population of a 
triplet 3GS state. The presence of a 
massive ruthenium atom in the 
complex furthers the rapid ISC from 
the state S1 to Tn, so the fluorescence 
from the state S1 becomes 
impossible. The phosphorescence 
from 3GS does not occur due to the fast "barrier-free" ISC between the 3GS and GS 
states. Another transition from the 3GS level may lead to the MS2 population which 
can finally result in nitrosyl-isonitrosyl isomerization or release of nitric oxide. This 
case was discussed in paragraph 1.4.4. In the case of ruthenium-nitrosyl complexes 
with a terpyridine ligand containing a fluorenyl substituent, such as cis1, trans1 or 
bpy1, the electron transition of a lowest energy corresponds to the transfer of electron 
density from a donating fluorenyl moiety to LUMO located at a strongly withdrawing 
ruthenium-nitrosyl group. Thus, the electron density is shifted from the potentially 
fluorescent fluorenyl moiety: the population of the lower-energy triplet state with an 
electron localized on the Ru-NO fragment occurs very rapidly and the fluorescence 
becomes impossible.109
2.2 Study of the release of nitric oxide from the complex bpy1. 
As noted above, a study of the release of nitric oxide from the compounds cis1 
and trans1 published by the research group of I. Malfant revealed quite good quantum 
yields for these complexes,86 which are of the same order with those of the 
terpyridine complexes with similar structure obtained in the group of da Silva.110
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 lower – 0.11. The compound bpy1 shows a slightly reduced quantum yield compared 
to trans1 - 0.06. The changes in electronic spectra of all three compounds solutions in 
CH3CN during irradiation are depicted in figure 2.6. 
 It is interesting that the quantum yields for trans1 and bpy1 are similar to each 
other and at the same time differ significantly from the value of the quantum yield for 
the compound cis1, although formally, in terms of the structure of compounds, bpy1 
is closer to cis1. The values of quantum yields of NO-release are dependent on the 
nature of the ligand in the trans-position to the nitrosyl group: the presence of a 
pyridyl ring trans to NO instead of a chloro-ligand reduces the quantum yield of 
nitric oxide photorelease.111
2.3 Determination of the oxidation state of ruthenium in photoproduct 
through the analysis of its electronic spectrum. 
A characteristic feature of UV-visible spectra of photoproducts solutions formed 
after irradiation of cis1 and trans1 compounds is the presence of a wide absorption 
band in the region of 530-680 nm (Figure 2.6 a, b). It is important to notice that such 
a band is absent in the spectrum of the photoproduct solution formed as a result of 
irradiation of the bpy1 complex. Similar electronic transitions responsible for the 
appearance of this band are absent in the initial complexes, as evidenced by the 
absence of any significant absorption in their spectra in the region Ȝ> 500 nm. The 
reason for the appearance of this band could be the transition with the electron 
density transfer to the SOMO that appears due to the formation of the paramagnetic 
complex RuIII. To confirm this theory, we carried out TD-DFT calculations for the 
photoproduct trans(Cl, Cl)- [RuIII(FT)Cl2(CH3CN)]+. The spectrum calculated with 
the use of a hybrid functional taking into account the long-range correlation (long-
range corrected) CAM-B3LYP (Figure 2.7) was the closest to the experimentally 
obtained UV-visible spectrum of the compound. The lowest energy transition which 
causes the appearance of a band in the UV-visible spectrum is, according to 
calculations, a transition with energy of 2.41 eV. The difference in energy with a  
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similar absorption band in the 
experimental spectrum (§2 eV) is 0.4 
eV. This is an acceptable deviation, but 
rather high. 
The analysis of the orbitals 
involved in this electron transition shows 
that it occurs exclusively within the 
fluorenyl moiety, and represents the 
transfer of the electron density to the 
SOMO (Figure 2.8). 
The spectra calculated using other 
functionalities, in particular B3LYP, 
PBE0, B3PW91 etc., exhibit worse correlation with the experimentally obtained 
electronic spectrum. However, the lowest energy transition computed with B3LYP 
functional has the energy of 2.17 eV, and the difference with the corresponding band 
of the experimental spectrum is only 
0.17 eV. But unlike the transition at 2.41 
eV, obtained using CAM-B3LYP, the 
main contribution to this transition is 
made by the electron density transfer 
excitation from the d-orbitals of the 
metal to the ʌ-system of the fluorenyl 
moiety (Figure 2.8). Such calculations 
are consistent with the data obtained 
earlier in theoretical studies.112
The absence of such transitions in 
the spectrum of the photoproduct 
obtained by photolysis of bpy1 may indicate the formation of a diamagnetic complex 
– RuII-complex.107 Perhaps, the photoproduct formed after NO-release, containing 
RuIII, is instantaneously reduced in solution, and the only compound observed as a 
Figure 2.7. Experimental and DFT-
computed spectra of photoproduct 
[RuIII(FT)Cl2(CH3CN)]+.
Figure 2.8. Orbitals that participate in 
low-energy transitions of compound 
[RuIII(FT)Cl2(CH3CN)]+ computed using 
the functionals CAM-B3LYP (on the 
left) and B3LYP (on the right). 
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photoproduct is [RuII(FT)bpy(CH3CN)]2+. The presence of distinct isosbestic points 
in a series of spectra obtained during the process of nitric oxide photorelease (Figure 
2.6c) speaks in support of such a theory. 
2.4 Investigation of two-photon absorption of cis2, trans2 and bpy2 
compounds. 
The first attempt to measure the two-photon absorption of cis1 and trans1 
compounds was unsuccessful due to insufficient solubility of both complexes in 
CH3CN (the required concentration for investigation of TPA of compounds by means 
of z-scan experiment is 10-2 M), therefore we have obtained analogues of these 
complexes, in which the position 9 of the fluorenyl fragment of FT ligand is 
substituted with two n-hexyl chains. The presence of long alkyl chains in the 
structure of the dHFT (4'-(9,9-dihexyl-9H-fluoren-2-yl)-2,2':6',2''-terpyridine) 
significantly increased the solubility of the complexes, leaving ʌ-ʌ* electronic 
transitions in compounds almost unchanged. Thus, we obtained the cis(Cl,Cl)-
[RuII(dHFT)Cl2(NO)](PF6) – cis2, trans(Cl,Cl)-[RuII(dHFT)Cl2(NO)](PF6) – trans2, 
and [RuII(dHFT)(bpy)(NO)](PF6)3 – bpy2 (Figure 2.8).107
a – cis(Cl,Cl), b – trans(Cl,Cl) c 
Figure 2.8. The structure of obtained complexes: ɚ) cis2, b) trans2, c) bpy2.
Today, there are two main methods for determining the TPA cross-section ı: 
z-scan and the two-photon-excited fluorescence (TPEF) method yet there are others, 
for example the method of thermal lens and photo-acoustic methods.104 Although the 
most sensitive among them is TPEF, its use is limited to cases of fluorescence 
compounds.  Z-scan is a direct method to determine the nonlinear absorption in bulk 
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materials consists in monitoring the transmittance of the sample under test as a 
function of the incident intensity of a laser beam. In the practice this is achieved by 
changing the position (Z coordinates) of the sample in the vicinity of a focal plane of 
the radiation source. A more detailed description of the z-scan method is given in the 
experimental part. 
The study of two-photon absorption of compounds was carried out using a 
femtosecond laser radiation source. The use of short-pulse radiation excludes other 
nonlinear optical phenomena that can significantly overestimate the value of the 
cross-section ıTPA. In particular moving from femtosecond to nanosecond lasers in 
the TPA study may increase the measured ı hundreds of times due to undesirable 
additional absorption of excited levels.100,104,107 
As noted above, from absorption spectra of cis1 and trans1 and TDDFT analysis 
of their excited states it can be seen that the electronic transition that initiates the 
transfer of the electron density from the fluorenyl substituent onto {Ru-NO} 
fragment has an energy of about 3 eV corresponding to the energy of electromagnetic 
radiation with a wavelength of about 400 nm (Figure 2.3). The use of two-photon 
absorption reduces the energy of exciting radiation and makes possible switching 
from 400 nm to 800 nm.  
In spite of the fact that the corresponding band in the UV-visible spectrum of the 
bpy1 compound is shifted bathochromically to 450 nm (corresponding to 900 nm in 
TPA process) compared with derivatives with chloro-ligands, the study of TPA of its 
analog bpy2 was also carried out at a wavelength of 800 nm. The reason for such a 
choice is the practical aspects of the use of TPA. In the biophotonics the most 
promising is the use of wavelengths of 700-900 nm,107 but obtaining radiation with a 
wavelength of 800 nm is much simpler and cheaper. In fact, the TPA study requires 
the use of a Ti-Sapphire laser (Ti:Sa), and the peak intensity of such an oscillator is 
just at 800 nm. 
For comparison we still carried out a TPA study at 900 nm for bpy2, but as will 
be shown below there was no significant difference between the values of ı900 and 
ı800. 
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The research was conducted at different laser irradiation intensities. The energy 
of electromagnetic radiation pulses varied from 30 nJ to 95 nJ. For the three 
investigated compounds at different intensities of irradiation symmetric z-scan curves 
were observed, that is an important characteristic as it confirms the absence of other 
potential nonlinear optical phenomena that often appear at higher energy of light 
pulses and significantly distort typical transmission curves. The asymmetry of the 
curves in the study of compounds capable of photoinitiated chemical transformations 
may also indicate the formation of new compounds – photoproducts. Since the 
formation of new compounds in the z-scan experiment is inevitable, their ability to 
change sample absorption should be taken into account. The good reproducibility of 
the experiment and the absence of artifacts on the transmission curve indicate a poor 
change in the concentration of the studied complexes and photoproducts. 
The TPA curves obtained for the compounds cis2, trans2 and bpy2 are shown in 
Figure 2.9(a, b, c).  
For each of the studied complexes, at least 20 scans were performed at different 
light-pulse energies, and, as expected, an increase in the intensity of the light beam 
resulted in a decrease in the transmittance (T (z)) of the studied sample in the focal 
plane (z = 0). In all cases, irrespective of the compound and energy of irradiation, the 
approximation of data was in accordance of high accuracy with the law that 
corresponds to the change in absorption intensity at TPA. 
ɚc 
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Taking into account the measurement error, we can say that the obtained values 
of ı have the same order and fall in the region of 100 GM, with some tendency to 
increase the efficie ncy of the TPA in the series trans2 <cis2 <bpy2. 
Investigation of the compound bpy2, however, requires some additional 
explanation. Since the absorption band in the electronic spectrum of this compound is 
shifted by about 2500 cm-1 bathochromically and is at 450 nm, it seems more logical 
to undertake TPA studies at 900 nm. But it is important to keep in mind that the 
spectrum of two-photon absorption of compounds can differ significantly from the 
spectrum of single-photon absorption, although for compounds with a strictly linear 
structure it’s less common. In this regard, moving to 900 nm for TPA does not 
necessarily have to increase the absorption cross-section ı. And, as noted above, 
another advantage of using a laser irradiation of 800 nm is its low cost and ease of 
obtaining. Nevertheless, we analyzed the ability of the compound bpy2 to the TPA 
upon the excitation with 900 nm waves. However, there was no significant change in 
the ı-value (Table 2.4). 
The obtained values of nonlinear optical parameters for compounds cis2, trans2 
and bpy2 are close to those published in literature where the donating fragment is 
represented by fluorene fragment.107 These values are also close to the nonlinear 
parameters of typical push-pull molecules, in particular, 4-dialkylamino-4'-
nitrostilben (DANS, ı = 88 GM), disperse red (ı = 110 GM). However the obtained 
complexes possess a considerably lower capability of participating in TPA regarding 
to the highest known ı among the ruthenium complexes. In particular, for one of the 
ruthenium coordination compounds – tris(bipyridyl) complex, in which the ligands 
contain donating dibutylaminophenylvinyl substituents – this value is 2200 GM. But 
the comparison of the complexes cis2, trans2 and bpy2 with this type of compounds 
may be somewhat incorrect because of their substantially different structure. Thus, 
the high value of ı for the described tris(bipyridyl) ruthenium complex is likely to be 
due to its octupolar structure and to the presence of strong donating substituents in 
bipyridyl ligands.113
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Thus, we have proposed a new nitric oxide donor – [RuII(FT)(bpy)(NO)] (PF6)3, 
which has several advantages over previously known [RuII(FT)Cl2(NO)](PF6). Those 
are: a simpler method for obtaining a compound, its higher stability (as a result of 
replacing of labile chloro-ligands with chelate 2,2'-bipyridine) that will definitely 
increase its stability in the biological environment. The quantum yield of NO release 
from the new complex is 0.06 and is close to trans1, which is likely to be due to the 
trans-effect of pyridine rings in complexes. The TPA cross-sections for all three 
compounds cis2, trans2 and bpy2 have been investigated and are within 80-120 GM 
at the wavelength Ȝ = 800 nm. 
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CHAPTER 3. PYRIDOISOINDOLE AND ISOMERIC HETEROCYCLES 
AS DONATING FRAGMENTS IN {Ru-NO} COMPLEXES: THEORETICAL 
INVESTIGATION. 
The fluorenyl substituent acting as a donor fragment in the studied ruthenium-
nitrosyl complexes cis1, trans1, bpy1 and their analogs containing alkyl substituents 
in the 9th position of fluorene plays the role of a source of electron density 
transmitted to the {Ru-NO} withdrawing group upon excitation of the compound 
with electromagnetic radiation of 405 nm wavelength in single-photon activation, or 
800-900 nm in two-photon absorption. In addition, fluorene plays the role of an 
antenna for the absorption of two photons in TPA. The high efficiency of this 
polycyclic fragment in TPA is confirmed by numerous studies and an increasing 
interest in its application in the design of compounds with nonlinear optical (NLO) 
properties.114,115 
The mechanism of the nitric oxide photorelease from ruthenium-nitrosyl 
compounds remains a controversial issue. And its investigation by methods of 
theoretical chemistry is an urgent question. However, the first step in obtaining NO 
from its coordination compounds is believed to be the transfer of electron density 
toward a strongly withdraing group {Ru-NO}. It was therefore assumed that the 
enhancement of the push-pull nature of the complex can increase the efficiency of 
this transition. Given that this electronic transcription should also be active in the 
TPA, further work was aimed at finding potential donor fragments that being 
introduced into complexes with already available acceptor group {Ru-NO} would 
enable the design of effective one-dimensional push-pull systems highly active in 
TPA.116
In the case of long range delocalized push-pull effects, the expression of ıTPA
can be tentatively approached by a simple two-level model involving the current gĺ
e transition as follows:117
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3.1 
In this equation, Ege is the energy of the transition,  its oscillator strength, Ɋ୥୥
and Ɋୣୣ the dipole moments in the ground and excited states, respectively. It is 
interesting to point out that equation 3.1 is reminiscent of the simplified but widely 
used “two-level” description of the first hyperpolarizability (ȕ in equation 3.2), which 
relates the property to the sum of the contribution of each of the g ĺ ei transitions as 
follows:118
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3.2 
an expression in which m is the mass of the electron. 
In the case of species exhibiting strong push-pull charge transfer capabilities, the 
summation is usually restricted to the contribution of a single and low-lying 
HOMO ĺ LUMO based (g ĺ e) transition. Furthermore, the second term of the 
right part of equation (3.2) is a dimensionless coefficient accounting for ȕ dispersion 
by resonance effect, when the incident (԰ɘ) or frequency doubled (ʹ԰ɘ) energy of 
the laser is getting close to the transition energy (୥ୣ). It is therefore more relevant to 
use the intrinsic hyperpolarizability (ȕ0), independent of the laser frequency: 
઺૙ ൎ
૜܍૛԰܎൫ૄ܍܍ െ ૄ܏܏൯
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3.3. 
It is noteworthy that expressions (3.1) and (3.3) involve the same parameters 
(Ɋୣୣ െ Ɋ୥୥, f, and୥ୣ). These similarities imply that a promising strategy in the 
search for molecules with high ıTPA values should be to target molecules designed for 
high ȕ values for which the two-level model (ȕ0) has long been applied 
successfully.119
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3.1. Pyridoisoindoles and isomeric heterocycles as potentially more effective 
fluorene analogues 
In the compound trans1that was taken as the reference for this study the 
fluorenyl substituent A (Figure 3.1), as noted, plays the role of a donor of electron 
density. However, the donating properties of fluorene are quite moderate. The 
introduction of an electron rich center delocalized within the polycyclic structure 
should be a means of guaranteeing an enhancement of the donating capabilities of the  
substituent. For instance, the 
introduction of pyrrole-type nitrogen 
atom in the central node leads to the 
pyrido[2,1-a]isoindole species, in which 
a 14-ʌ-electrons path of delocalization 
can provide a sizeable push-pull effect 
either towards position 6 or 4 (B and C 
respectively, Figure 3.1).  
In the studies of Kovtunenko and Voitenko it was previously shown by 
theoretical calculations using several approaches and then proved with X-ray 
diffraction analysis and mass spectrometry that the nitrogen atom of the isoindole is 
strongly involved in the ʌ-delocalized structure.120,121 Owing to an electron-rich o-
quinonic structure, isoindole can act as an efficient electron-donating moiety. Joining 
an additional pyridine ring to the isoindole core evolves 10 ʌ-electron system to 14 ʌ-
system along with conservation of a conjugation over the entire extend of the rings.121
Pyrido[1,2-a]indole (compound D, Figure 3.1) could theoretically also act as a donor, 
and the joining of the terpyridine-ruthenium-nitrosyl moiety exactly at position 6 of 
such a system will potentially involve all double bonds in the ʌ-system conjugation.  
In the present work, various [RuII(R-terpy)(Cl)2(NO)]+ complexes bearing R 
donating substituents (isomeric to pyrido[2,1-a]isoindolyl residue) are investigated 
computationally in a research effort aimed at targeting suitable candidates for high ȕ
values, and therefore potentially enhanced TPA response. 
Figure. 3.1. Several polycyclic systems
with donating capabilities.
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For more thorough analysis of formally similar tricyclic systems with one 
nitrogen atom, we extended the spectrum of compounds and systems with those 
constructed from skeleton E (Fig. 3.1), varying the position of the nitrogen atom in 
the compound. Altogether, this approach leads to a total of 107 potential isomers. 
Owing to the large number of isomers, the only ones selected here were those having 
the whole 14 ʌ-electrons potentially involved in the path of conjugation from the 
nitrogen atom to the linkage towards the terpyridine, for a better comparison of their 
induced push-pull capabilities. The different structures can be gathered in two groups 
depending on the position of the 5-membered ring either on the side (6-6-5) or in the 
center (6-5-6) of the moiety (Scheme 3.1). 
Scheme 3.1. Isomeric ruthenium-nitrosyl complexes with donating tricyclic
substituents 6-6-5 (3.1-3.11) and 6-5-6 (3.12-3.22)and a reference compound Ⱥ' .
79 
 Note that, for the sake of simplification, the 3-fused rings systems 
(acenaphtylene derivatives) or bent structures (like an analog of linear 2-methyl-2ɇ-
benzo[f]isoindole (compound 3.1) – 2ɇ-benzo[e]isoindole) were discarded from the 
selection. 
Each system is further identified by the position of the nitrogen atom, and by 
that of the linkage. Depending on the place of the nitrogen in the rings, and to ensure 
that a tertiary amine is present in any case, any –NH group is replaced by –NMe. 
Finally, an ethenyl (-CH=CH-) unit is inserted between the polyaromatic system and 
the terpyridine moiety to reduce the steric hindrance in the molecules. This 
modification is achieved in order to decrease undesirable torsion angles and to 
enhance the conjugation of ʌ-bonds. Such alteration allows us to compare the real 
influence of the isomeric heterocycles on optical and electronic properties of the 
complexes. The compound with a fluorenyl donor substituent A' (Scheme 3.1) is a 
reference for comparing the nonlinear-optical properties of the studied complexes. 
The ruthenium complexes were optimized in gas phase using the Gaussian-09 
program package within the framework of the DFT. The details for the computed 
coordination spheres of the 23 complexes under investigations are provided in 
Table 3.1. 
The details of computational methods used are presented in experimental part of 
the work (Chapter 6).  
In the table 3.1 the parameters of cordination sphere of 23 complexes are 
compared to that of the previously reported complex trans1. The computed 
coordination spheres appear similar in any case, with largest relative bond lengths 
difference of 0.6 % observed at the Ru-N (central pyridine) between 3.7 (1.993 Å) 
and 3.12 (2.006 Å). The agreement with the experimental data available is found 
satisfactory, with a general shortening of bond lengths in the X-ray geometries, from 
those computed by DFT. 
80 
Compound Ru-NNO Ru-N 
(central py) 
Ru-N 
(lateral py) 
Ru-Cl Cl-Ru-Cl 
3.1 1.760 1.994 2.087 2.405 172.5 
3.2 1.759 2.002 2.087 2.401 171.8 
3.3 1.758 2.001 2.088 2.401 171.9 
3.4 1.759 1.995 2.087 2.404 172.4 
3.5 1.759 1.998 2.087 2.403 172.1 
3.6 1.763 1.994 2.086 2.405 172.5 
3.7 1.761 1.993 2.086 2.406 172.6 
3.8 1.764 1.998 2.085 2.404 172.1 
3.9 1.758 2.005 2.087 2.400 171.4 
3.10 1.760 1.999 2.087 2.402 172.0 
3.11 1.760 2.000 2.087 2.402 171.9 
3.12 1.758 2.006 2.088 2.399 171.4 
3.13 1.759 2.000 2.087 2.402 171.9 
3.14 1.759 1.996 2.087 2.404 172.5 
3.15 1.759 2.003 2.087 2.401 171.6 
3.16 1.758 2.001 2.087 2.402 171.9 
3.17 1.759 2.003 2.087 2.400 171.6 
3.18 1.760 1.994 2.086 2.405 172.6 
3.19 1.760 1.996 2.086 2.404 172.3 
3.20 1.759 2.005 2.087 2.400 171.4 
3.21 1.760 1.998 2.087 2.402 172.1 
3.22 1.760 1.996 2.087 2.404 172.4 
A' 1.760 2.004 2.088 2.400 171.6 
      
trans1 1.759 2.001(5) 2.081(6) 2.348(2) 172.58(6) 
   2.073(6) 2.364(2)  
Table 3.1. Main bond lengths (in Å) and angles (in °) in the computed coordination 
spheres of compounds 3.1-3.22. The values for B are experimental X-ray data, 
provided as references.  
3.2. Quantum-chemical calculations of nonlinear optical parameters of 
complexes. 
The relevant NLO parameters (β, β0, and σTPA) of the 22 selected isomers are 
gathered in Table 3.2. It is important to note that, while β corresponds to the 
quadratic NLO response of the entire molecule (equation 3.2), β0, and σTPA refer to 
response of an individual transition from the (g) ground to a given (e) excited state. 
The excited states given in the table correspond to the only ones providing significant  
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β0 values. To further simplify the understanding, β0, and σTPA are expressed as 
relative values, those of the A' reference system being taken as 1. 
The first thing to observe in the Table 3.2 is that the β values of compounds 3.1-
3.22 are generally larger than that of the reference compound A'. This confirms the 
donating capabilities of the electron-rich heterocyclic amines. Nevertheless, this 
tendency is not observed in compounds 3.3, 3.9, 3.12, 3.14, and 3.20, which 
Compound β 
(10−30 cm5 esu-1) 
# excited state relative β0
value 
relative 
σ value 
3.1 487.2 i=1 0.83 0.24 
3.2 732.3 i=1 0.96 0.56 
 i=5 0.63 0.57 
3.3 450.4 i=1 1.32 1.01 
3.4 475.8 i=1 0.90 0.30 
3.5 502.3 i=1 1.34 0.48 
3.6 2709.9 i=1 0.58 < 0.01 
3.7 1539.5 i=1 2.82 0.57 
3.8 2751.7 i=1 3.34 0.09 
3.9 301.4 i=1 0.29 0.15 
3.10 1130.0 i=1 0.96 0.10 
3.11 733.2 i=1 1.37 0.03 
3.12 233.1 i=3 0.48 0.52 
 i=5 0.15 0.21 
3.13 754.2 i=1 1.43 0.48 
3.14 376.1 i=1 0.74 0.24 
3.15 540.4 i=1 0.85 0.28 
3.16 553.3 i=1 1.04 0.53 
3.17 975.3 i=1 0.97 0.28 
3.18 855.1 i=1 1.30 0.27 
3.19 782.8 i=1 0.94 0.08 
 i=8 0.19 0.10 
3.20 328.8 i=1 0.21 0.03 
 i=7 0.21 0.11 
3.21 1289.8 i=1 1.48 0.34 
3.22 1041.2 i=1 1.11 0.25 
  i=8 0.54 0.43 
Ⱥ' 463.2 i=4 1 1 
Table 3.2. NLO quadratic (β and relative β0 related to the ith transition) and 
cubic (relative σTPA cross-section related to the ith transition) for 3.1-3.22, and 
Ⱥ' for which β0 and σTPA are set at 1, and used as references.
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emphasizes the role of the conjugation path, although the delocalization over the 
whole extent of the π-system is present in any case. 
More generally, what strikes from the examination of Table 3.2 is the magnitude 
of the computed values, for isomeric species containing the same acceptor (NO), 
conjugated path length (arylethenyl-substituted terpyridine) and closely related 
donors. Indeed, β ranges from 233.1 (3.12) to 2751.7 (3.8) × 10-30 cm5 esu-1, β0 from 
0.21 (3.20) to 3.34 (3.8), and σTPA from <0.01 (3.6) to 1.01 (3.3). 
3.3 Push-pull effects in studied complexes  
Computed ȕ values around 100·10-30 cm5 esu-1 are rather common in conjugated 
organic species.122 Values larger than 1000·10-30 cm5 esu-1 have occasionally been 
found in the case of donor-acceptor effects extended over a path of conjugation in the 
range of 20 bonds.123 Few experimental data have been reported in which the 
withdrawing core is based on a RuII center. Representative examples are provided in 
Figure 3.2.  
  
ȕ = 420 ·10-30 ɫm5 esu-1 ȕ0 = 300 ·10-30 ɫm5 esu-1
Figure 3.2. Ruthenium-organic chromophores with sizeable
experimental quadratic NLO response in dipolar (left) and 
octupolar (right) geometries.
They are associated with typical ȕ values around 300-500·10-30·cm5 esu-1. Therefore, 
the large values computed here (ȕ = 2709.9 and 2751.7·10-30 cm5 esu-1 for 3.6 and 
3.8, respectively) may be accurate and therefore deserve further analyses. 
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Following the conventional picture of donor-acceptor chromophores, increasing 
β would imply increasing the push-pull effect from the heterocyclic amine towards 
the Ru(NO) core. This should normally lead to an increase of the electron transfer to 
an antibonding π* orbital of the nitrosyl ligand, with the outcomes of an increase of 
the electron density (Mulliken population) on NO, and a decrease of the Ȟ(NO) 
stretching frequency. This is illustrated in Figure 3.3.  
It is worth pointing out 
that the computed Ȟ(NO)
frequencies appear larger 
than experimental data,92 a 
discrepancy which has to be 
related to the modest 
accuracy of the 
computational method. 
Nevertheless, comparing the 
differences in frequencies 
instead of the absolute 
values is more reliable in this case. 
Owing to the crude tendency observed in the Figure 3.3, the ȕ values of 
compounds 6 and 8 should lie in the 1000 – 2000·10-30 cm5 esu-1 range. Therefore, 
the large computed values (> 2500·10-30 cm5 esu-1) strongly suggest that the 
properties cannot be fully understood within the framework of the simplified two-
level model in these species. 
The possible explanation for the observed ȕ values could be the following 
statement: the larger the shortest conjugation path, the higher the hyperpolarizability. 
In other words, the most efficient of them are those in which the 14 π-electrons are 
necessarily involved in the path of delocalization. This is exemplified in Scheme 3.2 
for complexes 3.10 (β = 1130 × 10-30 cm5 esu-1), and 3.11 (β = 732 × 10-30 cm5 esu-1), 
which contain the same R isomer, and accepting (A) moieties, but differ in the  
Figure 3.3. ȕ values against Ȟ(NO) frequencies for 
the series of 3.1-3.22 derivatives. 3.6 and 3.8 are 
excluded for the computation of the trend line.
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position of the linkage. While the 
only path of delocalization involves 
the 14 π-electrons in 3.10, a shorter  
possibility occurs in 3.11 in which 
only 10 π-electrons contribute to the 
mesomeric equilibrium (bottom of 
Scheme 3.2). 
In support of such theory it is 
worth mentioning that all compounds, 
in which the shortest conjugation path 
is represented by 6ʌ-electons chain 
(3.1, 3.3, 3.4, 3.14, 3.16) don’t 
display hyperpolarizability values higher than 553.3 (for compound 3.16). 
Interestingly, the only complexes in which the whole π-electrons of R are 
necessarily involved in the path of delocalization are 3.6, 3.7, 3.8, and 3.10. They 
correspond to the species associated to the highest β values, which suggests that this 
is probably a key electronic parameter to account for their enhanced capabilities. 
Additionally, the β0 values associated to the contribution of the dominant 
transitions of 3.1-3.22 are gathered in Table 1. In most cases, a single and low-lying 
HOMO ĺ LUMO based transition leads to a significant β0, as anticipated in most 
push-pull organic chromophores.119 Nevertheless, a second transition is involved in 
complexes 3.2, 3.12, 3.19, 3.20, and 3.22, however with a reduced weight, except in 
the case of 3.20, where two transitions (0 ĺ 1 and 0 ĺ 7) lead to the same β0 value. 
At this stage, the issue of a correlation between β and the dominant β0 arises 
naturally, in an attempt to provide a simple picture of the quadratic NLO response. β
is drawn against β0 in Figure 3.4.  
Scheme 3.2. Possibilities for mesomeric 
equilibrium between the nitrogen rich donor 
and the accepting (A) moieties in 3.10 and 
3.11.
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Figure 3.4. Relative β0 against β for 3.1-3.22 and Ⱥ'.
Asserting that β0 scales like β would far be excessive. Nevertheless, there is a 
rough tendency, for larger β0 values in the case of larger β value, except in compound 
3.6. The parameters used in the computation of β0 (equation 3.3) are gathered in 
Table 3.3. Finding λmax values in the 500 – 1 000 nm range is fully acceptable in 
push-pull molecules with delocalization over the whole extent of a chain containing  
more than 20 π-electrons. Nevertheless, λmax values larger than 2 000 nm (3.6 and 
3.8) are rather surprising. The fact that they are associated with transitions of 
unusually weak intensity (3.8) or unusually reduced μee – μgg value (3.6) makes these 
species definitely unconventional. And understanding of the nature of these 
compounds requires both more profound theoretical and experimental analyses that, 
by-turn, raises the issue of the synthetic feasibility of such complexes. 
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Compound transition λmax f μee – μgg composition 
3.1 0 ĺ 1 581 1.14 8.22 HOMO ĺ LUMO (87 %) 
3.2 0 ĺ 1 623 0.46 19.2 HOMO ĺ LUMO (83 %) 
3.3 0 ĺ 1 578 0.70 21.7 HOMO ĺ LUMO (82 %) 
3.4 0 ĺ 1 569 1.18 9.17 HOMO ĺ LUMO (85 %) 
3.5 0 ĺ 1 662 0.76 13.5 HOMO ĺ LUMO (76 %) 
3.6 0 ĺ 1 2183 0.12 1.07 HOMO ĺ LUMO (59 %) 
3.7 0 ĺ 1 824 0.96 11.7 HOMO ĺ LUMO (84 %) 
3.8 0 ĺ 1 2236 0.06 10.9 HOMO ĺ LUMO (85 %) 
3.9 0 ĺ 1 727 0.07 22.9 HOMO ĺ LUMO (77 %) 
3.10 0 ĺ 1 881 0.45 6.84 HOMO ĺ LUMO (83 %) 
3.11 0 ĺ 1 896 0.32 13.3 HOMO ĺ LUMO (67 %) 
3.12 0 ĺ 3 496 0.39 22.7 HOMO ĺ LUMO (80 %) 
3.13 0 ĺ 1 699 0.67 13.9 HOMO ĺ LUMO (80 %) 
3.14 0 ĺ 1 555 1.14 8.43 HOMO ĺ LUMO (87 %) 
3.15 0 ĺ 1 709 0.38 13.9 HOMO ĺ LUMO (80 %) 
3.16 0 ĺ 1 603 0.68 15.6 HOMO ĺ LUMO (80 %) 
3.17 0 ĺ 1 920 0.13 20.8 HOMO ĺ LUMO (74 %) 
3.18 0 ĺ 1 656 1.34 7.60 HOMO ĺ LUMO (92 %) 
3.19 0 ĺ 1 919 0.41 6.50 HOMO ĺ LUMO (67 %) 
3.20 0 ĺ 1 999 0.03 13.9 HOMO ĺ LUMO (78 %) 
0 ĺ 7 514 0.30 11.8 HOMO-1 ĺ LUMO (73 %) 
3.21 0 ĺ 1 756 0.68 11.1 HOMO ĺ LUMO (87 %) 
3.22 0 ĺ 1 822 0.59 9.77 HOMO ĺ LUMO (65 %) 
Ⱥ' 0 ĺ 4 464 1.21 18.4 HOMO ĺ LUMO (79 %) 
Table 3.3. Dominant transition for ȕ0: absorption maxima (Ȝmax) in nm, intensity (f), 
ȝee – ȝgg in D, and composition of the configuration interaction. 
3.4 Quadratic (β) against cubic (σTPA) properties of complexes. 
The capability of the complexes 3.1-3.22 for TPA is estimated by the relative ı
values (ı for the reference compound A' taken as 1), calculated by formula 3.1. The 
experimental value is known only for the complex with the fluorenyl substituent A 
(Figure 3.1), which is 100 ± 13 GM.107
The examination of the data leads to the first conclusion that, in spite of their 
donating capabilities, the heterocyclic amines do not enhance the σTPA values with 
respect to that of the fluorenyl-based A' reference. More generally, there is no 
correlation between σTPA and β0. Additionally, it can be observed in Table 3.2 that, 
when two low-lying intense transitions are present (compounds 3.2, 3.12, 3.19, 3.20, 
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3.22), the lowest energy transition is associated with the highest β0 value. This is not 
the case for σTPA where the highest energy transition appears to be that of larger 
cross-section, except in 3.12. This difference points out the versatility of the energy 
as a key parameter in the prediction of the NLO properties.  
In push-pull species, the fact that β varies as 1/E3 leads to the expectation of 
efficient NLO effects restricted to the contribution of the 1st (HOMO/LUMO-based) 
excited state. In the [R-T-RuII(Cl)2(NO)]+ complexes built up from R-donor 
substituted terpyridines, the electron densities at the LUMO level are mostly located 
on the Ru(NO) moieties and therefore, are rather unaffected by the presence of the 
substituent.86 By contrast, R provides the main contribution to the HOMO level. This 
is illustrated in Figure 3.5. 
The HOMO energy level 
appears to be the ultimate 
microscopic parameter to account 
for β, along the 3.1-3.22 series: 
the highest the HOMO energy, 
the lowest the transition energy, 
and hence the highest the β value.  
By contrast, the 
requirement for low-energy 
transition appears much less 
pressing in σTPA. Indeed, in the 
case of compounds 3.2, 3.12, 
3.19, 3.20, and 3.22, where two low-lying intense transitions are present, the trend is 
that the second transition leads to higher σTPA value. In Table 2, the only parameter 
which varies as σTPA within a given molecule is the oscillator strength f, which leads 
to the conclusion that, in push-pull species, the two-photon absorption spectrum 
should be reminiscent of the one-photon absorption. Nevertheless, determining 
Figure 3.5. HOMO (blue) and LUMO (red) 
energies of compounds 3.1-3.22 against ȕ.
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precisely the full extent of σTPA within a series of related molecules (e.g. 3.1-3.22) 
remains a very challenging issue. 
The prediction of extremely large β values in some of the isomers under 
investigation within the 3.1-3.22 series raises the issue of their synthetic feasibility. 
This should likely depend on the availability of the heterocyclic amine system (R) 
and the possibility of its modification for further coupling with the terpyridine 
moiety. To reach these target species, several strategies are currently being the 
subject of intense investigation, notably indenopyridines (3.17-3.22),124 isoindoles 
(3.1) and pyridoisoindoles (3.13-3.14).125 A literature survey reveals that the 
cyclopentaquinolines species precursors of molecules 3.6-3.8 were never approached, 
either theoretically or experimentally that could be related to their potential 
instability. In order to evaluate the stability of the complexes in the first 
approximation, we compared their free Gibbs energies (ǻG) obtained by quantum-
chemical calculations. 
To be relevant, the comparison has to be carried out on molecules having the 
same formula, which are here the molecules in which –NH was replaced by –NMe. It 
appears that, while the 
carbazole-based compound 
3.12 is the stablest one, the 
most efficient materials 
(3.8, 3.6, and 3.7) 
correspond to the most 
unstable species (Figure 
3.6). In order to find a 
simple rationale to account 
for the relative instability of 
molecules such as 3.6, 3.7, 
3.8, the examination of 
Scheme 3.1 shows that they 
Figure 3.6. Gibbs free energy of isomers with 
N-methylheterocyclic substituents drawn against β. 
The energy of the carbazole-based 3.12 is set at zero.
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possess no aromatic sextets, by contrast to the stable species 12, which possesses 2 of 
them. 
Thus in this theoretical study, for the complexes 3.1-3.22, the nonlinear optical 
parameters of the second order (ȕ) and the third order (ı) vary in wide range. The 
values of the TPA cross-section ı are generally lower than those of the reference 
compound A'. But the values of their hyperpolarizability in some cases are several 
times higher than that for A '. Nevertheless, the most promising systems correspond 
to the isomers of higher free Gibbs energy, thus pointing out the challenging issue of 
their synthetic availability.  
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CHAPTER 4. ENHANCEMENT OF THE EFFICIENCY OF 
RUTHENIUM-NITROSYL COMPLEXES IN TPA 
Replacing two chloro-ligands with the 2,2'-bipyridine molecule, as shown in 
chapter 2, leads to a decrease in the quantum yield of nitric oxide photorelease, but 
somewhat increases the efficiency of the complex in two-photon absorption (TPA). 
The overall efficiency of NO-donor can be estimated from its ability to release NO 
when the compound is activated by two photons. For this purpose it is convenient to 
use a parameter similar to brightness for fluorescent compounds, which is the product 
of the molar extinction coefficient of luminescent material (İ) and the quantum yield 
of the luminescence (ĳ). For ruthenium-nitrosyl compounds that release nitric oxide 
when irradiated with UV light this parameter will be the product of the molar 
extinction coefficient of the complex and the NO-release quantum yield (ĳ) - İ·ĳ. By 
replacing the molar extinction coefficient with its corresponding parameter for two-
photon absorption, the TPA cross-section ı, we obtain the expression ı·ĳ, which can 
serve as a parameter for comparing two ruthenium-nitrosyl complexes in their ability 
to act as NO-donors under two-photon activation. 
The strategy of the search for the optimal NO-donor should be based on an 
increase of both parameters, while we give preference to the enhancement of ı. This 
choice is primarily due to the fact that an increase in the quantum yield of a 
photorelease up to several times can significantly complicate the process of obtaining 
and further work with ruthenium-nitrosyl complex, since even a momentary 
exposition of the compound to the radiation of UV-visible frequency range of the 
spectrum will initiate the decomposition of the complex. 
This chapter is devoted to the attempts made to increase the value of the cross-
section of TPA by chemical modification of the structure of organic ligands present 
in ruthenium-nitrosyl complexes. In particular, there will be discussed the effect of 
improvement of the conjugation between the donor group and the ruthenium-
terpyridine fragment on the ability of the complexes to two-photon absorption, as 
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well as the correlation between the donating ability of the substituents in the structure 
of the complex and their nonlinear optical property.  
  
4.1. Influence of the efficiency of conjugation between fluorenyl and 
terpyridine-ruthenium nitrosyl fragments on the ability of complexes to TPA 
The efficiency of the electron density transfer from a donor to an acceptor in an 
organic fluorenyl-terpyridine ligand of ruthenium-nitrosyl complexes depends on the 
angle between the terpyridine plane and the donating fragment plane. As it was noted, 
the overlap of orbital is stronger, the greater the cosine of the angle between them. 
The compounds described in the Chapter 3 contain a double bond between the 
tricyclic system and terpyridine. In this way, the energy of the steric interaction of the 
hydrogen atoms belonging to these two parts of the ligand is reduced, which makes 
possible the flattenning of the ligand. A smaller angle between the mean planes of the 
donor and acceptor fragments makes the conjugation more efficient, and increases the 
ability of the molecules to display nonlinear optical properties. 
We adopted this idea to obtain ruthenium-nitrosyl complexes potentially more 
effective in TPA. The compound bpy1 was taken as a base for them (Figure 2.2). As 
a donor fragment, it was decided to use a fluorenyl substituent, which showed one of 
the highest values of the ıTPA in the theoretical study comparing to heterocyclic 14 ʌ-
electronic aromatic systems.116
Thus, in order to find out how the diminution of the torsion angle will affect the 
efficacy of the compounds in TPA, we sought to obtain the compounds shown in 
Figure 4.1 – [Ru(FCCT)(bpy)NO](PF6)3 and [(FCC3T)(bpy)NO](PF6)3, wherein the 
organic ligands FCCT and FCC3T are the compounds (E)-4'-(2-(9,9-dihexyl-
9H-fluoren-2-yl)vinyl)-2,2':6',2''-terpyridine and 4'-((9,9-dihexyl-9H-fluoren-2-
yl)ethynyl)-2,2'6',2''- terpyridine respectively . Besides, inserting the multiple bond 
between two fragments will not only improve the conjugation but also enlarge the ʌ-
system of the molecule. Along with the decreasing of the angle, this effect would 
improve the polarizability of the system and consequently its ability to TPA. 
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Figure 4.1. Compounds [Ru(FCCT)(bpy)NO](PF6)3
(bottom) and [Ru(FCC3T)(bpy)NO](PF6)3 (top).
According to the DFT calculations on these complexes, the angle between the 
terpyridine and fluorenyl mean planes indeed diminishes with the introduction of a 
multiple bond for the spatial separation of the two fragments. It acquires a lesser 
value in complex with a ligand containing a double bond, but the values of the cosine 
almost do not differ for both compounds, and are approximately equal to 1 (Table 
4.1). 
L = FT 
 FCCT 
 FCC3T 
Į = 31.99° (cos Į = 0.85) 
Į = 1.56° (cos Į § 1) 
Į = 3.35° (cos Į § 1) 
Table 4.1. The values ot the angles between the mean plane of fluorenyl 
and terpyridine fragments in [Ru(L)(bpy)NO]3+  and the corresponding 
cosine values.
4.1.1 The synthesis of FCCT and FCC3T ligands 
An attempt to obtain the ligand FCCT containing a double bond between 
terpyridine and fluorene through a convergent synthesis method made it possible to 
obtain the compound in a very low overall yield. Given the fact that the final step of 
synthesis occurs with a yield of about 4%, the total yield made 0.3%. The scheme of 
synthesis followed is shown in Scheme 4.1. 
C6H13 C6H13
N
N
N
Ru N
N
NO
(PF6)3
C6H13 C6H13
N
N
N
Ru N
N
NO
(PF6)3
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Scheme 4.1. Ligand FCCT synthesis by a convergent approach.
The terpyridine core was formed in two stages according to the approach 
previously utilized by Constable and Ward.126 According to this method, at the first 
stage the Claisen condensation between 2-acetylpyridine and acetone leads to the 
obtaining of 1,5-di(pyridine-2-yl)pentane-1,3,5-trione 4.1, and subsequent cyclization 
with ammonia makes possible the formation of the terpyridine central ring substituted 
at the 4th position (4.2). Depending on how carefully the compound 4.2 was purified, 
the peak around 11 ppm in the 1H-NMR spectrum (DMSO-d6) may appear. This 
signal belongs to acetic acid, which according to the literature, forms a stable adduct 
1:1 with ketone 4.2.127 This, however, does not have a significant influence on the 
proceeding of the next step. The conversion of 4.2 to the bromo derivative is usually 
carried out using POBr3 as a solvent.128 We’ve replaced the latter with a cheaper N,N-
dimethylformamide that almost did not affect the yield of the reaction. Compound 4.5
was prepared according to the method described in the literature.129
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In order to improve the solubility of the ruthenium-nitrosyl complexes up to that 
required for the TPA (10-2 M), we introduced two n-hexyl chains in the 9th position 
of the fluorenyl system, that was done at the first stage of the modification of the 
fluorene component. The last step of obtaining of FCCT ligand, namely the coupling 
reaction, occurs with a low yield, as noted above. Unfortunately, we were not able to 
identify the by-products of this reaction. Nevertheless, we have tried to increase the 
yield of the final stage of synthesis by modifying the conditions of the reaction and 
the catalyst. 
In particular, we tried to change the position of the vinyl group. In this reaction 
modification, the aryl halide component of the Heck reaction was terpyridine triflate, 
while the vinyl moiety was attached to the fluorene. This alternative approach is 
shown in scheme 4.2. 
Scheme 4.2. An alternative way of FCCT synthesis.
The presence of a better leaving triflate group could facilitate the first stage of 
the reaction - the oxidative addition of terpyridine triflate to the catalyst. Such an 
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approach, however, did not lead to an increase of the yield of the last step of 
synthesis. 
In order to try to improve the yield of FCCT synthesis, we varied the solvent 
used (Et3N, dioxane, DMF) and the catalyst (Pd(OAc)2/PPh3, Pd(OAc)2/P(o-tolyl)3, 
[Pd(PPh3)4]). Either potash or Et3N were used as bases. None of the studied variations 
of the reaction conditions resulted in a significant increase of the total yield of the 
ligand synthesis. 
So far as previous attempts to obtain the compound were not effective, we 
decided to substantially change the approach of obtaining of FCCT ligand. Unlike the 
original convergent variant, the new path involves a linear transformation of the 
parent compound (Scheme 4.3). 
Scheme 4.3. The synthesis of FCCT ligand by a linear approach.
This method is based on the introduction of a double bond, already 
functionalized, through the Heck reaction between the alkylated bromofluorene 4.6
and ethyl acrylate. The further possibility of a direct transformation of the ester group 
into the terpyridine core eliminates the necessity for another coupling reaction. The 
cross-coupling stage was carried out according to an optimized technique described 
96 
in the literature for similar compounds.130 The reduction of the ester 4.9 followed by 
the oxidation of the resulting allyl alcohol leads to the formation of the aldehyde 
4.11. As the reference for this step we took the procedure of the reduction of 
substituted acylates, well-described in the literature.131 Then following the typical 
method of obtaining of terpyridines based on the Claisen condensation of 
corresponding aldehyde we received a chalcone 4.12. A further Michael reaction 
between the compound 4.12 and the Kröhnke salt followed by heterocyclicization 
allowed obtaining of FCCT with the total yield of 11%. The mechanism of the 
reaction is given in scheme 4.4. 
Scheme 4.4. Mechanism of Michael reaction between aldehyde 4.12 and the Kröhnke 
salt followed by heterocyclicization. 
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The structure of the FCCT molecule was confirmed by NMR (1H, 13C), 
2D-NMR spectroscopy and high resolution mass spectrometry (HRMS). 
The Kröhnke salt, 1-(2-oxo-2-(pyridin-2-yl)ethyl)pyridine-1-ium iodide was 
obtained according to the known methodology of the Ortoleva-King reaction, 
according to which 2-acetylpyridine interacts with pyridine solution of iodine 
(scheme 4.5).132
Scheme 4.5. The synthesis of the salt 1-(2-
oxo-2-(pyridin-2-yl)ethyl)pyridine-1-ium 
iodide.
The ligand containing the triple bond between the donor and acceptor fragments 
of the complex was synthesized according to a convergent scheme in 7 steps 
(Scheme 4.6). 
The reaction of terpyridone 4.2 with triflate anhydride proceeds to give a good 
yield of terpyridine triflate 4.7, which was confirmed by the appearance of the signal 
at -72.9 ppm in the 19F-NMR spectrum. 
Scheme 4.6. The synthesis of FCC3T ligand.
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The alkylated fluorene derivative 4.6 reacts with ethynyltrimethylsilane through 
Sonogashira cross-coupling giving the compound 4.13; the trimethylsilyl group was 
subsequently removed under basic conditions with the formation of ethynylfluorene 
4.14. 
The final step in the synthesis of the ligand is the reaction of cross-coupling of 
2-ethynyl-9,9-di-hexyl-9H-fluorene 4.14 with (2,2':6',2''-terpyridin-4'-yl) 
trifluoromethylsulfonate 4.7 giving FCC3T with a yield of 42%. The total yield of 
ligand synthesis was 4.6%. The structure of the compound was confirmed by NMR 
(1H, 13C) and elemental analysis. 
4.1.2 Synthesis of ruthenium-nitrosyl complexes with FCCT and FCC3T ligands 
The first step of the synthesis of ruthenium-nitrosyl complexes with terpyridine 
ligands FCCT and FCC3T is the interaction of the latter with ruthenium (III) chloride 
(Scheme 4.7). 
Scheme 4.7. The general scheme of the synthesis of ruthenium-nitrosyl complexes
with terpyridine ligands FCCT and FCC3T and 2,2'-bipyridine. The chemical shift of 
the proton highlighted in blue is the most senstitive to the substitution of monodentate 
ligand.
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The method of synthesis chosen differs from that used to obtain cis1 and trans1 
compounds, in which the ruthenium-nitrosyl moiety is introduced into the structure of 
the complex in one step by the interaction of K2[RuCl5(NO)] with a ligand.86 The 
main advantage of a new approach is the reduced formation of undesirable 
homoleptic complexes [Ru(tpy)2]2+. 
Thus the first stage of complex synthesis is the interaction of FCCT or FCC3T 
compounds with RuCl3, which results in the formation of a paramagnetic complex A 
(Scheme 4.7). In the second step, A interacts with 2,2'-bipyridine in the presence of 
triethylamine to form a diamagnetic complex B. Use of triethylamine facilitates the 
reduction of RuIII to RuII. A possible mechanism of this process is presented in 
Scheme 4.8. 
Scheme 4.8. The possible mechanism of RuIII reduction
The assumption of the mechanism is based on previously proposed mechanisms 
for the reduction of transition metal complexes with amines.133,134 These mechanisms 
involve the coordination of amines to metal atoms, with the subsequent inclusion of 
the latter in the adjacent C-H bond, which is accompanied by its breakage. The 
process ends up with the reduction of the metal center and the dissociation with the 
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proton elimination. A similar mechanism of the first stage of the process was 
published for a series of transition metal complexes (Pd, Rh, Fe, Ru, Au).134,135,136
However, in the case of complexes assuming the octahedral geometry ([Fe(CN)6]3-, 
[Ru(bpy)3]3+) that apparently are not capable of coordinating an additional 
triethylamine molecule through an associative mechanism, the process of electron 
transfer from triethylamine molecule is likely to occur without direct bidning (step 1, 
scheme 4.8). Complex B is more likely to be attributed to this case. 
An iminium cation formed as a result of the oxidation of triethylamine 
undergoes hydrolysis to carbinolamine (step 2, scheme 4.8) that breaks down to form 
diethylamine and acetaldehyde (step 3). 
The use of lithium chloride in the second step of the synthesis prevents the 
formation of a significant amount of homoleptic complex due to the decreasing of the 
dissociation of chloro-ligands in the complex B. 
The formation of complexes C and D can be easily monitored by NMR 
spectroscopy. The proton H(1) in position 6 of bipyridine (depicted in blue in scheme 
4.7) is spatially approached to a single monodentate ligand present in the complex. Its 
chemical shift in the 1H-NMR spectra strongly depends on the nature of this ligand 
(Cl, NO2, NO). In fact, according to the crystallographic data for the analogous 
complex that will be described in Chapter 5 containing substituted terpyridine and 
2,2'-bipyridine ligands ([RuII(MeO-Phtpy)(bpy)(NO)](PF6)3), the distance between 
proton H(1) and atoms of nitrosyl ligand N(1) and O(1) in the complex D are 
2.595(1) and 2.719(1) Å respectively. Therefore the replacement of the ligand ClØ
with ଶି  and finally with NO+ leads to a gradual move of the peak of atom H(1) 
upfield. This effect is shown in Figure 4.2 for the FCC3T-based complex. When in 
addition to the terpyridine ligand and 2,2'-bipyridine the coordination polyhedron 
contains the Cl-atom, the chemical shift of the proton H(1) is 10.23 ppm (in 
CD3OD), whereas for its nitroanalogue the peak of the proton H(1) is at 9.90 ppm (in 
CD3OD). In the final ruthenium-nitrosyl complex the peak of the corresponding 
proton is located at 9.31 ppm (in CD3CN). 
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4.1.3 Electronic spectra of [Ru(FCCT)(bpy)NO](PF6)3 and 
[Ru(FCC3T)(bpy)NO](PF6)3.  
Experimental electronic spectra of both complexes and spectra obtained from 
quantum-chemical computations are presented in Figure 4.3. 
Figure 4.3. Experimental and computed electronic spectra of compounds
[Ru(FCCT)(bpy)NO](PF6)3 (left) and [Ru(FCC3T)(bpy)NO](PF6)3 (right).
Figure 4.2. The changes in 1ɇ-NMR spectra when replacing the monodentate ligand 
in the structure of complex. Spectra of compounds [Ru(FCC3T)(bpy)Cl]Cl and
[Ru(FCC3T)(bpy)NO2]Cl are obtained from the solutions in CD3OD, 
[Ru(FCC3T)(bpy)NO]Cl – from the solution in CD3CN. 
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To facilitate the process of optimization of the geometries of molecular ions the 
quantum-chemical calculations were carried out on complexes containing methyl 
groups in the 9th position of the fluorenyl moiety instead of n-hexyls. This however 
doesn’t affect significantly the distribution of electron density in the ion.  
The most obvious difference of spectrum of the complex with FCC3T ligand 
from the one of the complex with FCCT ligand is the presence of two absorption 
bands in the region 350-500 nm, while the electronic spectrum of the compound 
[Ru(FCCT)(bpy)NO](PF6)3 shows only one absorption band at these wavelength. The 
spectra calculated by the TD-DFT method are in an acceptable agreement with the 
experimental results. The largest deviation of 0.35 eV can be observed for the low-
energy band of the complex [Ru(FCCT)(bpy)NO](PF6)3.  
The parameters of the absorption bands in the experimental and computed 
electronic spectra of the complexes [Ru(FCCT)(bpy)NO](PF6) and 
[Ru(FCC3T)(bpy)NO](PF6)3  are presented in Table 4.2 and Table 4.3, respectively. 
 Experimental spectrum Computed spectrum 
Ȝmax (nm) İ (M-1·ɫm-1) Ȝmax (nm) f
Band 1 308 36 215 291 0.8189 
Band 2 493 25 103 432 1.6337 
Table 4.2. Absorption bands in experimental electronic spectrum of the compound 
[Ru(FCCT)(bpy)NO](PF6)3 compared to those of electronic spectrum for the ion 
[Ru(FCCT)(bpy)NO]3+ computed by TD-DFT  at CAM-B3LYP/6-31G* level of 
theory. 
 Experimental spectrum Computed spectrum 
Ȝmax (nm) İ (M-1·ɫm-1) Ȝmax (nm) f
Band 1 296 47 386 279 0.8010 
Band 2 375 18 729 381 0.8425 
Band 3 465 20 200 457 0.8027 
Table 4.3. Absorption bands in experimental electronic spectrum of the compound 
[Ru(FCC3T)(bpy)NO](PF6)3 compared to those of electronic spectrum for the ion 
[Ru(FCC3T)(bpy)NO]3+ computed by TD-DFT  at CAM-B3LYP/6-31G* level of 
theory. 
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The analysis of orbitals involved in the electronic transitions in the cation 
[Ru(FCCT)(bpy)(NO)]3+ shows that none of the possible excitations of a molecule 
results in an activation of the transfer of electron density directly from fluorenyl 
fragment to the {RuNO} center, and the least energetic intense transition (0 ĺ 7) 
occurs purely within the fluorenyl-terpyridine ligand. 
A completely different picture is observed for the ion [Ru(FCC3T)(bpy)(NO)]3+. 
Both low-energy absorption bands (Ȝ = 465 nm, Ȝ = 375 nm) appear due to the 
presence of transitions in which the electron density moves from fluorene to the 
strongly accepting ruthenium-nitrosyl fragment (Table 4.5). 
Although similar transitions are still present in the compound 
[Ru(FCCT)(bpy)(NO)](PF6)3 their intensity is very small. In particular, the transition 
to the second excited state (Ȝ = 559 nm) is basically a HOMO-LUMO (71%) 
transition and this excitation causes 
the electron transfer from fluorene to 
{Ru(bpy)NO}, however, we do not 
observe such an absorption neither in 
the theoretical computed spectrum 
nor in the experimental because of its 
low intensity (f = 0.0009). An 
explanation for this may be the 
orthogonality of the HOMO (ʌ of 
fluorene-terpyridine) and the LUMO 
(dʌ* of RuNO) orbitals (Figure 4.4), 
and therefore the impossibility of the 
efficient transfer of the electron from the donor to the acceptor. 
Another transition, which, according to calculations, involves the contribution of 
the electronic density transfer from fluorene to the ruthenium-nitrosyl fragment, is the 
transition 0 ĺ 6 at Ȝ = 441 nm. According to Table 4.4, this excitation doesn’t imply 
the charge transfer from fluorene to ruthenium-nitrosyl moiety, but as little as 4% of 
contribution to 0 ĺ 6 is still made by the excitation Ȥ174ĺ Ȥ176, where 174 - HOMO, 
Figure 4.4. HOMO and LUMO orbitals of 
the cation [Ru(FCCT)(bpy)(NO)]3+. 
106 
and 176 is an orbital located on the {RuNO}-fragment and rotated by an angle of 90° 
around the axis Ru-N relative to the orbital 175 (LUMO), shown in Figure 4.4. This 
arrangement of the orbitals 174 and 176 makes it possible the electron transfer from 
fluorene to the ruthenium-nitrosyl fragment, but its small contribution to the 
transition 0 ĺ 6 makes it ineffective. 
As opposed to the compound 
[Ru(FCCT)(bpy)(NO)](PF6)3, all 
transitions in the complex with FCC3T 
ligand implying fluorene ĺ {RuNO} 
contribution have significant intensity, and 
in particular, the HOMO and LUMO 
orbitals involved in the least energetic 
electron transition 0 ĺ 1 and inducing the 
appearance of the band 3, are not 
orthogonal (Fig. 4.5). 
Taking into account the results of the 
theoretical study, we assumed that the 
release of nitric oxide under irradiation of 
the complex with triple bond would be much more effective than in the case of the 
complex with the ligand FCCT.  
4.1.4. The study of NO-release from complexes [Ru(FCCT)(bpy)NO](PF6)3 and 
[Ru(FCC3T)(bpy)NO](PF6)3
The investigation of the process of nitric oxide photorelease from complexes 
was carried out on their solutions in acetonitrile. The excitation occurred at a 
wavelength Ȝ = 436 nm. This wavelength corresponds to the transition 0 ĺ 7 in the 
compound with double bond and lies between transitions 0 ĺ 1 and 0 ĺ 6 in the 
compound with triple bond. Thus both exciations provide very different charge 
transfer character: ligand-to-ligand in [Ru(FCCT)(bpy)NO](PF6)3 and ligand to 
RuNO in [Ru(FCC3T)(bpy)NO](PF6)3. The change in the electronic spectra of 
Figure 4.5. HOMO and LUMO 
orbitals of the cation 
[Ru(FCC3T)(bpy)(NO)]3+.
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acetonitrile solutions of compounds observed during the experiment is presented in 
Figure 4.6. 
Figure 4.6. The changes in electronic spectra of acetonitrile solutions of compounds
[Ru(FCCT)(bpy)(NO)](PF6)3 (left) and [Ru(FCC3T)(bpy)(NO)](PF6)3 (right) 
observed under irradiation with electromagnetic waves Ȝ = 436 nm.
The presence of sharp isosbestic points in both cases (393, 354, 327, 255 nm – 
compound [Ru(FCCT)(bpy)(NO)](PF6)3; 491, 461, 383, 253 – compound 
[Ru(FCC3T)(bpy)(NO)](PF6)3) indicates the direct transformation of the starting 
complexes into final photoproduct without the formation of intermediates. The back-
reaction was not observed when the irradiation of the solutions was suspended. 
Interestingly, the quantum yield of the photoreaction of the nitric oxide release for 
both compounds was the same – 0.03. This contradicts the assumption that a 
compound in which the excitation results in the transfer of electron density from the 
fluorene to ruthenium nitrosyl fragment – [Ru(FCC3T)(bpy)(NO)](PF6)3 – should 
display an enhanced value of NO-release quantum yield. Obviously, the transition of 
the electron density from the donating moiety of the complex to the antibonding 
orbital located on the fragment {RuNO} is not the only factor that influences the 
efficiency of the photoactivation of NO-release. 
It should be noted that, as in the case of bpy1, the absence of a wide absorption 
band in the spectra of photoproducts in the region of 500-700 nm may indicate the 
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formation of the complex with ruthenium in oxidation state +2 – 
[Ru(FCCT)(bpy)(CH3CN)]2+ and [Ru(FCC3T)(bpy)(CH3CN)]2+. 
4.1.5 The study of two-photon absorption of compounds 
[Ru(FCCT)(bpy)(NO)](PF6)3 and [Ru(FCC3T)(bpy)(NO)](PF6)3 
Investigation of two-photon absorption of both complexes was carried out at 
different values of the intensity of laser radiation. The increase in the energy of laser 
pulses (which corresponds to an increase in the intensity of the exciting light) leads to 
an almost linear decrease in the transmission of radiation by a sample (Figure 4.7). 
This fact, as well as the absence of significant distortion of the background 
transmission line, suggests that other effects, other than two-photon absorption, do 
not occur during the experiment. The transmission curves are shown in Figure 4.7. 
Figure 4.7. Laser irradiation (Ȝ = 800 
nm) transmission curves for compounds 
[Ru(FCCT)(bpy)(NO)](PF6)3 (top left) 
and [Ru(FCC3T)(bpy)(NO)](PF6)3 (top 
right). Decrease in the transmission with 
the increase of the laser pulses intensity 
(bottom right). 
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The obtained values of the two-photon absorption coefficients and the 
corresponding values of the TPA cross-sections are summarized in Table 4.6. 
Compound ȕ·1011 cm/W ı, GM 
[Ru(FCCT)(bpy)(NO)](PF6)3 3.17 131 
[Ru(FCC3T)(bpy)(NO)](PF6)3 3.63 150 
Table 4.6. Two-photon absorption coefficients ȕ and the corresponding 
values of the TPA cross-sections ı for compounds cis2, trans2, bpy2. 
Thus, the introduction of a multiple bond between the donor group and the 
acceptor terpyridine ruthenium-nitrosyl fragment in the organic ligand reduces the 
steric interaction between two moieties and increases the polarizability of the 
compound. This leads to a more efficient interaction of the ʌ-systems of both parts of 
the ligand and facilitates the process of intramolecular charge transfer. This effect 
manifests itself in the bathochromic shift of low-energy electronic transitions in the 
compounds and the increase of their efficiency in two-photon absorption. The 
compound [Ru(FCCT)(bpy)(NO)](PF6)3 exhibits a slightly lower capacity for two-
photon absorption at wavelength Ȝ = 800 nm compared to the 
[Ru(FCC3T)(bpy)(NO)](PF6)3 complex. The introduction of the triple bond leads to 
an increase in the TPA cross-section by 40%, while the double bond causes an 
increase of ı only by 21%. An explanation for such a difference could be the 
configuration of the electronic transitions of both compounds, namely: none of the 
electronic transitions in the molecular ion [Ru(FCCT)(bpy)(NO)]3+ by its nature is 
the transfer of the electronic density from fluorene to {RuNO}-moiety, thus there is 
no possibility of an intense transition with a significant change in the dipole moment 
of the molecule. 
4.2. Influence of the donating ability of the substituents in terpyridine 
ligands on the efficiency of ruthenium-nitrosyl complexes in TPA. 
The capacity of compounds for TPA depends on many factors. One of the key 
parameters of a molecule which determines its ability to absorb two photons of a 
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given energy is the symmetry of a molecule. In particular, it is known that the 
selection rules for transitions in centrosymmetric molecules differ from those for 
noncentrosymmetric molecules, and the spectra of two-photon and single-photon 
absorption are often very different.104 Ruthenium-nitrosyl complexes studied within 
the scope of the work refer to noncentrosymmetric dipolar compounds. As indicated 
in Chapter 3, an approximate two-level model can be used to estimate the TPA cross-
section of polar molecules, in which the excitation results in an intense transfer of 
electronic density. According to this model, ı can be described by formula 3.1 (see 
chapter 3): 
࣌ࢀࡼ࡭ ൎ 
૚૟࣊૛ࢌሺࣆࢋࢋ െ ࣆࢍࢍሻ૛
૞¾૛ࢉ૛ʒࡱࢍࢋ
Enhancement of conjugation in the chain of ʌ-bonds between a donor and an 
acceptor in a molecule results in a decrease of the energy gap between HOMO and 
LUMO, which reduces the Ege value, and increases the intensity of the transition (f). 
These changes eventually lead to some growth of ı. Another factor that has a 
significant effect on the absorption cross section is the change in the dipole moment 
(ǻȝ = ȝee - ȝgg) of the molecule during excitation, and ı depends on this parameter 
quadratically. 
 The increase in the ǻȝ-parameter can be achieved by increasing the polarity of 
the molecule. In this case, in the presence of a highly withdrawing ruthenium-nitrosyl 
site, the introduction of an electron-rich donating group into the structure could 
provide a significant increase in the dipole. Fluorene partially plays the role of such a 
group, but an additional increase in its donating ability will allow us to understand 
how the increase in the polarity and push-pull nature of the molecule will affect its 
capacity for TPA. Therefore, we attempted to introduce a donor substituent in the 
fluorenyl fragment of terpyridine ligand. The dimethylaminogroup (DMA) was 
chosen as such a substituent. The target ligands thus were DMAFT and DMAFCCT 
(Figure 4.8). 
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Figure 4.8. Strategies for increasing of TPA cross-section through 
modification of the terpyridine ligand structure. 
4.2.1. Syntheses of the ligands DMAFT, DMAFCCT and ruthenium-nitrosyl 
complexes based on them. 
At the first attempt the DMAFT ligand was obtained in 7 steps (Scheme 4.9).  
Scheme 4.9. The scheme of DMAFT synthesis.
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 The first four of them are the modification of the fluorenyl moiety – the 
introduction of n-hexyl substituents to form compound 4.6, its nitration (compound 
4.15), the reduction of the nitrogroup in the position 7 to the amino-function 
(compound 4.16), and subsequent methylation of the latter to form 7-bromo-9,9-
dihexyl-N, N-dimethyl-9H-fluorene-2-amine (4.17). The modification was carried 
out by a slightly modified approach, described in the literature.137 The last two steps 
of synthesis – condensation with 2-acetylpyridine and the Michael reaction followed 
by heterocyclicization – were carried out similarly to the reactions used to synthesize 
the FCCT compound, although with somewhat lower yields. Thus, the total yield of 
the DMAFT compound synthesis made 2%. 
An attempt to optimize the synthesis path made it possible to increase the total 
yield of the product to 6%. The lowest yield among all the steps of synthesis was 
observed for methylation of aminogroup process. Along with the formation of a 
desired product in the reaction mixture there was a monomethylated derivative and 
the starting material, while the use of larger quantities of methyl iodide did not allow 
the production of exclusively dimethylaminofluorenyl derivative; though all three 
compounds could be isolated by column chromatography and re-introduced to the 
reaction.  
In the year 2014, another method for the obtaining of dimethylamino derivatives 
of aromatic compounds was published. The starting compounds for these amines 
according to the approach are corresponding nitro compounds (Scheme 4.10).138,139 
ɋɯɟɦɚ 4.10. Obtention of aromatic tertiary amines 
in one step from corresponding nitro derivative.  
This method is not yet widely used, but allows to obtain a dimethylamino 
derivative in one step without the use of toxic methylating reagents, such as methyl 
iodide or dimethyl sulfate. The transformation occurs in one step, in the presence of 
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Fe2+ ions playing the role of catalyst. The methylating agent in the reaction is 
dimethyl sulfoxide. The mechanism of the reaction involves the primary reduction of 
nitrofluorene to the corresponding amine. This is the point where, according to the 
studies of Beller and colleagues, iron ions play the role of a catalyst, and formic acid 
acts as a donor of hydrogen atoms.140 The acylation of DMSO leads to the formation 
of an intermediate, which, by the Pummerer rearrangement transforms into methylene 
sulphonium cation 4.20 (Scheme 4.11). 
Scheme 4.11. The mechanism of methylation fo aromatic aminogroup by
DMSO in the presense of formic acid (R = 7-bromo-9,9-dihexy.-9H-
fluoren-2-yl).
The subsequent nucleophilic attack of amine leads to the formation of 
compound 4.21, and elimination of methylthiol from 4.21 leads to the imine 4.22, 
which by-turn being reduced with formic acid produces a monomethyl derivative. 
Acting as a nucleophile the intermediate product 4.23 attacks the cation 4.20 once 
again that results in the formation of a dimethylaminogroup. 
The yield of the methylation reaction in such conditions is 63%, while the 
approach involving the transformation of nitro compound in dimethylamine 
derivative in two steps through the reduction step in total makes 22%. Thus we 
increased the yield of the synthesis of DMAFT ligand almost three times, which 
eventually made 6%. 
An attempt to obtain DMAFCCT by a convergent synthesis method (8 steps) 
similar to those shown in Schemes 4.1 and 4.2 for compound FCCT was ineffective. 
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The total yield was 0.2%. As in the case of the FCCT synthesis, the last stage, namely 
the Heck coupling between compounds 4.17 and 4.5, proceeds with a very low yield 
of 3%.Therefore, the DMAFCCT synthesis was carried out according to a linear 
scheme, which is a combination of methods for obtaining of FCCT and DMAFT. The 
first three steps are analogous to the first stages of the synthesis of DMAFT (Scheme 
4.9), the last five steps – are similar to the conversion of compound 4.6 to the final 
FCCT ligand (Scheme 4.3), with the only difference that the fluorene in this case 
contained a dimethylaminogroup. 
However, the introduction of the donor function into the fluorene structure 
substantially changed the passage of the step of coupling with ethyl acrylate and the 
subsequent transformation of the ester group. In particular, the yield of Heck reaction 
between ethyl acrylate and compound 4.17 was almost 4 times lower than for a 
similar reaction of compound 4.6, which proceeded under the same conditions 
(Scheme 4.12). 
Scheme 4.12. Comparison of the yields of coupling reaction of 
ethyl acrylate with 2-bromofluorene (4.6) and its dimethylamino 
analogue (4.17) before the optimization.  
An attempt to replace the catalytic system Pd(OAc)2/P(o-tolyl)3 with another 
palladium catalyst -[Pd(PPh3)4] increased the yield by only 2%. However, in the case 
when both catalysts were introduced into the reaction mixture the yield of compound 
4.24 made 77%. 
The following transformations performed to obtain the DMAFCCT compound 
are shown in Scheme 4.13. 
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Scheme 4.13. The synthesis of DMAFCCT.
The reduction of the ester 4.24 with diisobutylaluminum hydride leads to the 
formation of an alcohol 4.25, which under oxidation converts to aldehyde 4.26. A 
similar transformation for compound 4.9 (analogue of compound 4.24 without 
dimethylamino) readily occurs. However, the reduction and further oxidation of 
compound 4.24 is not so easy to perform. 
According to the methodology compound 4.25 is not to be purified and after 
being isolated from the reaction mixture, it is introduced in the next step with 
possible impurities present therein. This procedure reduces the possibility of side 
reactions of this allyl alcohol possible when it is exposed to the air. In the analogous 
case of the synthesis of the FCCT compound, an allyl alcohol obtained by the 
reduction of the corresponding ester was dissolved in CHCl3 and oxidized with a 
manganese(IV) oxide that resulted in the formation of a desired aldehyde with a good 
yield. However, even during a short-term exposure of the compound 4.25 to the air, it 
undergoes certain transformations that are easy to observe with the help of thin-layer 
chromatography (TLC). Quickly, instead of one pale yellow with blue fluorescence 
spot, corresponding to the alcohol 4.25 another one appears, having a slightly lower 
value of Rf. The subsequent oxidation of the mixture of these two products leads to 
the formation of the desired aldehyde 4.26 and another product. Moreover, the ratio 
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between the values of Rf for these two components of the mixture is the same as for 
the compounds in the previous step. 
Unfortunately, we were not able to identify the structure of by-products. One of 
the possible unwanted reactions that occur with compound 4.25 may be an allyl 
rearrangement. As has been shown in the studies of Jin Qu,141 allyl alcohols are 
capable of undergoing rearrangement in the presence of water, albeit at elevated 
temperatures. Thus heating of their aqueous solutions to 40-100 °C leads to 
isomerisation of allyl alcohols with yields from 56% to 99%, while water plays the 
role of acid catalyst. It was also found that the presence of donor groups conjugated 
with ʌ-bond of allylic alcohol facilitates the process of isomerisation. In view of this, 
we assume that the following reaction could take place in the process of isolation of 
an alcohol 4.25 from the reaction mixture and its exposure to the air: 
Scheme 4.14. Isomerisation of allyl alcohol 4.25 in the 
presence of water.
This step of the synthesis and the subsequent oxidation process significantly 
reduce the overall yield of the DMAFCCT ligand. In contrast to the oxidation 
reaction of compound 4.10 with MnO2 which ends in two days, the oxidation of allyl 
alcohol 4.25 does not occur at all, while long-term staying of the compound in the 
solution results in the formation of an even greater amount of the by-product. 
Additional air passage through the solution contributes to partial oxidation with the 
formation of aldehyde 4.26, but rapid alcohol degradation does not allow using this 
approach as preparative. 
In the search of an appropriate oxidant the experiments on oxidation of alcohol 
with pure oxygen, 2 iodoxybenzoic acid (IBX) were conducted as well. The most 
effective method was the oxidation of alcohol with Dess-Martin reagent. The 
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maximum yield observed for this reaction was 79%. The following condensation and 
Michael reaction worked with fairly good yields.  
Syntheses of coordination compounds based on DMAFT and DMAFCCT 
ligands were conducted similarly to the general scheme 4.7. However, the attempts to 
obtain ruthenium-nitrosyl complexes were not successful with any of them. At the 
second step of the reaction – obtaining of complex B – where it becomes possible to 
study the product by NMR (the complex becomes diamagnetic), we observed a 
decrease in the integral intensity of methyl protons of dimethylamino group, and the 
ratio between the peak intensities of protons of n-hexyl substituents and protons of 
the group -NMe2 increased. In an utmost case we observed a loss of one of methyl 
radicals of dimethylamino group with the formation of monomethylamine derivative. 
A possible explanation for this phenomenon could be the probable oxidation of the -
NMe2 group with the participation of RuIII, which occurs similarly to the 
triethylamine oxidation process at the second step of the synthesis of the complex 
described in paragraph 4.1.2. Thus the reduction of RuIII and the addition of the 2,2'-
bipyridine molecule leads to the formation of a monomethylamine derivative 
(Scheme 4.15). 
Scheme 4.15. A possible demethylation of [Ru(DMAFT)(bpy)Cl]Cl during the
second step of the complex synthesis.
This process is unexpected for us, since unlike in triethylamine the lone pair of 
electrons of the nitrogen atom of the amino group in the DMAFT ligand is strongly 
conjugated with the ʌ-system of the complex, which is evidenced by the flat structure 
of the ligand obtained during the DFT-optimization of the ion geometry. Therefore, 
the reducing properties of the -NMe2-group in the complex are probably weaker. As a 
result, the reaction mixture contained several compounds that are, unfortunately, 
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difficult to separate. Nevertheless, obtaining of the complexes with these ligands may 
be possible with the modification of the approach used in this work. 
4.2.2. Dependence of the TPA cross-section on the donor strength of the 
substituent in a row of ruthenium-nitrosyl complexes with substituted 
phenylterpyridines 
Proceeding from the complexity of the process of obtaining of substituted 
fluorenyl-terpyridines, we have synthesized a series of ruthenium-nitrosyl complexes 
containing phenylterpyridines as ligands. In these compounds, the position 4 of 
benzene ring is substituted with groups of different electron-donating abilities: -NO2, 
-H, -Br, -OMe, -NEt2. The coordination polyhedra of the complexes is supplemented 
with two chloro-ligands, and thus the synthesized compounds are analogs of the 
compounds cis1 and trans1. The first stage of their preparation, as in the case of other 
complexes described in this work, is the interaction of ruthenium(III) chloride with 
the corresponding phenylperpyridine; the second step involves passing of gaseous 
NO through the solution of the complex in DMF that leads to the formation of cis- 
and trans- isomers of the complex [Ru(RPh-tpy)Cl2NO]+. The process of nitric oxide 
photorelease from the obtained compounds was also investigated. The data are 
presented in Table 4.7. 
R ĳ(NO) 
 cis- trans- 
-NO2 0.24 0.05 
-ɇ 0.39 0.12 
-Br 0.32 0.11 
-OMe 0.28 0.07 
-NEt2 0.23 0.13 
Table 4.7. The structure of the complexes 
[Ru(RPh-tpy)Cl2NO]+, and the quantum yields  of NO-
release from them. 
A detailed discussion on the ability of these complexes to release nitric oxide 
and the dependence of their quantum yields on the structure is given in the 
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corresponding publication.102 An exception is the compounds with the group -NEt2: 
the data on these two isomers are not published at the time of the defense of the 
thesis, the values were obtained by M. Tasse, P. G. Lacroix and I. Malfant. 
The study of the efficiency of these compounds in two-photon absorption by z-
scan method was carried out on their acetonitrile solutions at a concentration of 
10-2 M. The curves of laser radiation (800 nm) transmission by the complexes 
solutions are shown in Figure 4.9. 
Figure 4.9. Laser irradiation (800 nm) 
transmission curves, obtained during the 
z-scan study of complexes with 
substituted phenylterpyridine ligands. 
(the energy of laser impulses is equal to 
49 nJ).
Among 10 complexes studied only 4 exhibited two-photon absorption, which 
could be registered in the experimental conditions. Obviously, 6 other complexes 
exhibit very low ability for TPA. As expected, those of them that contain a donating 
group, either methoxyl or dimethylamino groups, have the highest absorption cross-
sections. Compounds bearing nitrogroup, an atom of bromine or hydrogen atom, 
most of the time gave a characteristic curve similar to that shown in figure 4.9 for the 
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compound cis(Cl, Cl)-[Ru(NO2-Phtpy)Cl2NO]PF6. A characteristic sinusoidal form 
indicates that there is a thermal effect that reduces the sensitivity of the measurement. 
However, even when it was possible to obtain a curve without displaying a thermal 
effect, the signal corresponding to the minimum transmittance in the focus of the 
laser radiation source was commensurable to the background oscillations, which 
made it impossible to determine the TPA cross-sections for these compounds. 
Complexes [Ru(MeOPh-tpy)Cl2NO]PF6 and [Ru(Et2NPh-tpy)Cl2NO]PF6, both 
cis- and trans- isomers, gave typical z-scan curves shown in Figure 4.9. The study of 
all four complexes was carried out at different values of the intensity of the exciting 
radiation; and with the increase of the intensity a linear decreasing of the 
transmittance was observed. 
The values of the two-photon absorption coefficients (ȕ) and TPA cross-sections 
for compounds are shown in Table 4.8. 
 [Ru(MeOPh-tpy)Cl2NO]PF6 [Ru(Et2NPh-tpy)Cl2NO]PF6
 cis- trans- cis- trans- 
ȕ·1011 cm/W 3.22 3.73 3.44 2.73 
ı, GM 133 154 142 113 
Table 4.8. TPA coefficients and cross-sections for cis- and trans- isomers of 
compounds [Ru(MeOPh-tpy)Cl2NO]PF6 and [Ru(Et2NPh-tpy)Cl2NO]PF6.
  
All values fall in the same range of about 110-150 GM. In general, compounds 
with methoxyl substituent appear to be more efficient in TPA, in contrast to our 
expectation that the introduction of dimethylamino-function will increase the 
difference in the dipole moments between the main and the excited state more 
strongly and thus will lead to higher values of ı. Therefore more detailed theoretical 
studies of compounds are required to deeply understand the key factors that play a 
role in the two-photon absorption of ruthenium nitrosyl complexes with electron-
donating substituents. 
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Thus, we have synthesized new ruthenium-nitrosyl complexes 
[Ru(FCCT)(bpy)NO](PF6)3 and [Ru(FCC3T)(bpy)NO](PF6)3, where the torsion angle 
between fluorenyl and terpyridine fragments is reduced in comparison with bpy1. 
This effect along with the elongation of the ʌ-system enhances the interaction 
between fragments and the polarizability of the compound. A more effective transfer 
of electronic density in a complex with a FCC3T ligand does not lead to a higher 
value of the quantum yield of NO-release, but it probably contributes to an increase 
in the TPA cross-section by 40% compared with bpy1, whereas for the compound 
[Ru(FCCT)(bpy)NO](PF6)3 this value is higher by only 21%. 
It was shown that the acceptor groups in the terpyridine ligand do not lead to the 
increase in the value of ı for ruthenium-nitrosyl complexes, in contrast to the electron 
donating substituents. 
From the point of view of the ability of the compounds to release nitric oxide 
upon the two-photon activation, compounds with chloro-ligands are more effective 
comparing to their analogs with 2,2'-bipyridine. This conclusion can be made based 
on the values of the product of the quantum yield of NO-release and the TPA 
cross-section (Table 4.9). 
ĳ(NO) ı, GM ĳ(NO)·ı
cis1 0.31 100 31.0 
trans1 0.11 87 9.57 
bpy1 0.06 108 6.48 
[Ru(FCCT)(bpy)NO](PF6)3 0.03 131 3.93 
[Ru(FCC3T)(bpy)NO](PF6)3 0.03 150 4.50 
cis(Cl,Cl)-Ru(MeOPh-tpy)Cl2NO]PF6 0.28 133 37.2 
trans(Cl,Cl)-Ru(MeOPh-tpy)Cl2NO]PF6 0.07 154 10.8 
cis(Cl,Cl)-Ru(Et2NPh-tpy)Cl2NO]PF6 0.23 142 32.7 
trans(Cl,Cl)-Ru(Et2NPh-tpy)Cl2NO]PF6 0.13 113 14.7 
Table 4.9. The values of quantum yields, TPA cross-sections and the products of 
these two parameters for ruthenium-nitrosyl complexes, studied within the scope 
of this thesis. 
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The main effect on the product ĳ(NO)·ı is made by the quantum yield of NO-
release, since these values vary considerably more broadly – the maximum value 
(0.31) is 10 times larger than the smallest (0.03), whereas the difference between the 
largest value of ı (154 GM) and the smallest (87 GM) one is only 77%.
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CHAPTER 5. INVESTIGATION OF THE MECHANISM OF NO-
PHOTORELEASE FROM RUTHENIUM-NITROSYL COMPLEX WITH 
THE LIGAND 4'-(4-METOXYPHENYL)-2,2':6',2''-TERPYRIDIN 
The nitric oxide release from terpyridine ruthenium-nitrosyl complexes is not a 
one-stage process, it is quite complex to be descibed in a simplified model of 
electronic density transfer from a donor to an acceptor. As shown in Section 4, the 
introduction of donor groups leads to an increase in the TPA efficiency of the 
compound. However, an obvious correlation between the donor ability of the 
substituent and the quantum yield of nitric oxide release was not observed. This 
chapter is devoted to the study of some aspects of the release of nitrogen monoxide - 
the dependence of NO-release on the energy of exciting radiation, the structure of the 
photoproduct and the transformation of the released nitric oxide in vitro. 
Taking into account that the highest value of the TPA cross-section was 
observed for the compound with the terpyridine ligand containing donating 4-
methoxyphenyl substituent, this ligand was selected for the synthesis of the complex 
with 2,2'-bipyridine and the study of the nitric oxide photorelease was conducted on 
this complex. 
5.1 Synthesis and characterisation of the complex [RuII(MeO-
Phtpy)(bpy)(NO)](PF6)3 
The ligand 4 '- (4-methoxyphenyl)-2,2':6', 2''- terpyridine (MeO-Phtpy) was 
synthesized according to the method described previously142, which involves carrying 
out the aldol condensation followed by the Michael addition. Following the 
procedure, 2 equivalents of 2-acetylpyridine are introduced in the reaction with 4-
methoxybenzaldehyde in a water-ethanol solution in the presence of KOH followed 
by addition of ammonium acetate. Equation of reaction and its mechanism are shown 
in scheme 5.1. 
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Scheme 5.1. The synthesis of the ligand 4'-(4-metoxyphenyl)-2,2':6'2''-terpyridine 
and the mechanism of the reaction. 
The complex [RuII(MeO-Phtpy)(bpy)(NO)](PF6)3 was obtained in 4 steps, 
similar to the complexes with FCCT and FCC3T ligands, the synthesis of which is 
described in section 4 (scheme 4.7). The use of 2D-NMR spectroscopy techniques, in  
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Figure 5.1. Chemical shifts of 1H and 13C in the NMR spectra of acetonitrile 
solutions of the complex [RuII(MeO-Phtpy)(bpy)(NO)](PF6)3, correlated with 
the help of COSY, HMQC, HMBC techniques. 
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particular homonuclear COSY and heteronuclear HMQC and HMBC, allowed to 
confirm the structure of the resulting complex and correlate signals in NMR spectra 
of 1H and 13C (Figure 5.1). 
The frequency of the valence vibrations of the N-O bond is 1940 cm-1. The value 
is very close to the frequency Ȟ(NO) in the bpy1 complex – 1942 cm-1 – in  which 
2,2'-bipyridine and terpyridine ligand substituted with a donating fluorenyl 
substituent play the role of ligands.107 However, it is much larger than the frequency 
of the valence vibrations of this bond in complexes, where the coordination sphere of 
ruthenium contain two chloro-ligands instead of bidentate 2,2'-bipyridine86,102. The 
difference between these values of 40-50 cm-1 is likely to arise as a result of the ʌ-
backdonating interaction between 2,2'-bipyridine and the ruthenium atom and the 
decrease in the population of the antibonding orbitals of the nitrosyl ligand. 
The structure of the complex was confirmed by X-ray diffraction analysis.  An 
assymetric unit of the elementary cell consists of one cation [RuII(MeO-
Phtpy)(bpy)(NO)]3+, three anions PF6Ø and a molecule of acetonitrile (Figure 5.2). 
No ʌ-interaction was observed 
between the ligands – either between 
2,2'-bipyridine fragments of two 
adjacent complex ions, or between 
terpyridine ligands. There is a weak 
interaction between the nitrosyl 
ligand and the anion PF6Ø (O(1) – 
F(14) = 2.767(10) Å, O(1) - F(8) = 
2.873(7)). 
The terpyridine fragment is 
almost planar with the largest 
deviation from the mean plane (18 atoms) of 0.154 Å (C14 atom). The bipyridine 
ligand is more flat with the greatest deviation from the mean plane of 0.043 Å (C9 
atom). The terpyridine and bipyridine planes are almost orthogonal with a torsion 
angle of 87.88 °. An important parameter of the structure is the torsion angle between 
Figure 5.2. The structure of the asymmetric
unit of the elementary cell of the complex
[RuII(MeO-Phtpy)(bpy)(NO)](PF6)3. 
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the phenyl ring and the terpyridine ligand plane – 6.59° – indicating a potentially 
effective transfer of the electron density from donating methoxyphenyl to accepting 
ruthenium-nitrosyl fragments. 
As mentioned in chapter 1, the ambiguity in the distribution of the electronic 
density between the metal atom and the NO ligand (RuII(NO+) or RuIII(NO·) form) is 
eliminated by the use of the Enemark-Feltman notation, according to which the 
complex [RuII(MeO-Phtpy)(bpy)(NO)](PF6)3 should be attributed to {Ru(NO)}6. 
Nevertheless, the definition of the most typical resonance form in each case for 
ruthenium-nitrosyl complexes makes possible deeper inderstanding of the electronic 
and magnetic properties of the compounds. In this case, the linear fragment Ru-NO 
(the angle Ru-N-O is 172.93 °) indicates the proximity of the complex to the structure 
RuII(NO+). An alternative parameter that could indicate the oxidation state of 
ruthenium atom could be the length of the Ru-Npy bonds. However, it has previously 
been shown that the Ru-N bonds are almost the same in the compounds [Ru(bpy)3]2+
and [Ru(bpy)3]3+, and have the length 2.053(2) Å and 2.057(3) Å 143, therefore this 
parameter can not be used to estimate the oxidation state of ruthenium. 
Other important interatomic distances and angles in the coordination sphere of 
the complex are presented in Table 5.1. 
Nitrosyl Terpyridine Bipyridine 
Ru(1) – N(1) 1.7668(9) Ru(1) – N(4) 2.0888(8) Ru(1) – N(2) 2.1002(8) 
N(1) – O(1) 1.1313(11) Ru(1) – N(5) 1.9880(8) Ru(1) – N(3) 2.0881(8) 
Ru(1)-N(1)-O(1) 172.94(8) Ru(1) – N(6) 2.0840(8)   
Table 5.1. The main interatomic distances (Å) and angles (°) in coordination sphere 
of the complex [RuII(MeO-Phtpy)(bpy)(NO)](PF6)3. 
5.2 Electronic spectrum and basic electronic transitions in the compound 
[RuII(MeO-Phtpy)(bpy)(NO)](PF6)3
The UV-visible spectra of [RuII(MeO-Phtpy)(bpy)(NO)](PF6)3 and that of the 
related MeO-Phtpy ligand recorded in acetonitrile are compared in figure 5.3. The 
ligand exhibits a single and very intense band with an absorption maximum (Ȝmax)  at 
284 nm (İ = 37 700 mol-1 L cm-1). By contrast, [RuII(MeO-Phtpy)(bpy)(NO)](PF6)3  
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exhibits a more complex spectrum. 
While the high energy band is 
present (Ȝmax = 292 nm, İ = 38 900 
M-1·cm-1) and slightly red-shifted, 
two additional features appear at 375 
nm (band 2)  and 420 nm (band 3) 
with intensities of 18 900 mol-1 L 
cm-1 and 12 400 mol-1 L cm-1, 
respectively. The differences 
observed between ligand and metal 
complex strongly suggests that the 
contributions of the ruthenium 
nitrosyl withdrawing fragment are 
important in the low energy bands 2 and 3. Therefore, it encourages a computational 
analysis of the related electronic transitions. complex is, of course, more complicated. 
The comparison of the experimental and computed electron spectra of the 
complex is presented in the table 5.2. 
 Experimental spectra Computed spectra 
Ȝmax (nm) İ (M-1·ɫɦ-1) Ȝmax (nm) f
Band 1 292 38 900 265 0.628 
Band 2 375 18 900 342 0.632 
Band 3 420 12 400 417 0.227 
Ɍɚɛɥɢɰɹ 5.2. Absorption bands in the electronic spectrum of the complex 
[RuII(MeO-Phtpy)(bpy)(NO)](PF6)3, and corresponding absorption bands for the ion 
[RuII(MeO-Phtpy)(bpy)(NO)]3+, computed by means of TD-DFT on the CAM-
B3LYP/6-31G* level of theory. 
The comparison between the experimental (UV-visible) and computed (TD-
DFT) data are provided in Table 5.3. Although the computed wavelengths are slightly 
blue-shifted, the agreement is found satisfactory, thus making the interpretation at the 
orbital level fully reliable.  
Figure 5.3. UV/vis spectra of the ligand 
MeO-Phtpy (blue) and the complex
[RuII(MeO-Phtpy)(bpy)(NO)](PF6)3 (red) in 
acetonitrile  showing the three (1-3) bands of 
interest present in the ruthenium(II) complex.
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Band 1 exhibits a ʌ ĺ ʌ * character, and involves the contribution of two 0 ĺ
20 and 0 ĺ 23 transitions centered on the bipyridine and the terpyridine, 
respectively. As anticipated, both low-energy bands 2 and 3 possess a strong charge 
transfer character towards the Ru(NO) fragment. This is further illustrated in Figure 
4, where the main orbitals of interest contributing to bands 2 and 3 are drawn, with 
their relative energy levels. 
Figure 5.4. Orbitals involved in electronic transitions of bands 2 
and 3 in UV-visible spectra of the compound 
[RuII(MeO-Phtpy)(bpy)(NO)](PF6)3. 
Band 3 is readily described as a HOMO ĺ LUMO based charge transfer with 
the excited state electron density being totally located on the Ru(NO) fragment. 
Therefore, this transition should induce an efficient NOǜ release process. By contrast, 
band 2 involves the contribution of three (0 ĺ 6, 0 ĺ 9, and 0 ĺ 10) transitions in 
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which the dominant charge transfer occurs towards the LUMO+1 level. Interestingly, 
the electronic features of the LUMO+1 are closely related to those of the LUMO, 
with a rotation of 90° around the Ru-NO axis, and hence with the same expected 
effect in term of NO release capabilities. Nevertheless, the transitions involved in 
band 2 also involve a charge transfer towards the orbital 147 which is strongly 
located on the terpyridine fragment (Figure 4). Based on the assumption that the NOǜ
release process implies a single charge transfer transition towards the nitrosyl 
fragment, it should readily be concluded that an irradiation will be less efficient on 
band 2 than on band 3.   
5.3 NO-release from the complex [RuII(MeO-Phtpy)(bpy)(NO)](PF6)3
As previously shown, the release of nitric oxide from ruthenium-nitrosyl 
complexes results in the formation of a photoproduct in which the ruthenium is in the 
oxidation state +3, and the coordination position previously occupied by the nitrosyl 
ligand is occupied by the molecule of the solvent molecule:86
[RuII(NO)+] + solventĺ [RuIII(solvent)] + NO·
However, as discussed in chapter 2 in the case of bpy1, the photoproduct that we 
observe when the photoreaction finished may be different from the expected one. 
Owing to the presence of two bands in the UV-visible spectrum having absorption 
maxima located at 375 nm (band 2) and 420 nm (band 3), the irradiations were 
performed at 365 nm and 436 nm  using a set of available filters, in order to 
determine the NOǜ release efficiencies for bands 2 and 3, respectively. 
The changes in the electronic absorption spectrum of [RuII(MeO-
Phtpy)(bpy)(NO)](PF6)3 exposed to 365 nm light in acetonitrile are shown in figure 
5.5 at the top. The presence of isosbestic points at 268, 344 and 434 nm indicates a 
clean conversion of the RuII(NO+) complexes to related photolysed species. No back-
reaction is observed when the light is turned off. In the photolysed species, new 
bands located at 286, 308,434 and 470 nm arise. The fact that the photoproduct does 
not absorb significantly at 365 nm leads to a fast photoreaction process, completed  
after 80 minutes w
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7 hours to reach completeness. Nevertheless, both experiments leading to the same 
photoproduct, the two figures 5.5a and 5.5b appear nearly identical. 
 The quantum yield of NOǜ release (ĳ) observed for [RuII(MeO-
Phtpy)(bpy)(NO)](PF6)3 is equal to 0.08 and 0.03 under light irradiation at 365 nm 
(band 2) and 436 nm (band 3), respectively.  These values are in complete 
disagreement with the expectation of a more efficient NOǜ release when the charge 
transfer towards the Ru(NO) fragment appears more significant. Within these 
experimental features, the issue of the real mechanism involved in the NOǜ release 
process is naturally addressed. Clearly, an explanation based on the analysis of a 
single charge transfer transition appears to be an oversimplified picture of a 
mechanism, which seems to be more complex. As described in section 1.4.4, a recent 
theoretical investigation has suggested that the NOǜ release could require more than 
one photon, with the contribution of an intermediate triplet state.91 Moreover, the 
investigation of the ultrafast dynamics of the photoinduced NOǜ release in a 
ruthenium-nitrosyl complex with terpyridine has also provided experimental 
evidences for a secondary photochemical process within a few ps, although it was not 
possible to determine the nature of the intermediate state.144
Additionally, it is interesting to observe that the shape of the photoproduct UV-
spectrum (red line in figure 5.5) corresponds to a RuII complex, because of the lack of 
band at 600 nm characteristic of RuIII species (see section 2.3). A similar situation 
was observed in the case of bpy1 compound: replacing of the chloro-ligands in 
terpyridine ruthenium-nitrosyl complexes with 2,2'-bipyridine led to the 
disappearance of such absorption in the spectrum of photoproduct.107
In view of the presence of distinct isosbestic points in experiments with 
spectrophotometric monitoring of the NO-release process (Figure 5.5, Figure 2.6c), 
we assume that in the case when in addition to terpyridine a molecule of 2,2'-
bipyridine is present in the coordination environment of ruthenium in the ruthenium-
nitrosyl complex the photoproduct with a ruthenium atom in oxidation +3, formed in 
photoreaction 
{RuII(tpy)(bpy)-NO}3+ + CH3CN ĺ {RuIII(tpy)(bpy)-CH3CN}3+ + NO, hȞ
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is instantly reduced to {RuII(tpy)(bpy)CH3CN}2+, and this photoproduct is the final 
one. Thus, according to our theory the cation of the complex 
[RuII(MeO-Phtpy)(bpy)(NO)](PF6)3 is converted to 
[RuII(MeO-Phtpy)(bpy)(CH3CN)]2+. Additional studies to confirm this theory have 
been carried out. 
5.4. Oxidation state of ruthenium within the release process 
The study we conducted is based on a series of spectroscopic methods for 
analyzing the photoproducts and the very process of release of NO-radical – 
electronic spectra, NMR, ESR and X-ray structural studies145. 
If the reduction process is indeed occurs in photoproducɟ, then it passes very 
quickly, since formation of the intermediate RuIII compound is not observed in UV-
visible spectra. The absence of paramagnetic particles was confirmed by NMR 
spectroscopy. 
In view of the fact that the back reaction is not observed under the suspension of 
complex irradiation, we conducted an experiment to monitor the release of nitric 
oxide by NMR. Deuterated acetonitrile was taken as the solvent for the 
[RuII(MeO-Phtpy)(bpy)(NO)](PF6)3 complex and the irradiation of the compound 
occurred directly in the ampoule for NMR studies. As a source of radiation a simpler 
and cheaper (in comparison with the Hg-lamp used for kinetics of NO-release 
studies), homemade device based on LEDs with a light wavelength range of 350-450 
nm was used (see Experimental part). After 5 minutes of irradiation, the sample was 
studied by 1H-NMR spectroscopy, and then the irradiation continued for another 5 
min etc. The evolution of the 1H-NMR spectrum of [RuII(MeO-
Phtpy)(bpy)(NO)](PF6)3 under irradiation in the 350-450 nm range is presented in 
figure 5.6. 
The gradual transformation of the complex into a diamagnetic photoproduct is 
apparent in the figure (e.g. the singlet of methyl group protons at 4.00 ppm decreases 
while the corresponding signal of photoproduct at 3.95 ppm rises). In general several  
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peaks show some broadening, but it’s small and it confirms the absence of any 
paramagnetic RuIII complex. 
Figure 5.6. 1H-NMR-tracking of NOǜ release from [RuII(MeO-
Phtpy)(bpy)(NO)](PF6)3 irradiated with continuous light in the 350-450 nm 
range, in CD3CN.  
The most noticeable evolution in Figure 1 is the shift of a peak tentatively 
attributed to traces of water from 2.13 ppm in the initial solution to 6.85 ppm after 
155 minutes of irradiation. An explanation for such a change may be the change of 
the acidity of the solution, which is probably caused by the formation of derivatives 
of nitrogen in higher oxidation stages (in particular nitrite and nitrate anions), as a 
result of the oxidation of nitrogen monoxide by the air and the interaction with water 
traces which are inevitably present in the solvent.
No attempts were made to deoxygenate and to dry the solvent. As an example of 
possible transformations, the following chemical reactions could be proposed: 
4NO· + O2 + 2H2O ĺ 4NO2Ø + 4H+, 
4NO· + 3O2 + 2H2O ĺ 4NO3Ø + 4H+
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An attempt to recreate the NO-photorelease experiment in the absence of 
oxygen and water was carried out using DMSO-d6 as a solvent. The initial spectrum 
of the [RuII(MeO-Phtpy)(bpy)(NO)](PF6)3 complex and the spectrum of the resulting 
photoproduct are shown in Figure 5.7. 
Figure 5.7. 1ɇ-NMR spectra of [RuII(MeO-Phtpy)(bpy)(NO)](PF6)3 in DMSO-d6
(bottom) and the obtained solution of photoproduct (top). 
In contrast to the previous experiment with the acetonitrile solution of the 
complex, the broadening of signals was not observed at any of the steps of 
photoreaction, and the spectrum of the complex after the NO-release completion is 
similar to the spectrum of the initial substance in relative position of the signals and 
their integral intensity. A singlet at 3.34 ppm, characteristic for protons of water 
molecules is not shifted strongly in the weak field, the main shifting is observed in 
first minutes of irradiation. So, after 5 minutes of the sample exposure to 
electromagnetic radiation, the peak of water shifts from 3.34 to 4.09 ppm, and then, 
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its position remains almost unchanged, moving in a weak field in general by another 
0.11 ppm until the end of the photoreaction. 
A good correspondence of the spectra of the initial complex and the 
photoproduct allows us to assume that the structure of the complex has not changed 
significantly, and apart from replacing the nitrosyl ligand with the solvent molecule, 
the constitution of the molecular ion has not changed. 
The structure of the cationic part of the photoproduct was confirmed by the 
single crystal X-ray diffraction analysis of the photoproduct. The crystal was grown 
from an acetonitrile solution of a photoproduct that was obtained after irradiation of 
the solution of [RuII(MeO-Phtpy)(bpy)(NO)](PF6)3 in CH3CN. 
The photoproduct crystallizes 
in P21c monoclinic space group. The 
asymmetric unit of the elementary 
cell of the crystal is shown in Figure 
5.8. It consists of one cation 
[RuII(MeO-Phtpy)(bpy)(CH3CN)]2+, 
two NO3Ø anions and a molecule of 
acetonitrile. 
As predicted, the structure of 
the cation of the photoproduct 
differs from the cation of the initial 
complex only in the presence of a 
coordinated molecule of acetonitrile instead of the nitrosyl ligand. But unexpectedly, 
the anions in the structure of the photoproduct are not PF6Ø, but ions NO3Ø. The 
presence of nitrate anions could apparently be explained by the release and 
subsequent oxidation of nitric oxide, which confirms the assumption that the acidity 
of the solution during the irradiation of the initial complex (Figure 5.6) may increase 
as a result of the formation of the species containing nitrogen in higher oxidation 
states. The change of the anion from PF6Ø to NO3Ø was already observed earlier for 
ruthenium-nitrosyl complexes, in particular for the compound 
Figure 5.8. The structure of the asymmetric 
unit of the elementary cell of the complex 
[RuII(MeO-Phtpy)(bpy)(CH3CN)](NO3)2. 
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[RuII(FT)Cl2(NO)](PF6).146 The geometry of the nitrate anions in the structure of the 
complex somewhat deviate from the absolute planarity. The nitrogen atoms N(8) and 
N(9) are located in 0.217 Å and 0.405 Å above the average plane of the three oxygen 
atoms. A high disorder of anions may partially be caused by this deviation. It is 
important that the structure of the complex consists of only two anions, which 
indicates that the ruthenium atom is in the oxidation state +2. 
The coordination sphere of the ruthenium atom in the complex ion 
[RuII(MeO-Phtpy)(bpy)(CH3CN)]2+ is similar to that in the starting complex 
[RuII(MeO Phtpy)(bpy)(NO)](PF6)3. In particular, there are slight differences in the 
lengths of the Ru-Npy bonds. Thus, in both structures, the length of the bond between 
the central atom and the nitrogens atom of the central pyridine ring of terpyridine is 
approximately 0.1 Å shorter in comparison with the bonds of the ruthenium atom 
with the pyridine rings. Also, on the average, Ru-Nbpy bonds are slightly longer than 
Ru-Ntpy bonds. The terpyridine fragment is more flat than in the initial complex with 
a maximum deviation from the average plane in 0.059 Å for the C(19) atom. The 
angle between the terpyridine and bipyridine planes is 85.91 °, and the torsion angle 
between the terpyridine and methoxyphenyl moieties is slightly higher than the value 
in the initial complex - 8.50 °. 
This is likely to indicate a less efficient conjugation between the phenyl and 
pyridine rings, which by-turn is caused by the reduced withdrawing effect of the 
{Ru(tpy)(bpy)(CH3CN)} fragment compared with the highly accepting 
ruthenium-nitrosyl group. Some parameters of the ruthenium coordination sphere, in 
particular the important interatomic distances and angles, are given in Table 5.4. 
Acetonitrile Terpyridine Bipyridine 
Ru(1) – N(1) 2.031(6) Ru(1) – N(4) 2.080(6) Ru(1) – N(2) 2.071(6) 
Ru(1)-N(1)-ɋ(1) 175.1(6) Ru(1) – N(5) 1.967(6) Ru(1) – N(3) 2.039(6) 
  Ru(1) – N(6) 2.072(6)   
Table 5.4. Main bond lengths (Å) and angles (°) in the coordination sphere of 
ruthenium in [RuII(MeO-Phtpy)(bpy)(MeCN)]2+. 
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The fact that NO-release leads to the formation of a photoproduct in the 
oxidation state +2 raises the issue of the real nature of the NO-species liberated under 
irradiation, which might not be NO-radicals, but the alternative, and undesirable 
NO+-cation produced by the following reaction: 
[RuII(NO)+] + solvent ĺ [RuII(solvent)] + NO+. 
Nevertheless, the photo-generation of NOǜ instead of NO+ can be demonstrated 
experimentally, by EPR spectroscopy under standard excitation at Ȝ = 365 nm or 436 
nm, since spin trapping combined with EPR spectroscopy is considered as one of the 
best methods for the direct detection of NOǜ radicals.89 Namely, we used Iron(II)-N-
methyl-D-glucamine dithiocarbamato [FeII(MGD)2] to trap NOǜ due to its high 
probability of adduct formation and to the high stability of its spin adduct. The 
appearance of the characteristic triplet signal of NOǜ is shown in Figure 5.9. 
Figure 5.9. Triplet EPR signals from NOǜ trapped by 
[Fe(MGD)2] for [RuII(MeO-Phtpy)(bpy)(NO)](PF6)3 
upon one photon  excitation at room temperature 
and at Ȝ > 400 nm (Hg lamp) (bottom), and control 
signal before irradiation (top). 
The hyperfine splitting constant value is aN = 1.24 10-3 cm-1, g-factor is equal to  
2.040. These values are fully consistent with the literature report for [FeII(MGD)2-
NO] adduct.89  
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The initial complex shows first two reduction waves at 0.44 V and 0.27 V 
(Figure 5.10a). At the same time, the process corresponding to the first one is 
reversible (Fig. 5.10c), and, according to the literature data for similar complexes, 
corresponds to the process of reduction of nitrosyl ligand RuIINO+ ĺ RuIINO·.147,148
Naturally, after irradiation and NO release completion, this reduction wave 
disappears. 
The second wave of reduction is likely to correspond to the RuIINO· ĺ RuIINOØ
process, which is not reversible. This attribution is also consistent with the published 
data.148 Additional waves observed at significantly lower potentials appear due to the 
processes of reduction of organic ligands that are present in the complex. 
The oxidation of the initial ruthenium-nitrosyl complex occurs at a potential of 
1.99 V. The corresponding potential for the photoproduct is 1.93 V. The processes 
that determine the appearance of these waves are associated with the oxidation of 
ligands, most likely terpyridine, which is more enriched with electronic density. A 
similar behavior was observed earlier for the compound cis-
[RuII(MeO-Phtpy)Cl2(NO)](PF6): the oxidation was observed at a potential of 1.9 V. 
The most important result of the study of electrochemical oxidation of the 
photoproduct solution was the value of the redox potential for RuIII/RuII pair , which 
makes 1.27 V. Observation of this wave in the process of the complex oxidation 
confirms the fact that ruthenium is in the oxidation state +2 in the compound149. 
The data of electrochemical study can be used to evaluate the stability of 
RuII/RuIII forms in solution depending on the coordination environment of the metal 
center. Indeed, RuIII complexes should be more prone to reduction in the case when 
the coordination sphere of the central atom contains five pyridine rings, i.e. 
{Ru(bpy)(tpy)}, than when it contains strong ı-donating ligands, such as chloro-
ligands. This conclusion comes from the fact that the greater possibility of ruthenium 
electron density delocalization through ʌ-backdonating interaction is possible in the 
case of pyridine ligands. This effect stabilizes the lower oxidation state of the metal, 
in other words, it increases the redox potential of the RuIII/RuII pair. As can be seen 
from Table 5.5, the replacement of chloro-ligands with 2,2'-bipyridine results in an 
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increase in the potential of RuIII/RuII pair from 0.4 V (for the compound 
cis-[RuII(MeO-Phtpy)Cl2(CH3CN)]+/0 to 1.27 V (for the compound 
[RuII(MeO-Phtpy)(bpy)(NO)]+3/+2). 
Taking into account the results of the physical-chemical studies of the complex 
and the resulting photoproduct, it can be concluded that the release of nitric oxide 
from the ruthenium-nitrosyl complex [RuII(MeO-Phtpy)(bpy)(NO)](PF6)3 leads to the 
formation of a product containing ruthenium atom in the oxidation state +3, which, 
immediately reducing transforms into [RuII(MeO-Phtpy)(bpy)(CH3CN)]2+. 
The nature of the reductant, however, has not been investigated. On the one hand, the 
presence of nitrate anions in the crystalline structure of the photoproduct may 
indicate that the released nitric oxide can act as a reducing agent for compounds of 
Ru(III). On the other hand, the oxygen present in the solution can cause oxidation of 
NO, so there is no undeniable evidence of the direct interaction of Ru(III) complex 
with nitric oxide after its photorelease. 
5.5. The by-product of the reaction of NO-release from the complex 
[RuII(MeO-Phtpy)(bpy)(NO)](PF6)3
An attempt to crystallize a photoproduct resulted in the formation of two types 
of crystals. Some of the crystals corresponded to the structure of the compound 
[RuII(MeO-Phtpy)(bpy)(CH3CN)](NO3)2 described above. While the X-ray 
diffraction analysis of crystals of the second type revealed the structure of another 
photoproduct formed during the release of nitric oxide from the initial complex. 
Unfortunately, crystals of the second type were of a quality not good enough for X-
ray study and obtaining a crystal of higher quality of this photoproduct failed. So at 
this stage only the structure of the cationic part of the complex was obtained with 
sufficient accuracy. Its structure is shown in Figure 5.11. 
As in the case with the main photoproduct, the nitrosyl ligand in the by-product 
is replaced with the molecule of acetonitrile, but the main difference is that the 
phenyl ring of the terpyridine ligand in the case of a by-product is substituted with the 
nitrogroup in the third position. The formation of this compound was not detected 
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either by UV visible spectroscopy or NMR spectroscopy during a direct experiment 
on the release of nitrogen monoxide from the ruthenium-nitrosyl complex. This fact 
indicates that the formation of such a cation occurs during some time after irradiation. 
Interestingly, the structure of the obtained nitro-derivative or rather 3-nitro-4-
methoxyphenyl substituent is similar to the product of tyrosine amino acid nitration 
in living organisms. 
As described in section 1.2, the formation of various reactive nitrogen species 
(RNS) capable of oxidizing and nitrating biomolecules takes place in tissues in the 
presence of nitric oxide and high concentrations of reactive oxygen forms. Such RNS 
are peroxynitrite anion, nitrogen(IV) oxide and some others. Although several 
hypothetical mechanisms for nitration of the amino acid residues of tyrosine are 
proposed, all of them suggest a radical mechanism of the process.150,151 One of the 
possible ways of nitration is shown in Figure 5.12.151
Figure 5.12. One of possible radical mechanisms of nitration of tyrosine with the 
formation of 3-nitrotyrosine. 
Given that the methoxyphenyl substituent present in the MeO-Phtpy ligand 
cannot form a stable radical particle, the radical mechanism of the formation of the 
cation shown in Figure 5.11 is hardly probable. Possibly, nitration could occur 
through the mechanism of aromatic electrophilic substitution. In this case nitration 
could be attributed to the compounds of nitrogen in higher oxidation states, the 
presence of which in the system is confirmed by the presence of nitrate anions in the 
crystalline structure of the main photoproduct. 
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[RuII(MeO-Phtpy)(bpy)(NO)]3+ releases NOǜ under irradiation in the UV-visible 
domain, with a  quantum yield which appears significantly reduced when the 
involved transition exhibits a stronger push-pull charge transfer towards NO. This 
behavior indicates that the real mechanism of the NO-release cannot be restricted to 
the effect of an individual transition. Although NO is undoubtedly generated as NOǜ
radical, the concomitant RuIII photoproduct is readily reduced to a RuII complex of 
formula [RuII(MeO-Phtpy)(bpy)(MeCN)]2+, probably by the action of a fraction of 
the nitric oxide photo-released during the irradiation process. In the presence of 
oxygen and water nitrogen monoxide is capable of being converted into species 
containing nitrogen at higher oxidation states that are capable of further interaction 
with the photoproduct [RuII(MeO-Phtpy)(bpy)(CH3CN)]2+ forming its nitro-
derivative. 
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EXPERIMENTAL PART 
Instrumentation.
Elemental analysis was performed on Perkin Elmer 2400 series II Instrument in 
LCC. 1H NMR and 13C NMR spectra were recorded on Bruker Avance III 400 (400 
and 101 MHz respectively) or  Bruker Avance 300 (300 and 75 MHz respectively) 
spectrometer at 298 Ʉ in DMSO-d6, CDCl3,CD3OD, CD3CN or THF-d8; the internal 
standard is the residual peaks of deuterated solvents. The degree of carbon atom 
substitution was determined by NMR spectra acquired according to the DEPT-135 or 
JMOD methods. Two-dimensional (2D) (COSY, HMQC, HMBC) spectra were 
recorded on a Bruker Avance III 400 (400 MHz) spectrometer. Coupling constants 
(J) are reported in Hz, chemical shift (δ) in ppm. The multiplicity of signals is 
indicated using the following abbreviations: s = singlet, bs = broad singlet, d = 
doublet, t = triplet, q = quartet, quint = quintet, dd = doublet of doublets, ddd = 
doublet of doublets of doublets, dt = doublet of triplets, td = triplet of doublets and m 
= multiplet. 
Electronic spectra were recorded on Hewlett Packard 8454A. IR-spectra were 
recorded on Perkin–Elmer 1725. 
Electron paramagnetic resonance spectra (EPR) were recorded on Bruker ESP 
500E. The following parameters and methods were used: microwave power 20 mW, 
amplitude of field modulation 0.1 mT, field modulation frequency 100 kHz, 
microwave frequency 9.782512 GHz. N-Methyl-D-glucamine dithiocarbamate was 
synthesized in advance and injected into the reaction with ammonium iron(II) sulfate 
to obtain [Fe(MGD)2].152 The 90 μl 1 mM of [Ru(MeO-Phtpy)(bpy)(NO)](PF6)3 in 
acetonitrile was mixed with 10 μl of 2 mM [Fe(MGD)2] (in water) and injected into a 
quartz capillary. The sample was irradiated in EPR spectrometer by mercury lamp 
250 W Oriel (Palaiseau, France). The emission light passed through the filter Oriel 
WG 400 UV (Palaiseau, France, Ȝ > 400 nm) and was directed with the help of 
optical fiber. 
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High resolution mass spectra (HRMS) were recorded on GCT Premier 
spectrometer upon electron spray ionization (ESI). 
The melting points were determined on Stuart melting point apparatus SMP10. 
In the experiment when NO-release was studied by NMR-spectroscopy, the 
irradiation of complex was carried out by homemade LED device at 350-450 nm 
wavelength range.  The study was made on the samples dissolved in CD3CN 
introduced into NMR ampoules in the following conditions: 5 min of irradiation – 1ɇ
NMR – 5 min of irradiation and so on until the disappearance of peaks of starting 
material.   
Electrochemical investigations were carried out at room temperature in a 
homemade sealed tri-electrode cell connected to vacuum-argon line using the 
Autolab PGSTAT100 potentiostat. A reference electrode was a saturated calomel 
electrode (SCE), separated from the solution by a bridge. Counter electrode was Pt 
wire with approximate surface area of 1 cm2. Main electrode was Pt microdisk (0.5 
mm diameter). Electrolyte, which was used for experiment was tetrabtylammonium  
hexafluorophosphate (n-Bu4N)[PF6] (Fluka, 99%, puriss, electrochemical grade) 
which was used directly after degassing with argon. Complex and electrolyte 
concentrations were about 10-3 M and 0.1 M, respectively. Before each experiment, 
the solution was degassed by Ar flow, and the main electrode was polished using a 
Presi P230 machine. Irradiation aimed at obtaining a photoproduct with the purpose 
of the study of the latter by electrochemical method was carried out using homemade 
LED device with a wavelength range of 350-450 nm. The irradiation continued until 
disappearance of a characteristic signal of 2,2'-bipyridine proton at 9.32 ppm and 
disappearance of NO+ĺ NO· reduction band in voltamperometric analysis. 
Photochemical studies. 
Kinetic studies of photolysis reactions were performed using a diode-array 
Hewlett Packard 8454A spectrophotometer. All experiments were performed for 
acetonitrile non-deoxygenated solutions (volume 2 ml) of substances with 
concentrations: [Ru(FT)(bpy)NO](PF6)3 (bpy1) – 4.94·10-5 M, 
[Ru(FɋɋT)(bpy)NO](PF6)3 – 4.43·10-5 M, [Ru(Fɋɋ3T)(bpy)NO](PF6)3 – 
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4.48·10-5 M, [Ru(MeO-Phtpy)(bpy)(NO)](PF6)3– 3.64·10-5 M (under irradiation with 
365 nm wavelength), 4.42·10-5 M (under irradiation with 436 nm wavelength). 
Optical fiber was fixed from the outside of the solution cuvettes. Absorption spectra 
were recorded every 10 seconds in fast scan mode. Irradiation was performed until a 
stable absorption value was achieved. The source of radiation was a mercury lamp, 
equipped with light filters, allowing to receive a monochromatic light of different 
wavelengths. The temperature was maintained at 25 °C throughout the experiment. 
Measurement of the quantum yield of NO-release reaction.  
Light intensities were determined before each photolysis experiment by 
chemical actinometry procedure. The actinometer used was potassium ferrioxalate 
trihydrate K3[Fe(C2O4)3]·3H2O. The determined light intensity for bpy1 is 10-6 M·s-1, 
for [Ru(FɋɋT)(bpy)NO](PF6)3 is 7.05·10-7 M·s-1, [Ru(Fɋɋ3T)(bpy)NO](PF6)3 is 
8.66·10-7 M·s-1, [Ru(MeO-Phtpy)(bpy)(NO)](PF6)3 is 8.2·10-7 M·ɫ-1 (under 
irradiation with 365 nm wavelenght), 7.81·10-7 M·ɫ-1 (under irradiation with 436 nm 
wavelength). The quantum yield (ࢥA) was determined by the program Sa3.3 written 
by D. Lavabre and V. Pimienta.153 It allows the resolution of the differential eq. 6.1 
܌ሾۯሿ
܌ܜ ൌ െ૎ۯ۷܉
ۯ ൌ െ૎ۯۯ܊ܛૃۯ۷૙۴ (6.1), 
where۷܉ۯ is the intensity of the light absorbed by the precursor; ۯ܊ܛૃۯ is the 
optical density before irradiation; I0, the incident intensity measured at 365 or 436 nm 
and F the photokinetic factor depending on total optical density ۯ܊ܛ܂ܗܜૃ  and given by 
eq. 6.2:  
۴ ൌ
ቀ૚ െ ૚૙ିۯ܊ܛ܂ܗܜૃ ቁ
ۯ܊ܛ܂ܗܜૃ
(6.2). 
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The equation was fitted with the experimental data parameters ĳȺ and İB (İB is 
the molar extinction coefficient measured at the end of the reaction) at two 
wavelengths, namely, the wavelength of irradiation Ȝirr and the wavelength of 
observation Ȝobs, which corresponds to the largest difference between molar 
extinction coefficient at the initial and final moment of the photochemical reaction. 
Optimization procedures were performed by using numerical integration and a non-
linear minimization algorithm.154  
bpy1:  
[A]0 = 4.94·10̄5 M, ࢿۯ૝૙૞ = 15729 M-1·cm̄1, ࢿۯ૝ૠ૙ = 12579 M-1·cm-1,  
ࢿ۰૝૙૞ = 7969 M-1·cm-1, ࢿ࡮૝ૠ૙ = 21422 M-1·cm-1
[Ru(FɋɋT)(bpy)NO](PF6)3:  
[A]0 = 4.43·10̄5 M, ࢿۯ૝૜૟ = 19639 M-1·cm̄1, ࢿۯ૜ૠ૙ = 17156 M-1·cm-1,  
ࢿ۰૝૜૟ = 14756 M-1·cm-1, ࢿ࡮૜ૠ૙ = 20442 M-1·cm-1
[Ru(Fɋɋ3T)(bpy)NO](PF6)3:  
[A]0 = 4.48·10̄5 M, ࢿۯ૝૜૟ = 17411 M-1·cm̄1, ࢿۯ૜ૠ૙ = 18973 M-1·cm-1,  
ࢿ۰૝૜૟ = 15106 M-1·cm-1, ࢿ࡮૜ૠ૙ = 30437 M-1·cm-1
[Ru(MeO-Phtpy)(bpy)(NO)](PF6)3: 
under irradiation with 365 nm wavelength: 
[A]0 = 3.64·10̄5 M, ࢿۯ૜૟૞ = 18874 M-1·cm̄1, ࢿۯ૝ૠ૙ = 7335 M-1·cm-1,  
ࢿ۰૜૟૞ = 5244 M-1·cm-1, ࢿ࡮૝ૠ૙ = 17672 M-1·cm-1
Under irradiation with 436 nm wavelength: 
[A]0 = 4.42·10̄5 M, ࢿۯ૝૜૟ = 11292 M-1·cm̄1, ࢿۯ૜ૠ૙ = 18735 M-1·cm-1,  
ࢿ۰૝૜૟ = 13412 M-1·cm-1, ࢿ࡮૜ૠ૙ = 5554 M-1·cm-1
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X-Ray analysis. 
The data were collected at low temperature (100(2) K) with a Bruker Apex II 
diffractometer equipped with a 30 W air-cooled microfocus Mo-KĮ radiation source 
(Ȝ = 0.71073 A) and an Oxford Cryosystems Cryostream cooler device, and ĳ and Ȧ
scans were used for data collection. An empirical correction using SADABS was 
used.155 The structure was solved by direct methods with SHELXT. All non-hydrogen 
atoms were refined anisotropically by least-squares procedures on F2 with the aid of 
the program SHELXL.156,157 All hydrogen atoms were refined isotropically at 
calculated positions in a riding model with their isotropic displacement parameters 
constrained to 1.5 times the equivalent isotropic displacement parameters of their 
pivot atoms for terminal sp3 carbon atom and 1.2 times for all other carbon atoms. In 
the crystal structure counter anions were highly disordered. In [Ru(MeO-
Phtpy)(bpy)(NO)](PF6)3 one hexafluorophosphate anion was disordered over two 
positions in 74:26 ratio; in [RuII(MeO-Phtpy)(bpy)(MeCN)](NO3)2 two nitrate anions 
were disordered over three positions in 48:22:30 and 40:29:3 ratios. Each disorder 
was modeled successfully with the atom ellipsoids restrained by SIMU, DELU and 
ISOR commands.  
Computational studies. 
All the calculations were performed using Gaussian-09 program package within 
the framework of Density Functional Theory (DFT). Optimization of structures of all 
ions was performed using the hybrid functional B3PW91, which for these systems 
shows the best match between the theoretical results and the experimental data. This 
choice is also in agreement with a previous investigation of ruthenium-nitrosyl 
complexes made by Mascharak158 and I. Malfant86 group. B3PW91 has been shown 
to outperform other hybrid functionals (e.g., B3LYP) and pure functionals (e.g., 
PW91) for numerous ruthenium complexes, especially when backbonding ligands 
(such as NO) are present. The vibrational analysis performed at the same level of 
theory as the oprimization of geometry was made to verify that the stationary points 
corresponded to minima on the potential energy surfaces.  
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The «double-ȗ» basis 6-31G* was used for all atoms except the heavy ruthenium 
atom, for which the LANL2DZ basis set was applied to account for relativistic 
effects. 
Complexes cis1', trans1' and bpy1' were optimized in a gas phase, UV/Vis 
electronic spectra were then computed at the CAM-B3LYP/6-31G* level, which was 
selected for its efficient reproduction of experimental transition energies within a 
maximum uncertainty of 0.3 eV. 
Solvent effects were included by using the polarizable continuum model (PCM) 
implemented in Gaussian09 for acetonitrile (İ = 35.688).  
Compounds 3.1-3.22 were optimized at a gas phase. For each molecule the two 
possible conformers resulting from the rotation around ı-bond between the fused 
heterocyclic system and the C=C double bond of the ethenyl linkage were considered 
(vide infra). The most stable one was selected by comparison of their Gibbs free 
energies (ΔG°). UV/Vis electronic spectra were then computed at the CAM-
B3LYP/6-31G* level of theory. The total hyperpolarizabilities (ȕ) were computed at 
CAM-B3PYP/6-31G** level, in which p polarization functions are used on hydrogen 
atoms. The ten independent ߚ௜௝௞ tensor components were computed by the derivative 
procedure implemented in Gaussian-09, according to the following equation:
઺ܑܒܓ ൌ െቆ
૒૜܅
૒۳ܑ૒۳ܒ૒۳ܒቇ۳ୀ૙
(6.3), 
where W is the energy and E the electric field. This expression is only valid for the 
static field limit, which corresponds to Kleinman conditions.159 The final ȕ value is 
given as the magnitude of the ȕ vector (ඥȾ௫ଶ ൅ Ⱦ௬ଶ ൅Ⱦ௭ଶ). The vectorial component 
ߚ௜is computed from the tensor components as: ߚ௜ ൌ ߚ௜௫௫ ൅ ߚ௜௬௬ ൅ ߚ௜௭௭Ǥ
Ions [Ru(FCC3T)(bpy)(NO)]3+, [Ru(FCCT)(bpy)(NO)]3+, [Ru(MeO-
Phtpy)(bpy)(NO)] 3+ and [Ru(FT)Cl2(CH3CN)]+ were optimized using PCM model 
for acetonitrile; UV/Vis electronic spectra were computed at the CAM-B3LYP/6-
31G* level of theory.  
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Molecular orbitals were plotted with GABEDIT 2.4.8.
Two-photon absorption study. 
The z-scan technique was used to measure the nonlinear absorption coefficients 
of the samples at Ȝ = 800 nm through the application of short laser pulses of 90 fs at a 
repetition rate of 1 kHz. The molecules under study were dissolved in acetonitrile at a 
concentration of 1·10-2 mol·L̄1. Z-scan traces for each solution were measured at 
different energies, namely, 30, 50, 75, and 95 nJ for cis2, trans2, bpy2; 40, 65, 75 nJ 
for cis(Cl,Cl)-[Ru(MeOPh-tpy)Cl2NO]PF6, trans(Cl,Cl)-[Ru(MeOPh-tpy)Cl2NO]PF6,  
cis(Cl,Cl)-[Ru(Et2NPh-tpy)Cl2NO]PF6, trans(Cl,Cl)-[Ru(Et2NPh-tpy)Cl2NO]PF6); 
40, 62, 100 nJ for [Ru(FCCT)(bpy)NO](PF6)3 and [Ru(FCC3T)(bpy)NO](PF6)3.  All 
samples were measured at least ten times at each energy. The increase in the energy 
of the radiation should be linearly related to the decrease in the transmission of the 
sample, which has been confirmed for each of the complexes. To verify the validity 
of our measurements, the same z-scan apparatus was first utilized in the closed-
aperture approach to measure the nonlinear refractive index n2 of the standard CS2. 
The results led to n2 values in the range 1.2·10-15 cm2/W, which are in very good 
agreement with the values accepted for this standard reference. Then, the laser dye 
rhodamine 6G (R6G) was measured along with the set of samples under test in the 
open-aperture approach. In this case, the ıTPA value of R6G was (67.5) GM, which is 
also in very good agreement with the value accepted in the literature.160  
The nonlinear absorption coefficient ȕ of each sample was obtained after fitting 
the normalized transmission T(z) according to eq. 6.4: 
܂ሺܢሻ ൌ ૚ െ ૚૛ξ૛઺
۷૙ܔ܍܎܎
૚ ൅ቀ ܢܢ૙ቁ
૛
   
(6.4), 
where I0 – laser pulse energy, leff – sample thickness (0.1 cm for all the experiments), 
z – sample position, z0 – Rayleigh length (parameter of the laser beam). Rayleigh 
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length was established by the «knife-edge method», and was 0.190 cm when studying 
cis2, trans2 and bpy2; 0.066 cm when studying cis(Cl,Cl)-[Ru(MeOPh-
tpy)Cl2NO]PF6, trans(Cl,Cl)-[Ru(MeOPh-tpy)Cl2NO]PF6,  cis(Cl,Cl)-[Ru(Et2NPh-
tpy)Cl2NO]PF6, trans(Cl,Cl)-[Ru(Et2NPh-tpy)Cl2NO]PF6; 0.101 cm when studying  
[Ru(FCCT)(bpy)NO](PF6)3 and [Ru(FCC3T)(bpy)NO](PF6)3. The values of 
absorption cross-sections were calculated according to formula 6.5: 
࣌ ൌࢎࣇࢼࡺ
   
(6.5), 
where N – concentration of the molecule (molecule/l), Ȟ – frequency of laser 
radiation. 
The procedures for the syntheses of ligands and their precursors.  
Compounds 4.1126, 4.2126, 4.5129, 4.7161, 1-(2-oxo-2-(pyridin-2-yl)ethyl)pyridin-1-ium 
iodide132, 4.15137, 4.16162, 4.17137, 4'-(4-methoxyphenyl)-2,2':6',2''-terpyridine142 were 
synthesized according to the reported procedures. 
  
The synthesis of FCCT and FCC3T ligands: 
4'-bromo-2,2':6',2''-terpyridine (4.3). 
PBr5 (8.09 g, 19 mmol) was added to the suspension of
(2,2':6',2''-terpyridin)-4'(1'H)-one 4.2 (1.93 g, 7.75 mmol) in 
DMF (50 mL) and heated at 90-93 °ɋ for 20 h.  The reaction 
mixture was then cooled down and 80-100 mL of water were 
carefully added followed by neutralization with Na2CO3. The mixture was extracted 
with CH2Cl2. The organic phase was washed with brine, dried over Na2SO4 and 
filtrated. The solvent was evaporated under reduced pressure and the residues were 
purified by column chromatography (elution system: CH2Cl2 – hexane, 2:1) on 
alumina yielding 1.69 g (5.42 mmol, 70%) of light beige solid.  
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2-bromo-9,9-dihexyl-9H-fluorene (4.6). 
2-Bromofluorene (11.65 g, 0.048 mol) and Ʉȱ (0.79 g, 4.76 
mmol) were dissolved in DMSO (96 mL) upon slight heating. 
After complete dissolving the mixture was degassed and put 
under inert atmosphere. KOH (9.16 g, 0.164 mol) was then pestled and added to the 
solution under Ar flow.  The mixture was stirred for 20 min followed by n-
bromohexane (17 mL, 0.121 mol) dropping into the reaction mixture in 5 portions, 
very slowly, with intensive stirring.  The interval between portions was 10 min. After 
the addition was completed, the mixture was left stirring at room temperature for 3 
hours followed by water addition and extraction with EtOAc. The organic layer was 
washed with brine and dried over Na2SO4. The product was purified by column 
chromatography (eluent: pentane, 100%) to yield 19.63 g (99.9%) of colorless oil.  
9,9-dihexyl-2-vinyl-9H-fluorene (4.8). 
2-Bromo-9,9-dihexyl-9H-fluorene (960 mg, 2.32 mmol), 
KBF3C2H3 (334 mg, 2.49 mmol), Pd(OAc)2 (70 mg, 0.31 
mmol), PPh3 (233 mg, 0.89 mmol) and Cs2CO3 (1936 mg, 
5.94 mmol) were suspended in THF (30 mL) and ɇ2Ɉ (1.5 mL) mixture and placed 
into  teflon reactor. The mixture was degassed under the intense Ar flow and sealed.  
The mixture was heated at 100 °C under the vigorous stirring over 48 h. The resulting 
mixture was diluted with H2O and extracted with CH2Cl2. Organic extracts were 
washed with brine, dried over Na2SO4 and filtrated. The solvent was evaporated 
under reduced pressure and the residues were purified by column chromatography 
(eluent: hexane, 100%) on silica gel to yield 227 g (0.63 mmol, 27%) of colorless oil.  
(E)-ethyl 3-(9,9-dihexyl-9H-fluoren-2-yl)acrylate (4.9). 
Ethylacrylate (1.12 mL, 10.50 mmol) and anhydrous DMF 
(7 mL) was added to the mixture of 2-bromo-9,9-dihexyl-
9H-fluorene 4.6 (2.89 g, 7.00 mmol), Pd(OAc)2 (47 mg, 
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0.21 mmol), PPh3 (138 mg, 0.53 mmol) and Et3N (0.98 mL, 7.00 mmol) in inert 
atmosphere. The resulting suspension was heated at 90 °ɋ under vigorous stirring 
over 14 h.  After the completion of the reaction was cooled down to rt followed by 
H2O (70 mL) adding.  The mixture was extracted with EtOAc; the organic extracts 
were washed with brine, dried over Na2SO4 and filtrated. The solvent was evaporated 
under reduced pressure and the residues were purified by column chromatography 
(elution system: n-hexane – EtOAc, 200:1) on silica gel to yield 2.48 g (5.73 mmol, 
82%) of yellow oil.  
 (E)-3-(9,9-dihexyl-9H-fluoren-2-yl)acrylaldehyde (4.11). 
The solution of DIBAL-H (30 mL, 1.5 M, 45 mmol) was 
dropped into the solution of (E)-ethyl 3-(9,9-dihexyl-9H-
fluoren-2-yl)acrylate 4.9 (6.49 g, 15 mmol) in anhydrous 
toluene (150 mL) under inert atmosphere at -78 °C. The reaction mixture was stirred 
vigorously until the complete disappearance of the starting material (TLC control). 
Then MeOH (3.6 mL) was added slowly to the reaction mixture until complete 
liberation of H2 followed by quick addition of AcOEt (300 mL). The mixture was 
allowed to reach a room temperature and left at intensive stirring for 1 hour followed 
by filtration through celite; the filtrate was evaporated under reduced pressure. 
The resulting mixture was dissolved in CHCl3 (225 mL) and MnO2 (9.78 g, 
112.5 mmol) was added. Heterogenic mixture was stirred at room temperature until 
complete disappearance of starting material (TLC control, for 2-3 days). After the 
reaction completion the mixture was filtrated through a plug of celite and filtrate was 
concentrated under reduced pressure. The residues were purified by column 
chromatography (elution system: n-hexane – EtOAc, 99:1) on silica gel to yield 3.43 
g (8.2 mmol, 70%) of yellow oil.  
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(2E,4E)-5-(9,9-dihexyl-9H-fluoren-2-yl)-1-(pyridin-2-yl)penta-2,4-dien-1-one (4.12). 
A solution of NaOH (1.35 mL, 1M, 1.35 
mmol) in water was dropped into the solution 
of (E)-3-(9,9-dihexyl-9H-fluoren-2-
yl)acrylaldehyde 4.11 (0.35 g, 0.90 mmol) and 2-acetylpyridine (0.10 mL, 0.90 
mmol) in EtOH under vigorous stirring.  The reaction mixture was stirred at rt until 
complete conversion of starting material (TLC control) The resulting precipitate was 
filtered off, rinsed with water and cold EtOH and dried under vacuum. The yield of 
4.12 was 0.20 g (0.52 mmol, 45%). After purification of filtrate by column 
chromatography (elution system: hexane – AcOEt, 9:1) the extra 0.06 g was obtained 
(13%). The total yield was 58%, yellow powder. 
(E)-4'-(2-(9,9-dihexyl-9H-fluoren-2-yl)vinyl)-2,2':6',2''-terpyridine (FCCT). 
1-(2-Oxo-2-(pyridin-2-yl)ethyl)pyridin-1-ium 
iodide (0.32 g, 0.99 mmol) and NH4OAc (1.04 g, 
13.5 mmol) were added to the suspension of 
(2E,4E)-5-(9,9-dihexyl-9H-fluoren-2-yl)-1-(pyridin-
2-yl) penta-2,4-dien-1-one 4.12 (0.44 g, 0.9 mmol) 
in EtOH (5 mL) and the mixture was refluxed until complete conversion of starting 
ketone 4.12 (TLC control). After the reaction finished the mixture was cooled down 
and evaporated under reduced pressure. The residue was diluted with water and 
extracted with EtOAc. The organic extracts were dried over Na2SO4 followed by 
filtration and solvent evaporation under educed pressure. The residue was purified by 
column chromatography: primarily – eluent: CH2Cl2, 100%; second time – elution 
system: hexane – acetone, 9:1 on alumina oxide to yield 0.19 g (0.32 mmol, 36%) of 
yellow oil. Rf 0.48 (heptane – acetone, 4:1, alumina oxide).
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2-ethynyl-9,9-dihexyl-9H-fluorene (4.14). 
The mixture of 2-bromo-9,9-dihexyl-9H-fluorene 4.6 (3.14 g, 
7.60 mmol), activated CuI (72 mg, 0.38 mmol) and 
PdCl2(PPh3)2 (133 mg, 0.189 mmol) were placed in inert 
atmosphere followed by addition of anhydrous THF (10 mL). The reaction mixture 
was heated to reflux followed by dropwise addition of DIPA (6 mL, 43 mmol) and 
ethynyltrimethylsilane (2.7 mL, 19 mmol); the condenser should be kept cold (the 
boiling point of ethynyltrimethylsilane is 57 °ɋ). After 12 h the reaction was stopped, 
the solution was cooled down, and EtOAc (15 mL) was added followed by washing 
with saturated NH4Cl solution. The product was purified by column chromatography 
(eluent: hexane, 100%) on silica gel to yield 1.84 g (4.26 mmol, 56%) of ((9,9-
dihexyl-9H-fluoren-2-yl)ethynyl) which was then suspended in the mixture of 
metanol (10 mL) and diethyl ether (10 mL) followed by potassium carbonate addition 
(2.11 g, 15 mmol). The mixture was stirred over 90 min and filtrated, filtrate was 
evaporated under reduced pressure. The residue was dissolved in hexane and filtrated 
through a plug of silica gel. Silica gel was thoroughly rinsed with hexane. Filtrate 
was evaporated under reduced pressure to yield 1.24 g (3.46 mmol, 81%) of colorless 
oil. 
4'-((9,9-dihexyl-9H-fluoren-2-yl)ethynyl)-2,2':6',2''-terpyridine (FCC3T). 
The mixture of 2-ethynyl-9,9-dihexyl-9H-fluorene 
4.14 (311 mg, 0.87 mmol), (2,2':6',2''-terpyridin)-4'-
yl trifluoromethylsulfonate 4.7 (330 mg, 0.87 
mmol), [Pd(PPh3)4] (50 mg, 0.043 mmol) was 
degassed and placed into inert atmosphere. 
Anhydrous PhMe (60 mL) and DIPA (8.2 mL) were after added to the reaction 
mixture and the resulting mixture was heated at 80 °ɋ over 36 h (TLC control). After 
the reaction completion it was cooled down and evaporated under reduced pressure.  
The residue was dissolved in CH2Cl2, rinsed with water, brine and dried over Na2SO4. 
The solvent was evaporated at reduced pressure. The product was purified by column 
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chromatography on silica gel in two steps: 1) elution system: pentane – CH2Cl2, 9:1; 
2) elution system pentane – EtOAc, 10:1 to yield 213 mg (42%) of yellowish oil. 
Synthesis of complexes. 
General procedure for the synthesis of [Ru(R-tpy)Cl3] (Ⱥ). 
Ligand (1 mmol) and RuCl3·xH2O (Ru: 40-49%; 251 mg for 
1 mmol of ligand, 1-1.22 equiv) were suspended in ethanol 
(65 mL for 1 mmol of ligand). The mixture was refluxed 
over 3h; the flask was covered by aluminium foil to protect 
the complex from radiation. After 3h the flask was cooled 
down and the volume of solvent was reduced to 1/3 of the initial volume upon 
evaporation under reduced pressure. The residue was left in the fridge for 2 h. The 
obtained precipitate was filtrated off and was thoroughly rinsed with cold water (until 
the colorless drops of filtrate), chilled EtOH and diethyl ether. The complex was 
dried under vacuum to yield brown-black solids.  . 
[Ru(FCCT)Cl3]: 
Starting materials: (E)-4'-(2-(9,9-dihexyl-
9H-fluoren-2-yl)vinyl)-2,2':6',2''-terpyridine
FCCT (216 mg, 0.364 mmol), RuCl3·xH2O 
(Ru: 40-49%; 96 mg), EtOH (22 mL). 
Yield – 262 mg (0.327 mmol, 90%). 
[Ru(FCC3T)Cl3]: 
Starting materials: 4'-((9,9-dihexyl-9H-
fluoren-2-yl)ethynyl)-2,2':6',2''-terpyridine
FCC3T (214 mg, 0.36 mmol), RuCl3·xH2O 
(Ru: 40-49%; 91 mg), EtOH (30 mL). Yield – 169 mg (0.34 mmol, 58 %). 
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[Ru(MeO-Phtpy)Cl3]: 
Starting materials: 4'-(4-methoxyphenyl)-2,2':6',2''-
terpyridine MeO-Phtpy (250 mg, 0.74 mmol), 
RuCl3·xH2O (Ru: 40-49%; 192 mg). EtOH (48 mL) 
Yield – 335 mg (0.61 mmol, 83 %). 
General procedure for the synthesis of [Ru(R-tpy)(bpy)Cl]Cl (ȼ). 
Complex [Ru(R-tpy)Cl3] (Ⱥ) (1 equiv), 2,2'-
bipyridine (1 equiv), LiCl (6 equiv) were added to 
75% EtOH/25% H2O  mixture (92 mL for 1 mmol of 
Ⱥ), followed by Et3N (1.6 equiv) addition. The 
mixture was refluxed over 3h; the flask was covered 
with aluminium foil to protect the complex from irradiation. After the reaction 
completion an undesired precipitate was immediately filtrated off from the hot 
solution. The precipitate was washed by ethanol and the filtrate was concentrated 
under reduced pressure until 1/6 of initial volume and left in the fridge over 2 h.  The 
obtained precipitate was filtrated off and rinsed with aqueous HCl solution (3M) 
(until the colorless drops of filtrate), a small amount of chilled EtOH and diethyl 
ether. The product was dried under the vacuum to yield purple solids.  
[Ru(FCCT)(bpy)Cl]Cl: 
Starting materials: [Ru(FCCT)Cl3]
(262 mg, 0.33 mmol), 2,2'-
bipyridine (51 mg, 0.33 mmol), 
LiCl (77 mg, 1.80 mmol), Et3N (74 
μL, 0.52 mmol), 75% EtOH/25% H2O (30 mL). Yield – 208 mg (0.23 mmol, 69%). 
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[Ru(FCC3T)(bpy)Cl]Cl: 
Starting materials: [Ru(FCC3T)Cl3]
(169 mg, 0.21 mmol), 2,2'-
bipyridine (33 mg, 0.21 mmol), 
LiCl (64 mg, 1.5 mmol), Et3N (60 
μL, 0.42 mmol), 75% EtOH/25% H2O (25 mL). Yield – 162 mg (0.23 mmol, 83%). 
[Ru(MeO-Phtpy)(bpy)Cl]Cl: 
Starting materials: [Ru(MeO-Phtpy)Cl3] (335 
mg, 0.61 mmol), 2,2'-bipyridine (96 mg, 0.62 
mmol), LiCl (146 mg, 3.5 mmol), Et3N (138 
μL, 1 mmol), 75% EtOH/25% H2O (56 mL). 
Yield – 390 mg (0.23 mmol, 69%). 
General procedure for the synthesis of [Ru(R-tpy)(bpy)NO2]Cl (ɋ). 
Complex [Ru(R-tpy)(bpy)Cl]Cl (B) (1 equiv) and 
NaNO2 (10 equiv) were dissolved in 75% EtOH/25% 
H2O mixture(124 mL for 1 mmol). The mixture was 
refluxed over 3h; the flask was covered with 
aluminium foil to protect the complex from 
irradiation. After the reaction completion the flask was cooled down and the volume 
of solvent was reduced to 1/6 of the initial volume upon concentration. The residue 
was left in the fridge for 2 h. The obtained precipitate was filtrated off and rinsed 
with cold water, a small amount of cold EtOH and diethyl ether. The complex was 
dried under the vacuum to yield dark red solids.  .
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[Ru(FCCT)(bpy)NO2]Cl: 
Starting materials: 
[Ru(FCCT)(bpy)Cl]Cl (208 mg, 
0.23 mmol), NaNO2 (156 mg, 2.26 
mmol), 75% EtOH/25% H2O (28 
mL). Yield – 139 mg (0.149 mmol, 66%). 
[Ru(FCC3T)(bpy)NO2]Cl: 
Staring materials: 
[Ru(FCC3T)(bpy)Cl]Cl (162 mg, 
0.22 mmol), NaNO2 (150 mg, 2.17 
mmol), 75% EtOH/25% H2O (28 
mL). Yield – 95 mg (0.10 mmol, 46%). 
[Ru(MeO-Phtpy)(bpy)NO2]Cl: 
Starting material: [Ru(MeO-Phtpy)(bpy)Cl]Cl
(390 mg, 0.58 mmol), NaNO2 (402 mg, 5.83 
mmol), 75% EtOH/25% H2O (72 mL). Yield – 
357 mg (0.53 mmol, 90%). 
General procedure for the synthesis of [Ru(R-tpy)(bpy)NO](PF6)3 (D). 
Complex [Ru(R-tpy)(bpy)NO2]Cl (ɋ) (1 equiv) 
was dissolved in EtOH (108 mL for 1 mmol of ɋ), 
and the solution was mixed with the solution of 
HCl (12M, 108 mL for 1 mmol of ɋ, 1300 equiv) 
in EtOH (216 mL for 1 mmol of ɋ). The mixture 
was heated to 60 °ɋ and left stirring over 1 h; the flask was covered by aluminium 
foil to protect the complex from radiation. After the reaction completion the flask was 
cooled down and the volume of solvent was reduced to 1/5 of the initial volume 
followed by addition of saturated solution of NH4PF6 (15 equiv) in water. The 
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mixture was left in the fridge for 2 h. The obtained precipitate was filtrated off, rinsed 
with a small amount of cold EtOH and diethyl ether. The complex was dried under 
vacuum. 
[Ru(FCCT)(bpy)NO](PF6)3: 
Starting materials: 
[Ru(FCCT)(bpy)NO2]Cl (60 mg, 
0.064 mmol), HCl (12M, 6.9 mL, 
83.8 mmol), EtOH (21 mL). Yield 
– 53 mg (0.041 mmol, 63%). 
[Ru(FCC3T)(bpy)NO](PF6)3: 
Starting materials: 
[Ru(FCC3T)(bpy)NO2]Cl (72 mg, 
0.078 mmol), HCl (12M, 8.3 mL, 
63.2 mmol), EtOH (16 mL). Yield 
– 68 mg (0.051 mmol, 66%). 
[Ru(MeO-Phtpy)(bpy)NO](PF6)3: 
Starting materials: [Ru(MeO-
Phtpy)(bpy)Cl]Cl (390 mg, 0.58 mmol), 
NaNO2 (402 mg, 5.83 mmol), 75% EtOH/25% 
H2O (72 mL). Yield – 357 mg (0.53 mmol, 
90%). 
Procedure for the synthesis of DMAFT and DMACCT: 
7-bromo-9,9-dihexyl-N,N-dimethyl-9H-fluoren-2-amine (4.17). 
2-Bromo-9,9-dihexyl-7-nitro-9H-fluorene 4.15 (1 g, 2.18 
mmol), HCOOH (96%, 2.24 mL, 57 mmol), Et3N (6.4 mL, 
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46 mmol) and DMSO (6.5 mL) were placed in the reactor intended for conducting the 
reactions under pressure and the mixture was thoroughly degassed by Ar bubbling. 
FeCl2·4H2O (9 mg, 0.045 mmol) was then added to the reaction mixture keeping the 
inert atmosphere in the flask. The reactor was sealed and heated at 150 °ɋ over 14 h. 
Then the reactor was cooled down to room temperature. The water (20 ml) was then 
added and the misture was extracted with EtOAc, organic phases were combined, 
washed with brine, dried over Na2SO4 and filtrated off.  The solvent was evaporated 
under reduced pressure. The residue was purified by column chromatography (elution 
system: hexane – EtOAc, 40:1) to yield 0.628 g (1.37 mmol , 63%) of colorless oil.   
7-(dimethylamino)-9,9-dihexyl-9H-fluorene-2-carbaldehyde (4.18). 
Solution of 7-bromo-9,9-dihexyl-N,N-dimethyl-9H-fluoren-
2-amine 4.17 (2.487 g, 5.44 mmol) in anhydrous THF (57 
mL) was placed into inert atmosphere and cooled down to 
-78 °ɋ. The solution of n-BuLi (2.5 M, 4.84 mL, 12.1 mmol) was adeed to the 
solution dropwise and the mixture was stirred over 1 h. At this point anhydrous DMF 
(2.12 mL, 27.4 mmol) was added dropwise to the mixture and the stirring continued 
for 2 h at -78 °ɋ. The solution was then left stirring at room temperature overnight, 
then quenched with 1M solution of HCl. The mixture is extracted with EtOAc, 
organic phases were combined, washed with brine, dried over Na2SO4 and filtrated 
off. The solvent was evaporated under reduced pressure. The residue was purified by 
column chromatography (elution system: CH2Cl2 – hexane, 7:1) to yield 1.39 g (3.41 
mmol, 63%) of yellow-green fluorescent oil. 
(E)-3-(7-(dimethylamino)-9,9-dihexyl-9H-fluoren-2-yl)-1-(pyridin-2-yl)prop-2-en-1-
one (4.19). 
To the solution of 7-(dimethylamino)-9,9-dihexyl-
9H-fluorene-2-carbaldehyde 4.18 (736 mg, 1.81 
mmol) in EtOH (10 mL), 2-acetylpyridine (204 μɥ, 
1.82 mmol) and then ground KOH (155 mg, 2.77 mmol) were added. The reaction 
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was controlled by TLC. After the reaction completion (around 3 h) the mixture was 
diluted with water and extracted with EtOAc. Organic extracts were washed with 
brine and dried over Na2SO4; the solvent was evaporated under reduced pressure. The 
residue was purified by column chromatography (elution system: pentane – EtOAc, 
100:1, with gradual increase of the polarity of the system during the elution) to yield 
517 mg (1.02 mmol, 56%) of red oil. 
7-([2,2':6',2''-terpyridin]-4'-yl)-9,9-dihexyl-N,N-dimethyl-9H-fluoren-2-amine 
(DMAFT). 
1-(2-Oxo-2-(pyridin-2-yl)ethyl)pyridin-1-yl iodide 
(180 mg, 0.55 mmol) and NH4OAc (638 mg, 8.28 
mmol) were added to a solution of (E)-3-(7-
(dimethylamino)-9,9-dihexyl-9H-fluoren-2-yl)-1-
(pyridin-2-yl)prop-2-en-1-one 4.19 (247 mg, 0.49 
mmol) in MeOH (5 mL). The mixture was refluxed until the complete conversion of 
starting ketone 4.12 (TLC control). When the reaction finished the flask was cooled 
down to room temperature and the solvent was evaporated. Water was then added 
and the mixture was extracted with EtOAc. The organic phases were then combined, 
washed with brine, dried over Na2SO4 and filtrated off. The residue was purified by 
column chromatography 2 times: 1) eluent: CH2Cl2, 100%; 2) elution system: n-
hexane – EtOAc, 15:1. The obtained oil was crystallized upon recrystallization from 
hexane to yield 84 mg (0.14 mmol, 28%) of yellow powder. 
(E)-ethyl 3-(7-(dimethylamino)-9,9-dihexyl-9H-fluoren-2-yl)acrylate (4.24). 
The mixture of 7-bromo-9,9-dihexyl-N,N-dimethyl-9H-
fluoren-2-amine 4.17 (1.012 g, 2.22 mmol), Pd(OAc)2
(25 mg, 0.11 mmol), P(o-tolyl)3 (118 mg, 0.39 mmol) 
and [Pd(PPh3)4] (131 mg, 0.11 mmol) was carefully 
degassed and placed into inert atmosphere. Et3N (1.3 mL, 9.34 mmol), ethylacrylate 
(1 mL, 9.2 mmol) and anhydrous DMF (2.53 mL) were then added to the reaction 
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mixture. The suspension was heated at 90 °ɋ for 14 h upon vigorous stirring. After 
the reaction completion the flask was cooled down to room temperature, and 30 ml of 
water was added to the mixture, that was then extracted with EtOAc. The organic 
phase is then washed with brine, dried over anhydrous Na2SO4, filtrated off, and the 
solvent was evaporated under reduced pressure. The residue was purified by column 
chromatography (elution system: n-hexane – EtOAc, 20:1. Yield – 814 mg (1.71 
mmol, 77%) of bright yellow fluorescent powder. 
(E)-3-(7-(dimethylamino)-9,9-dihexyl-9H-fluoren-2-yl)acrylaldehyde (4.26). 
DIBAL-H (545 μl, 1.5 M, 0.82 mmol) was added slowly in 
a dropwise manner to the solution of (E)-ethyl 3-(7-
(dimethylamino)-9,9-dihexyl-9H-fluoren-2-yl)acrylate
4.24 (125 mg, 0.26 mmol) in anhydrous toluene (2.8 mL) in inert atmosphere at  -78 
°C. The reaction mixture was vigorously stirred until complete conversion of starting 
material (TLC control, around 4 h). Then MeOH (80 μl) was added slowly to the 
reaction mixture until complete liberation of H2 followed by quick addition of AcOEt 
(6 mL). The mixture was allowed to reach a room temperature and left at intensive 
stirring for 1.5 hour followed by filtration through celite; the filtrate was evaporated 
under reduced pressure. 
The obtained alcohol 106 mg (the spectrum is given below) was placed under 
vacuum and was introduced in the next step as fast as possible. 1,1,1-Triacetoxy-1,1-
dihydro-1,2-benziodoxol-3(1H)-one (Dess-Martin periodinane (DMP), 114 mg, 0.27 
mmol) was suspended in CH2Cl2 (2 mL) and mixed with tert-butyl alcohol (26 μl, 
0.27 mmol). The mixture was left stirring for 20 min, then the solution of obtained 
alcohol in CH2Cl2 (2 mL) was added and the stirring continued for 2h in a closed 
system. Meanwhile (after 1 h 40 min of stirring) the suspension of DMP (73 mg, 0.17 
mmol) in CH2Cl2 (1.5 mL) and tert-buthanol (16 μL, 0.17 mmol) was prepared. It 
was stirred for 20 min and after added to the reaction mixture. The final mixture was 
stirred for 2 h. After the reaction finished the solvent was evaporated under reduced 
pressure and the residue was suspended in diethyl ether followed by rinsing with 
C6H13 C6H13 O
N
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Na2S2O3 (10%) and saturated aq. solution of NaHCO3 (1:1). The organic phase was 
rinsed with water and back extracted with small quantity of diethyl ether. Organic 
layers were combined, dried over Na2SO4, and the salt was filtrated off; the solvent 
was evaporated under reduced pressure. The residue was purified by column 
chromatography (n-hexane –EtOAc, 20:1) on silica gel to yield 84 mg (1.71 mmol, 
79%) of bright red oil.  
(2E,4E)-5-(7-(dimethylamino)-9,9-dihexyl-9H-fluoren-2-yl)-1-(pyridin-2-yl)penta-
2,4-dien-1-one (4.27). 
2-Acetylpyridine (12 μɥ, 0.1 mmol) was added 
to the solution of (E)-3-(7-(dimethylamino)-9,9-
dihexyl-9H-fluoren-2-yl)acrylaldehyde 4.26 (46 
mg, 0.11 mmol)  in EtOH (0.5 mL). Ground KOH (9 mg, 0.16 mmol) was then 
added. The reaction course was controlled by TLC. After the reaction finished 
(around 3 h) the mixture was diluted with water and extracted with EtOAc. Organic 
extracts were washed with brine and dried over Na2SO4; the solvent was evaporated 
under reduced pressure. The residue was purified by column chromatography (elution 
system: pentane – EtOAc, 100:1, with gradual increase of the polarity of the system 
during the elution) to yield 35 mg (0.065 mmol, 61%) of red oil. 
(E)-7-(2-([2,2':6',2''-terpyridin]-4'-yl)vinyl)-9,9-dihexyl-N,N-dimethyl-9H-fluoren-2-
amine (DMAFCCT). 
1-(2-Oxo-2-(pyridin-2-yl)ethyl)pyridin-1-yl 
iodide (99 mg, 0.30 mmol) and NH4OAc (350 
mg, 4.54 mmol) were added to a solution of 
(2E,4E)-5-(7-(dimethylamino)-9,9-dihexyl-9H-
fluoren-2-yl)-1-(pyridin-2-yl)penta-2,4-dien-1-
one 4.27 (143 mg, 0.27 mmol) in MeOH (5 mL). The mixture was refluxed until the 
complete conversion of starting ketone 4.27 (TLC control). After the reaction 
completed the flask was cooled down to room temperature. After the solvent was 
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evaporated under reduced pressure, water was added. The mixture was then extracted 
with EtOAc, organic phases were combined, washed with brine, dried over Na2SO4
and filtrated off. The residue was purified by column chromatography 2 times: 1) 
eluent: CH2Cl2, 100%; 2) elution system: n-hexane – EtOAc, 15:1 with gradual 
increase of the polarity of the system during the elution. Yield – 52 mg (0.08 mmol, 
31%) of yellow oil. 
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GENERAL CONCLUSIONS 
1. It was shown that the introduction of 2,2'-bipyridine as a ligand into the structure of 
ruthenium-nitrosyl complexes instead of the two chloro-ligands leads to a decrease 
in the quantum yield of nitric oxide photorelease from 0.11 (trans(Cl,Cl)-
[RuII(FT)Cl2(NO)](PF6)) to 0.06, however, it leads to an increase in the TPA cross-
section from 90-100 GM to 108 GM. 
2. By means of quantum-chemical calculations it has been demonstrated that the 
introduction of azaheterotricyclic systems with a 14ʌ-electron conjugation system 
into the structure of the terpyridine ligand in the ruthenium-nitrosyl complex may 
contribute to a weak increase in the efficiency of the compounds in two-photon 
absorption (the maximum TPA cross-section obtained for the compound 1-methyl-
1H -benzo[f] indole (compound 3.3) is only 1% higher than that for the reference 
compound trans1, the TPA cross-section for which is 87GM) However, the 
replacement of fluorene with such heterocyclic analogues substantially alters the 
ability of compounds to hyperpolarization, the value of which varies depending on 
the heterocycle from 233.1·10-30 cm5·esu-1 (compound 3.12) to 2751.7 ·10-30 
cm5·esu-1 (compound 3.8 ) 
3. Preparative methods for synthess of ruthenium-nitrosyl complexes with ligands 
containing different types of linker between donor fluorenyl and withdrawing 
terpyridine fragments have been developed – [Ru(FCCT)(bpy)NO](PF6)3, 
[Ru(FCC3T)(bpy)NO](PF6)3. 
4. It was shown that the enlargement of the conjugation and its efficiency 
enhancement through the decrease of the torsion angle between the donating and 
withdrawing fragments of the complex increases the efficiency of the compound in 
two-photon absorption due to an increase of the push-pull character of the 
compound (an increase in TPA cross-section observed is 20-40%). 
5. It has been demonstrated on the series of ruthenium-nitrosyl complexes with 
substituted phenyl-terpiridines that electron donating substituents increase the 
efficiency of compounds in two-photon absorption, while withdrawing groups do 
not lead to such improvement. The maximum TPA cross-section value is observed 
182 
for the complex with the ligand 4'-(4-methoxyphenyl)-2,2':6',2''-terpyridine – 
trans(Cl,Cl)-[Ru(MeOPh-tpy)Cl2(NO)]PF6  – 154 GM. 
6. The structure of the photoproduct formed during the release of nitric oxide from the 
ruthenium-nitrosyl complex containing 4'-(4-methoxyphenyl)-2,2':6',2''- terpyridine 
and 2,2'-bipyridine has been established. It has been proved that in contrast to 
complexes with chloro-ligands instead of 2,2'-bipyridine, the oxidation state of 
ruthenium in them is +2. It was also confirmed by means of EPR spectroscopy with 
the use of spin trap that NO is released in a form of radical. 
7. It has been established that, contrary to previous notions, the irradiation of 
compounds with electromagnetic waves of the energies corresponding to the energy 
of electron density transfer from donor to ruthenium-nitrosyl fragment does not 
play a decisive role in the efficiency of the compound in the process of NO release. 
Irradiation at higher energies could result in photorelase with higher quantum 
yields. 
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Summary of thesis 
The work “Two-photon induced photorelease of nitric oxide from ruthenium-
nitrosyl complexes containing ligands with various push-pull capabilities” was 
devoted to the revealing of main factors that determine the efficiency of 
ruthenium-nitrosyl complexes in two-photon absorption (TPA) and to the 
improvement of TPA cross-section through modification of the ligands nature and 
their structure. 
Starting from complexes previously obtained by the research group of Prof. I. 
Malfant we have modified their structure in several directions. It was shown that 
substitution of monodentate ligands by 2,2'-bipyridine in ruthenium complexes 
with nitrosyl ligand leads to a slight increase of their TPA cross-section, however 
this modification decreases the quantum yield of the nitric oxide photorelease.  
Synthetic part of the work was mainly aimed at the modification of the ligand 
4'-(9H-fluoren-2-yl)-2,2':6',2''-terpyridine. The elongation and flattening of the 
conjugation path could improve the polarizability of the ligand and the “push-pull” 
character of the complex. This subsequently results in an increased efficiency of 
the compounds in TPA that was confirmed in the current work. Insertion of double 
bond between two parts of the ligand leads to the enhancement of the TPA cross-
section by 20%, whereas the triple bond appears better linker leading to 36% 
improved efficiency of complexes in TPA. Another parameter of compounds, 
sensitive to the structural modifications, is the difference in dipole moments 
between the ground and excited states of the molecules. It deserves particular 
attention whereas it enters the expression of the TPA efficiency as the criterion of 
“push-pull” character of the molecule. With the purpose of increasing this 
difference we put as a goal the synthesis of the complexes with ligands bearing 
donating dimethylamino-groups. Having optimized the methodology of ligands 
syntheses, we, however, found out that usual way of complex synthesis in this case 
has not resulted in the desired complex obtention. During the second step of the 
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ruthenium-nitrosyl compound synthesis an incorporated dimethylaminogroup 
undergoes the oxidation process with its subsequent demethylation. 
However, having obtained a series of easier accessible complexes with groups 
displaying different donating abilities, we were able to discover some tendency. 
These complexes contain phenyl rings, carrying functional groups starting from 
withdrawing nitro- to donating metoxy- and dimethylaminogroups. It was shown 
that while accepting or neutral groups didn’t show any significant influence on the 
TPA cross-sections of complexes, donating moieties increased it with the highest 
value of 154 GM observed for complex with 4'-(4-methoxyphenyl)-2,2':6',2''-
terpyridine ligand. Thus the observation has confirmed the initial hypothesis that 
increasing of the difference in dipole moments between the ground and excited 
state would lead to an enhanced efficiency of complexes in TPA. 
In the current work theoretical calculations on the basis of density functional 
theory (DFT) are widely involved. Apart from studying the ability of complexes to 
release NO under irradiation a theoretical investigation of their nonlinear optical 
properties was made. In order to improve the conjugation and the length of the ʌ-
conjugation system we have assessed the effect of the fluorenyl-fragment 
substitution by 22 different heterocyclic analogues having similar tricyclic skeleton 
and containing donating Nitrogen atom in the system. It was shown, that in spite of 
the fact that such modification doesn’t lead to a desired improvement, such 
compounds could be indeed interesting as nonlinear optical materials. 
The structure of the photoproduct and ruthenium oxidation states are 
discussed in details. In contrast to photoproducts previously observed, complexes 
having five pyridine rings in the coordination sphere of metal form Ru(II) products 
during the process of NO-photorelease, whereas the formation of NO-radical is 
confirmed by EPR-spectroscopy. 
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Résumé de these 
Ce travail intitulé «Libération du monoxyde d’azote induite par deux photons 
à partir de complexes ruthénium-nitrosyle contenant des ligands de capacités push-
pull différentes» a été consacré à l’étude des principaux facteurs qui déterminent 
l'efficacité des complexes ruthénium-nitrosyle (Ru(NO)) dans l'absorption à deux 
photons (ADP) et à l'amélioration de leur section efficace ADP par modification de 
la nature et de la structure de leurs ligands.  
A partir de complexes précédemment obtenus dans le groupe de recherche du 
Prof. I. Malfant, nous avons effectué diverses modifications structurales. Il a été 
montré que la substitution des ligands monodentes par la 2,2'-bipyridine dans les 
complexes de Ru(NO) conduit à une légère augmentation de la section efficace, 
mais cette modification diminue le rendement quantique du relargage du 
monoxyde d’azote (NO). 
La partie synthétique du travail a principalement porté sur la modification du 
ligand 4'-(9H-fluorène-2-yl)-2,2':6',2''-terpyridine. L'extension de la conjugaison 
doit améliorer la polarisabilité du ligand et le caractère «push-pull» du complexe. 
Cela entraîne une efficacité accrue des composés en ADP qui a été confirmée 
expérimentalement durant ce travail. L'insertion d'une double liaison au centre du 
système entre les fragments donneurs et accepteurs conduit à une augmentation de 
20% de la section efficace, alors que la triple liaison apporte un gain de 36% et 
apparaît comme un meilleur transmetteur. La différence des moments dipolaires 
entre les états fondamentaux et excités des molécules est un paramètre additionnel 
particulièrement sensible aux modifications structurales des composés. Il mérite 
une attention particulière car il intervient dans l’expression de l’efficacité ADP en 
apportant une quantification de l’effet «push-pull». Pour augmenter sa valeur, nous 
nous sommes fixé comme objectif la synthèse de complexes possédant des ligands 
porteurs du substituent donneur diméthylamino. Après optimisation de la synthèse 
de ces ligands, l’obtention des complexes afférents par la méthode habituelle de 
synthèse des complexes Ru(NO) a été un échec. En effet, la deuxième étape de la 
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synthèse conduit à une oxydation progressive du groupement diméthyamino avec 
déméthylation.   
L’étude d’une autre série de complexes plus accessibles avec des 
groupements donneurs  de forces diverses a permis de mettre en évidence certaines 
tendances. Ces complexes contiennent des cycles phényles, portant des groupes 
fonctionnels accepteurs (nitro-) et donneurs comme métoxy- et diméthylamino-. Il 
a été montré que, si la présence de groupes accepteurs ou neutres a peu d’effet sur 
la section efficace, la présence de donneurs conduit à une amélioration des 
propriétés avec une valeur maximale de section efficace de 154 GM observée pour 
le complexe avec le ligand 4'-(4-méthoxyphényl)-2,2':6',2'' – terpyridine. 
L’expérience confirme l'hypothèse initiale selon laquelle l'augmentation de la 
différence des moments dipolaires entre les états fondamentaux et excités des 
molécules conduirait à une efficacité ADP accrue dans ce type de molécules.  
Une large part de ce travail a impliqué des calculs théoriques effectués à 
partie de la théorie de la fonctionnelle de la densité (DFT). En marge des effets liés 
à la photo-libération de NO, les propriétés optiques non linéaires des complexes de 
Ru(NO) ont été étudiées sur le plan théorique. L’effet de la substitution du 
fragment fluorényle par 22 analogues hétérocycliques différents ayant un squelette 
tricyclique similaire et contenant un atome d'azote donneur a été évalué afin 
d'améliorer la conjugaison et d’optimiser la longueur et la forme du système ʌ-
conjugué. Il a été montré que, bien qu'une telle modification ne conduise pas à une 
amélioration notable, de tels composés pourraient être intéressants en tant que 
matériaux pour l’optique non linéaire. 
La structure du photoproduit et le degré d'oxydation du ruthénium sont 
discutés en détail. Contrairement au photoproduit précédemment étudié, les 
complexes possédant cinq cycles pyridine dans la sphère de coordination du métal 
conduisent à des complexes de Ruthénium(II) pendant le processus de photo-
libération de NO, alors que la formation de radical NO est confirmée par 
spectroscopie RPE. 
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CONTENU PRINCIPAL 
Dans l'introduction le contexte du travail est expliquée, le but et les objectifs 
de l'étude sont énoncés avec la signification des résultats obtenus. 
Le premier chapitre de la thèse est consacré à la présentation de 
l’avancement de la recherche sur le sujet de la thèse. Une attention particulière est 
accordée aux types de donneurs d'oxyde nitrique connus aujourd'hui et à ceux mis 
en œuvre dans la pratique médicale, aux particularités de leur structure et aux 
conditions dans lesquelles le processus de libération de NO peut être observé. Les 
particularités de la structure des complexes ruthénium-nitrosyle sont examinées en 
détail. Les dernières avancées dans la chimie des complexes ruthénium-nitrosyle 
sont également mises en évidence. En particulier, les mécanismes théoriques par 
lesquels le processus de libération de NO peut se produire sont présentés en détail. 
Le second chapitre du travail est principalement axé sur les effets sur les 
propriétés des complexes ruthénium-nitrosyle provoqués par la substitution de 
deux ligands monodentés dans la sphère de coordination du ruthénium, à savoir 
deux atomes de chlore, avec la molécule de 2,2'-bipyridine (bpy). Le ligand 
principal restant inchangé était le 4'-(9H-fluorén-2-yl)-2,2': 6', 2''- terpyridine (FT). 
Ainsi, les objets de l'étude étaient cis(Cl,Cl)- RuII(FT)Cl2(NO)](PF6) (1a),
trans(Cl,Cl)-RuII(FT)Cl2(NO)](PF6) (1b) et [RuII(FT)(bpy)(NO)](PF6)3 (1c) 
(Figure 1). 
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Figure 1. La structure des cations des complexes cis(Cl,Cl)-
RuII(FT)Cl2(NO)](PF6) (1a), trans(Cl,Cl)-RuII(FT)Cl2(NO)](PF6) (1b) et 
[RuII(FT)(bpy)(NO)](PF6)3 (1c). 
Les spectres électroniques des solutions d'acétonitrile des trois composés sont 
présentés sur la figure 2. La bande d'absorption principale B est à la limite de la 
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région spectrale visible, mais pour le composé 1c, on observe un décalage 
bathochrome de cette bande par rapport aux complexes contenant des ligands 
chloro. Dans ce cas, le coefficient d'extinction molaire de la bande B du composé 
1c est légèrement inférieur.
Figure 2. Spectres électroniques des 
solutions des complexes 1ɚ, 1b, 1c dans 
CH3CN. 
Figure 3. Visualisation de HOMO et 
LUMO pour les composés 1a, 1b, 1c.
Une analyse détaillée des transitions électroniques responsables de 
l’apparition de la bande B dans les spectres montre que pour les trois composés les 
transitions les plus intenses sont essentiellement celles ayant la configuration 
HOMO-LUMO avec une certaine contribution de la transition HOMO-LUMO+2. 
La HOMO se concentre principalement sur le fragment fluorényle, qui est un 
substituant donneur dans les complexes, tandis que la principale contribution pour 
la LUMO est le fragment ruthénium-nitrosyle, dans lequel l'interaction dRu-ʌ*(NO) 
a un caractère antiliant (figure 3). C'est pourquoi le transfert de densité 
électronique vers la LUMO entraîne une diminution de la constante de force de la 
liaison Ru-N et déclenche la libération de NO. 
Les rendements quantiques de photolibération de l’oxyde nitrique des trois 
composés sous irradiation à une longueur d’onde de 405 nm donnent 0.31 (1a), 
0.11 (1b) et 0.06 (1c). Le composé 1c présente un rendement quantique légèrement 
inférieur par rapport au composé 1b. Les rendements quantiques pour 1b et 1c sont 
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assez similaires et diffèrent donc significativement du rendement quantique du 
composé 1a, bien que formellement, en termes de structure des composés, 1c
ressemble davantage à 1a. Les valeurs des rendements quantiques de libération de 
NO dépendent de la nature du ligand en position trans par rapport au nitrosyle: la 
présence du cycle pyridine en trans du NO au lieu du ligand chloro entraîne une 
diminution du rendement quantique. 
Les composés ont été étudiés pour leur capacité à absorber deux photons 
(ADP) par la méthode de z-scan. Dans cette approche pour la détemrination de la 
section efficace d’ADP (σ), une solubilité élevée des composés est requise. Cette 
condition a été remplie en introduisant des substituants n-hexyle en position 9 du 
fragment fluorényle. Les complexes résultants sont respectivement 1a', 1b' et 1c'. 
Des courbes de transmission typiques pour un rayonnement laser d'une longueur 
d'onde de 800 nm (utilisé pour activer les complexes de ruthénium-nitrosyle) pour 
des solutions de complexes d'acétonitrile sont présentées (Figure 4). 
1ɚ' 1b' 1c' 
Figure 4. Courbes de transmission d’irradiation laser pour les composés 
1a',1b'et 1c'. 
Les sections efficaces obtenues sont de 100 GM (1a'), 87 GM (1b') et 108 
GM (1c'). Compte tenu de l’erreur de mesure, on peut dire que les valeurs 
obtenues sont du même ordre et voisines de 100 GM, avec une tendance à 
l’augmentation de l’efficacité d’ADP dans la série 1a'<1b'<1c'. Nous avons 
également effectué mesuré les propriétés d’ADP du composé 1c' à la longueur 
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d'onde Ȝ = 900 nm. Cependant, il n'y avait pas de changement significatif dans la 
valeur de ı. Lorsque l'on change la longueur d'onde à 900 nm, soit presque deux 
fois la longueur d'onde du maximum d'absorption pour le composé 1c, la valeur de 
ı est de 89 ± 20 GM. 
Le troisième chapitre de la thèse est consacré à l’étude théorique de l’effet 
de la substitution du fragment fluorényle par des analogues hétérocycliques, 
représentés par des systèmes condensés tricycliques, en particulier le pyrido[2,1- 
a]isoindole et hétérocycles isomères. Au total, 22 complexes ont été analysés ; 
leurs fragments hétérocycliques sont indiqués dans le tableau 1. 
Les systèmes tricycliques contenant un atome d'azote ont été séparés du 
noyau de terpyridine par une double liaison afin de réduire la gêne stérique des 
atomes d'hydrogène des deux parties du ligand qui ont conduit à la conformation 
plane du ligand. Tous les complexes ont été classés selon l’emplacement du cycle à 
cinq atomes dans un hétérocycle: 6-6-5 (si le cycle à 5 atomes est situé sur le côté), 
6-5-6 (si le cycle à 5 atomes est entre les deux cycles à 6 atomes). 
L'idée de remplacer le fragment fluorényle est liée au fait qu'une telle modification 
peut potentiellement conduire à des valeurs de sections efficaces plus élevées. On 
sait que le pyrido[2,1-a]isoindole est un hétérocycle donneur avec un système de 
conjugaison de 14 électrons ʌ. Le fluorène est capable de fournir uniquement 10 
électrons ʌ. Le paramètre ı est un analogue du coefficient d’extinction molaire 
pour l’absorption à un photon et dépend des caractéristiques structurales de la 
molécule. Les principaux paramètres déterminant son ampleur sont notamment la 
longueur et l'efficacité de la conjugaison et la différence entre les moments 
dipolaires des états électroniques principal et excité des molécules. 
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Tableau 1. Les complexes isomères ruthénium-nitrosyle avec des substituants 
tricycliques donneurs: 6-6-5 (2-12) et 6-5-6 (13-23) et le composé de référence Ⱥ'.
Étant donné que le doublet non liant de l'atome d'azote dans la molécule de 
pyrido[2,1-a]isoindole est fortement conjugué au système ʌ de la molécule, il est 
intéressant d'utiliser un tel hétérocycle en tant que fragment donneur dans le 
complexe. L'augmentation de la capacité donneur de l'hétérocycle augmentera 
l'efficacité du transfert de densité électronique au LUMO et conduira à une 
modification plus significative du moment dipolaire lors de l'irradiation. 
Outre la capacité des complexes étudiés à participer au processus d’ADP, leur 
hyperpolarisabilité a également été analysée. Ceci est une caractéristique 
importante des matériaux optiques non linéaires. 
Les valeurs calculées de l'hyperpolarisabilité (ȕ) des composés varient 
largement - de 233·10-30 à 2751·10-30 cm5·esu-1. Les valeurs les plus élevées 
observées pour les composés 7 (2710·10-30 cm5·esu-1) et 9 (2752·10-30 cm5·esu-1) 
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dépassent les limites classiques rencontrées pour ces composés. Bien que ces 
valeurs soient théoriquement possibles, elles nécessitent des analyses et des 
recherches supplémentaires. L'explication possible des valeurs de ȕ observées 
pourrait être la suivante: plus le chemin de conjugaison est court, plus 
l'hyperpolarisabilité est grande. En d'autres termes, les composés les plus efficaces 
sont ceux dans lesquels les 14 électrons ʌ sont nécessairement impliqués dans la 
voie de la délocalisation. Ceci est illustré par la figure 5 pour les complexes 11 (ȕ = 
1130·10-30 cm5·esu-1) et 12 (ȕ = 732·10-30 cm5·esu-1), qui contiennent le même 
substituant isomère R et le fragment accepteur (A), mais qui diffèrent par la 
position de la substitution. Alors que la seule voie de délocalisation implique les 14 
électrons ʌ dans 11, une conjugaison plus courte apparaît dans 12 dans laquelle 
seuls 10 électrons ʌ contribuent à la mésomérie (bas de la figure 5), sans impliquer 
de doubles liaisons du cycle pyridine latéral. Il est probable que la présence du 
chemin de conjugaison plus court explique la diminution de l’hyperpolarisabilité 
du composé. 
L'augmentation de ȕ devrait entraîner une augmentation de l'effet push-pull 
vers le fragment accepteur {Ru-NO}. En raison de cet effet, la densité électronique 
sur l’orbitale antiliante ʌ* du ligand nitrosyle devrait augmenter, ce qui se 
traduirait par un affaiblissement de la constante de force de la liaison N-O et une 
diminution de sa fréquence de vibration de valence. La relation entre ȕ et la 
fréquence de vibration de valence de NO est illustrée (Figure 6). Les valeurs 
calculées des fréquences Ȟ(NO) sont très légèrement différentes des valeurs 
expérimentales pour ces composés et sont tout à fait fiables. 
Cela devrait normalement conduire à une augmentation du transfert 
d'électrons vers une orbitale ʌ* antiliante du ligand nitrosyle, avec pour 
conséquence une augmentation de la densité électronique (population de           
Mulliken) sur NO et une diminution de la fréquence d'étirement de Ȟ (NO) (Figure 
6). 
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Les propriétés d’ADP des complexes ont été évaluées à l'aide d'un modèle à 
deux niveaux, qui peut être appliqué à des systèmes présentant un fort caractère 
push-pull. L'analyse des résultats montre que, malgré l'augmentation du caractère 
donneur des substituants hétérocycliques, leur introduction dans les complexes 
ruthénium-nitrosyle n'augmente pas la capacité de cette dernière à absorber deux 
photons par rapport au complexe de référence A'. 
Le quatrième chapitre de la thèse décrit les résultats des expériences menées 
dans le but d’accroître l'efficacité des composés en absorption à deux photons. 
L'augmentation de l'efficacité de la conjugaison et de la longueur de la chaîne de 
conjugaison ʌ est l'un des moyens d’améliorer les propriétés d’ADP du composé.
L'introduction d'une liaison multiple entre la terpyridine et les fragments fluorényle 
pourrait conférer une meilleure capacité de polarisation du système ʌ du ligand, 
conduisant ainsi à des valeurs plus élevées de ı. Par conséquent, l'un des objectifs 
Figure 5. Structures de résonance du 
substituant hétérocyclique cyclopenta[b] 
quinolizine dans les complexes 11 et 12, 
où le groupe de retrait A est situé 
respectivement aux positions 6 et 4
Figure 6.  Les valeurs de 
l'hyperpolarisabilité  en relation avec 
la fréquence des vibrations de valence 
Ȟ(NO). Les valeurs pour les composés 
7 et 9 sont exclues lors du calcul de la 
ligne de tendance. 
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du travail a été de synthétiser des ligands terpyridine avec des liaisons multiples et 
d’obtenir les complexes ruthénium-nitrosyle correspondants (Figure 7). 
24ɚ 24b 
Figure 7. Les structures des complexes Ru(FCCT)(bpy)NO](PF6)3 (24a) et 
[Ru(FCC3T)(bpy)NO](PF6)3 (24b). 
Le ligand comprenant la double liaison FCCT a été obtenu par synthèse 
linéaire en 6 étapes avec un rendement total de 11% (schéma 1). 
Le 1- (2-oxo-2- (pyridine-2-yl) éthyl)pyridine-1-iodure de sel de Krönke a été 
préparé par le procédé de réaction Ortoleva-King, selon lequel la 2-acétylpyridine 
interagit avec une solution d’iode en pyridine. (Schéma 2). 
Schéma 1. La synthèse du ligand FCCT. 
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Schéma 2. La synthèse du 1-(2-oxo-2-(pyridin-2-
yl) éthyl)pyridine-1-iodure. 
Le ligand avec triple liaison FCC3T a été obtenu par synthèse convergente en 
7 étapes. Le rendement total de synthèse était de 4.6%. Dans ce cas, la synthèse du 
noyau terpyridine a été effectuée séparément (Schéma 3). 
Schéma 3. Synthèse du trifluorométhanesulfonate de [2,2':6',2''-terpyridine]-4'-yle 
(32). 
L'introduction de substituants n-hexyle en position 9 de fluorényle a été 
effectuée en utilisant comme agent d'alkylation n-C6H13Br, en présence de KOH 
solide dans DMSO. Dans ce cas, KI a joué un rôle de catalyseur. Le rendement 
d'alkylation est 100% (schéma 1 – la première étape de la synthèse). 
Schéma 4. La synthèse du ligand FCC3T. 
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La réaction de couplage de Sonogashira a été réalisée avec un rendement 
approprié de 42% dans une solution de toluène (Schéma 4). 
La synthèse des complexes ruthénium-nitrosyle a été réalisée en 4 étapes 
selon le schéma 5. 
Schéma 5. Schéma général de synthèse de complexes ruthénium-nitrosyle avec 
des ligands de terpyridine et la molécule de ligand de 2,2'-bipyridine. 
Une étude de la libération d'oxyde nitrique à partir des complexes résultants 
[Ru(FCCT)(bpy)NO](PF6)3 (24a) et [Ru(FCC3T)(bpy)NO](PF6)3 (24b) est 
apparue lorsque les composés ont été irradiés avec la lumière de longueur d'onde 
de 436 nm. La réaction a été contrôlée par spectroscopie électronique. Les 
changements des spectres électroniques des solutions d'acétonitrile de composés au 
cours de l'irradiation sont illustrés à la figure 8.  
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Figure 8. Evolutions des spectres électroniques des composés 
[Ru(FCCT)(bpy)(NO)](PF6)3 (gauche) et [Ru(FCC3T)(bpy)(NO)](PF6)3 (droite) 
dans l’acétonitrile Ȝ = 436 nm. 
Le rendement quantique de la réaction de libération d'oxyde nitrique est de 
0.03 et est identique pour les deux composés. L'introduction d'une liaison multiple 
entre le groupe donneur et le fragment terpyridine-ruthénium-nitrosyle en retrait 
dans le ligand organique réduit la gêne stérique entre eux et aplatit le ligand. Cela 
entraîne une interaction plus efficace des systèmes ʌ des deux parties du ligand et 
facilite le processus de transfert de charge intramoléculaire. Cet effet se retrouve 
dans le décalage bathochrome des transitions électroniques à faible énergie et dans 
l’augmentation de leur efficacité dans l’absorption à deux photons. Le composé 
24a (ı = 131 GM) a une capacité légèrement inférieure à absorber deux photons de 
longueur d'onde de 800 nm par rapport au complexe 24b. L'introduction de la 
triple liaison entraîne en général une augmentation de la section efficace 
d'absorption de 40% (pour le composé 24b ı = 150 GM), alors que la double 
liaison améliore ı de seulement 21%. Cette différence peut être expliquée par la 
configuration des transitions électroniques des deux composés, à savoir: aucune 
des transitions électroniques dans l'ion moléculaire [Ru(FCCT)(bpy)(NO)]3+ par 
nature ne correspond au transfert de la densité électronique du fluorène vers le 
fragment {RuNO}, il n'y a donc aucune possibilité de transition intense avec un 
changement significatif du moment dipolaire de la molécule. 
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Etant donné la difficulté d'obtention des fluorényl-terpyridines substituées, 
nous avons synthétisé une série de complexes ruthénium-nitrosyle contenant des 
phénylterpyridines en tant que ligands. Dans ces composés, la position 4 du cycle 
benzénique est substituée par divers groupes: -NO2, -H, -Br, -OMe, -NEt2. Ces 
complexes sont analogues aux composés 1a et 1b. 
Il a été montré que l'introduction de substituants donneurs (en particulier le 
méthoxyle et le diméthylamino) augmente l'efficacité des composés dans 
l'absorption à deux photons, tandis que des groupes accepteurs n’entraînent pas 
une telle amélioration. La plus grande valeur a été observée pour le complexe trans 
(Cl,Cl)-[Ru(MeOPh-tpy)Cl2NO]PF6, où MeOPh-tpy – 4'-(4-méthoxyphényl)-
2,2':6',2''-terpyridine. 
Dans le cinquième chapitre, certains aspects de la libération d'oxyde nitrique 
à partir de complexes ruthénium-nitrosyle avec leur activation à un photon sont 
examinés en détails. Il a été montré que l'irradiation des complexes ruthénium-
nitrosyle à des longueurs d'onde correspondant, selon les calculs de chimie 
quantique, à l'énergie de transfert le plus efficace de la densité électronique du 
donneur au fragment ruthénium-nitrosyle (généralement la transition HOMO-
LUMO) conduit à la libération de monoxyde d'azote avec un rendement quantique 
inférieur à celui obtenu par un processus de photoactivation aux énergies 
supérieures. Cela contredit l'idée précédente selon laquelle une augmentation du 
caractère donneur des substituants dans les ligands de la terpyridine devrait 
conduire à une augmentation des rendements quantiques de la libération de NO en 
raison de la population plus efficace de l'orbitale antiliante située sur la liaison Ru-
N. 
Une attention particulière est également accordée à la question de l'état 
d'oxydation du ruthénium dans les photoproduits. L’atome de ruthénium du 
photoproduit, contrairement à l’état d’oxydation habituel +3, se trouve dans l’état 
d’oxydation +2 à la suite de la libération de NO des complexes, dans lesquels les 
ligands sont représentés par la terpyridine et la 2,2'-bipyridine. La confirmation de 
ce résultat a été faite par plusieurs observations. Premièrement, l’évolution de la 
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photoréaction suivie par RMN, a montré que la solution de photoproduit ne 
contient pas d'espèces paramagnétiques. Deuxièmement, l’étude par diffraction des 
rayons X de monocristaux du complexe photoproduit a été réalisée. Deux anions 
de nitrate ont joué un rôle de contre-ion dans ce cas. Les structures du complexe 
ruthénium-nitrosyle initial et du photoproduit sont présentées à la figure 9. 
ɚ ɛ
Figure 9. Les structures du complexe initial [RuII(MeO-Phtpy)(bpy)(NO)](PF6)3
(ɚ) et du photoproduit correspondant [RuII(MeO-Phtpy)(bpy)(CH3CN)](NO3)2 (b). 
La seule source possible d'anions nitrate dans le complexe peut être l'oxyde 
nitrique libéré. La présence de ces deux ions dans la structure cristalline du 
composé indique que pendant ou après la réaction, le monoxyde d'azote libéré est 
oxydé par l'oxygène ou par le complexe de ruthénium(III) qui est rapidement 
réduit en ruthénium(II). L'oxydation du monoxyde d'azote s'accompagne de la 
formation d'autres espèces contenant de l’azote à des états d'oxydation plus élevés 
qui, en présence d'eau (dans une solution non déshydratée), augmentent l'acidité de 
la solution. Un tel effet peut être observé dans une série de spectres RMN obtenus 
lors de l’étude de la libération de NO par le complexe initial. Le pic correspondant 
aux protons d'eau (į = 2,13 ppm, 0 min) est décalé vers le champ faible lorsque 
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NO est libéré (į = 6,85 ppm, 155 min), ce qui se traduit par une diminution du pH 
de la solution (Figure 10). 
Figure 10. Suivi RMN de la libération de NOǜ par [RuII(MeO-
Phtpy)(bpy)(NO)](PF6)3 irradié avec une lumière continue dans la plage de 350-
450 nm, dans CD3CN. 
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CONCLUSIONS 
1. Il a été montré que l’introduction de la 2,2'-bipyridine en tant que ligand dans 
la structure des complexes ruthénium-nitrosyle à la place des deux ligands 
chloro entraîne une diminution du rendement quantique de la photolibération 
de l’oxyde nitrique de 0.11 (trans Cl,Cl)-[RuII(FT)Cl2(NO)](PF6)) à 0.06. 
Cependant, cela entraîne une augmentation de la section efficace d’ADP de 
90 à 100 GM à 108 GM.  
2. Par des calculs de chimie quantique, il a été démontré que l’introduction de 
systèmes azahétérotricycliques avec un système de conjugaison des électrons 
14ʌ dans la structure du ligand terpyridine dans le complexe ruthénium-
nitrosyle peut contribuer à une faible augmentation de l’efficacité du composé 
en absorption à deux photons (la section efficace maximale d’ADP obtenue 
pour le composé 1-méthyl-1H -benzo[f]indole (composé 4) est seulement 
supérieure de 1% à celle du composé de référence trans1, pour lequel la 
section efficace est de 87 GM. Cependant, le remplacement du fluorène par 
de tels analogues hétérocycliques modifie sensiblement l'aptitude des 
composés à l'hyperpolarisation, dont la valeur varie en fonction de 
l'hétérocycle de 233.1·10-30 cm5·esu-1 (composé 13) à 2751,7·10-30 cm5·esu-1
(composé 9). 
3. Des méthodes de préparation pour la synthèse de complexes ruthénium-
nitrosyle avec des ligands contenant différents types de d’espaceur entre le 
fluorényle donneur et des fragments de terpyridine ont été développées – 
[Ru(FCCT)(bpy)NO](PF6)3, [Ru(FCC3T)(bpy)NO](PF6)3. 
4. Il a été montré que l’augmentation de la conjugaison et l’amélioration de son 
efficacité par la diminution de l’angle de torsion entre les fragments donneurs 
et accepteurs du complexe améliorent les propriétés d’absorption à deux 
photons du complexe (une augmentation de la section efficace d’ADP 
observée est de 20 à 40%). 
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5. Il a été démontré sur les séries de complexes ruthénium-nitrosyle avec des 
phényl-terpiridines substituées que les substituants donneurs d'électrons 
augmentent l'efficacité des composés en absorption à deux photons, tandis 
que les groupes accepteurs ne permettent pas une telle amélioration. La valeur 
maximale de la section efficace d’ADP est observée pour le complexe 
contenant le ligand 4'-(4-méthoxyphényl)-2,2':6',2''-terpyridine – trans(Cl,Cl)-
[Ru(MeOPh-tpy)Cl2(NO)]PF6 - 154 GM. 
6. La structure du photoproduit formé lors de la libération d'oxyde nitrique du 
complexe ruthénium-nitrosyle contenant du 4'-(4-méthoxyphényl)-2,2':6',2''- 
terpyridine et de la 2,2'-bipyridine a été établie. Il a été prouvé que 
contrairement aux complexes avec des chloro-ligands au lieu de la 2,2'-
bipyridine, l'état d'oxydation du ruthénium chez eux est +2. Il a également été 
confirmé au moyen de la spectroscopie RPE en utilisant un piège à spin que 
NO est libéré sous forme de radical. 
7. Il a été établi que, contrairement aux idées précédentes, l'irradiation de 
composés à des énergies permettant le transfert de densité électronique d'un 
fragment donneur à un fragment ruthénium-nitrosyle ne joue pas un rôle 
décisif dans l'efficacité de la photolibération de NO par le composé. Une 
irradiation à des énergies plus élevées pourrait entraîner une photolibération 
avec des rendements quantiques plus élevés. 
